Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease .

Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease

Номер патента: WO2004043916A1
Опубликовано: 27-05-2004
Автор(ы): Craig A. Coburn, Joseph P. Vacca, Shawn J. Stachel
Принадлежит: Merck & Co., Inc.
Получить PDF файл: Открыть в новом окне

Рисунок 1. Взаимосвязь патентов (ближайшие 20).

Methods for the prevention or treatment of vascular hemorrhaging and Alzheimer's disease

Номер патента: US5589154A. Автор: Stephen Anderson. Владелец: Rutgers State University of New Jersey. Дата публикации: 1996-12-31.

A medication for the prevention or treatment of preclinical or clinical Alzheimer's disease

Номер патента: CZ2008595A3. Автор: Naoya Tsurushita,Maximiliano Vasquez,David M. Holtzman,Ronald Demattos,Kelly R. Bales,Steven M. Paul. Владелец: ELI LILLY AND COMPANY. Дата публикации: 2017-05-03.

Methods for the prevention or treatment of vascular hemorrhaging and alzheimer's disease

Номер патента: EP0792156A1. Автор: Stephen Anderson. Владелец: Rutgers State University of New Jersey. Дата публикации: 1997-09-03.

Alpha-(N-sulphonamido)acetamide derivatives as beta-amyloid inhibitors used for treating Alzheimer's Disease and Down's syndrome

Номер патента: NZ533603A. Автор: John E Macor,Lawrence R Marcin,Joanne J Bronson,Yonghua Gai,Carl P Bergstrom,Michael F Parker,Katharine E Mcelhone,Robert A Mate. Владелец: Bristol Myers Squibb Co. Дата публикации: 2007-02-23.

Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3

Номер патента: EP1458394A1. Автор: Philip Edwards,Stefan Berg,Sven Hellberg,Ratan Bhat. Владелец: AstraZeneca AB. Дата публикации: 2004-09-22.

Use of Oxindole Derivatives in the Treatment of Dementia Related Diseases, Alzheimer's Disease and Conditions Associated with Glycogen Synthase Kinase-3

Номер патента: US20090312322A1. Автор: Philip Edwards,Stefan Berg,Sven Hellberg,Ratan Bhat. Владелец: AstraZeneca AB. Дата публикации: 2009-12-17.

Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3

Номер патента: EP1458394B1. Автор: Philip Edwards,Stefan Berg,Sven Hellberg,Ratan Bhat. Владелец: AstraZeneca AB. Дата публикации: 2008-10-22.

Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3

Номер патента: EP1458711A1. Автор: Stefan Berg,Sven Hellberg,Ratan Bhat,Philip AstraZeneca Wilmington EDWARDS. Владелец: AstraZeneca AB. Дата публикации: 2004-09-22.

Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease

Номер патента: US09505739B2. Автор: Craig A. Coburn,Hao Wu,Shawn J. Stachel,Thomas G. Steele. Владелец: Merck Sharp and Dohme LLC. Дата публикации: 2016-11-29.

Compounds for treatment of alzheimer's disease

Номер патента: EP2349308A1. Автор: Arun K. Ghosh. Владелец: PURDUE RESEARCH FOUNDATION. Дата публикации: 2011-08-03.

Dual inhibitor compounds for use in the treatment of neurodegenerative disorders and alzheimer's disease

Номер патента: US09975861B2. Автор: Rita Scarpelli,Maria Laura Bolognesi,Andrea Cavalli,Giovanni Bottegoni,Daniela Pizzirani,Federica PRATI,Angelo Danilo Favia. Владелец: Universita di Bologna. Дата публикации: 2018-05-22.

Compounds and methods for the treatment of alzheimer's disease and/or cerebral amyloid angiopathy

Номер патента: US09994589B2. Автор: Robert Boyd. Владелец: Amicus Therapeutics Inc. Дата публикации: 2018-06-12.

Novel compounds and methods for the treatment of alzheimer's disease and/or cerebral amyloid angiopathy

Номер патента: CA3008266A1. Автор: Robert Boyd. Владелец: Amicus Therapeutics Inc. Дата публикации: 2017-06-22.

3-(5-isoxazolyl)-1-methyl-1,2,3,6-tetrahydropyridine useful for treating Alzheimer's disease

Номер патента: US5356912A. Автор: Per Sauerberg,Frank Watjen,Preben H. Olesen,Jens W. Kindtler,Lone Nielsen. Владелец: Novo Nordisk AS. Дата публикации: 1994-10-18.

Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease

Номер патента: US7291454B2. Автор: Jack R Wands,Suzanne De La Monte. Владелец: General Hospital Corp. Дата публикации: 2007-11-06.

Methods for the treatment and diagnosis of alzheimer's disease and traumatic brain injuries

Номер патента: EP3307392A1. Автор: Thierry Leveillard,José-Alain Sahel,Hawa Camara. Владелец: Universite Pierre et Marie Curie Paris 6. Дата публикации: 2018-04-18.

Methods for the treatment and diagnosis of Alzheimer's disease and traumatic brain injuries

Номер патента: US10857239B2. Автор: Thierry Leveillard,José-Alain Sahel,Hawa Camara. Владелец: Universite Pierre et Marie Curie Paris 6. Дата публикации: 2020-12-08.

Methods for the Treatment and Diagnosis of Alzheimer's Disease and Traumatic Brain Injuries

Номер патента: US20210069346A1. Автор: Thierry Leveillard,José-Alain Sahel,Hawa Camara. Владелец: Universite Pierre et Marie Curie Paris 6. Дата публикации: 2021-03-11.

Compositions and uses thereof for the treatment or prevention of alzheimer's disease

Номер патента: WO2013020723A1. Автор: Remi Palmantier,Daniel Larocque,Pascale Tribout-Jover. Владелец: GLAXOSMITHKLINE BIOLOGICALS S.A.. Дата публикации: 2013-02-14.

Pharmaceutical agents for the treatment of alzheimer's disease

Номер патента: CA2217513C. Автор: Joseph G. Lombardino,Leland D. Loose,Ethan S. Weiner. Владелец: Pfizer Ltd. Дата публикации: 2002-02-05.

Compounds for alzheimer's disease

Номер патента: WO2006041874A3. Автор: Mark B Anderson,Yevgeniya Klimova,Kenton Zavitz,Jon Adam Willardsen,Warren S Weiner,Rachel Slade,Ruth J Walton,Robert J Halter,Ashantai J Yungai. Владелец: Ashantai J Yungai. Дата публикации: 2007-01-25.

Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of Alzheimer's disease and dementia

Номер патента: JP2001500165A. Автор: エイチ．グレイグ，ニゲル,ユー，キアン―シェン,ブロッシ，アーノルド,ティー．ソンクラント，ティモシー,ホースマン，マービン. Владелец: ナショナルインスティテュートオブヘルス. Дата публикации: 2001-01-09.

Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias

Номер патента: US6410747B1. Автор: Nigel H. Greig,Qian-Sheng Yu,Arnold Brossi,Marvin Hausman,Timothy T. Soncrant. Владелец: US Department of Health and Human Services. Дата публикации: 2002-06-25.

Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias

Номер патента: EP0949920A1. Автор: Nigel H. Greig,Qian-Sheng Yu,Arnold Brossi,Marvin Hausman,Timothy T. Soncrant. Владелец: Axonyx Inc. Дата публикации: 1999-10-20.

New compounds for the treatment of alzheimer's disease

Номер патента: US20240327427A1. Автор: Jian Jin,Bin Zhang,Aiqun Li,Eric E. Schadt,Minghui Wang,Zhenyu Yue,Lap Ho,Lihuai QIN,Vahram HAROUTUNIAN,Xianxiao ZHOU,Husnu Umit KANISKAN,Kristen J. BRENNAND. Владелец: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. Дата публикации: 2024-10-03.

(hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease

Номер патента: WO2004094384A2. Автор: VARGHESE John,Ruth Tenbrink,Roy Hom,Shon Pulley,Jose Aquino,John A. Tucker. Владелец: Pharmacia & Upjohn Company LLC. Дата публикации: 2004-11-04.

Terphenyl derivatives for treatment of alzheimer' s disease

Номер патента: CA2649845C. Автор: Yan Zhang,Francis Wilson,Andrew Cansfield,Svenja Burckhardt,Jess Taylor,Mihiro Sunose,Valerie Reader,Chih Yung Ho,Jeremy Major,Richard John Harrison,Alison Reid,Kathryn Smelt,Cyrille Boussard,Remedios Hernadez-Perni,Adeline Leformal. Владелец: Ortho McNeil Janssen Pharmaceuticals Inc. Дата публикации: 2014-09-16.

Compounds to treat alzheimer's disease

Номер патента: NZ547529A. Автор: . Владелец: Pharmacia & Upjohn Co Llc. Дата публикации: 2008-04-30.

Furosemide analogues and compositions and uses thereof for treatment of alzheimer's disease

Номер патента: US20220259167A1. Автор: Zhiyu Wang,Donald Fredric WEAVER,Lisa DOYLE,Laura VILLAR,Prachi S. VILEKAR. Владелец: UNIVERSITY HEALTH NETWORK. Дата публикации: 2022-08-18.

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease

Номер патента: US20090069432A1. Автор: Gerardo M. Castillo,Alan D. Snow,Beth P. Nguyen,Lesley Larsen,Stephen D. Lorimer,Virginia J. Sanders,Thomas P. Lake,Rex T. Weavers,David S. Larsen,David L. Coffen,Chrlotte Coffen. Владелец: ProteoTech Inc. Дата публикации: 2009-03-12.

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease

Номер патента: CA2486869C. Автор: Gerardo M. Castillo,Alan D. Snow,Beth P. Nguyen,Lesley Larsen,Stephen D. Lorimer,Virginia J. Sanders,Thomas P. Lake,Rex T. Weavers,David S. Larsen,David L. Coffen (Deceased). Владелец: ProteoTech Inc. Дата публикации: 2011-09-13.

Compounds to treat Alzheimer's disease

Номер патента: US20030013881A1. Автор: VARGHESE John,Andrea Gailunas,Roy Hom,Shumeye Mamo,Jay Tung,Lawrence Fang. Владелец: Elan Pharmaceuticals LLC. Дата публикации: 2003-01-16.

Therapeutic preparation and preventive preparation for treating alzheimer's disease

Номер патента: RU2560171C2. Автор: Каору НАКАО,Наохиро ЯМАДА,Йохей МИЯМОТО. Владелец: Торэй Индастриз, Инк.. Дата публикации: 2015-08-20.

3,4-methylenedioxyphenylimidazolylethanonexime ether derivative, preparation method and use thereof, and drug for the treatment of Alzheimer's disease

Номер патента: US11680062B2. Автор: Ping Xiang,Jinming Gao,Bo REN,Jiangjiang Tang,Zhaoyuan Bian,Lanfang Huang. Владелец: NORTHWEST A&F UNIVERSITY. Дата публикации: 2023-06-20.

3,4-methylenedioxyphenylimidazolylethanonexime ether derivative, preparation method and use thereof, and drug for the treatment of alzheimer's disease

Номер патента: US20230159503A1. Автор: Ping Xiang,Jinming Gao,Bo REN,Jiangjiang Tang,Zhaoyuan Bian,Lanfang Huang. Владелец: NORTHWEST A&F UNIVERSITY. Дата публикации: 2023-05-25.

7-phenoxy-n-(3-azabicyclo[3.2.1]octan-8-yl)-6,7-dihydro-5h-pyrrolo[1,2-b][1,2,4]triazol-2-amine derivatives and related compounds as gamma-secretase modulators for the treatment of alzheimer's disease

Номер патента: EP3894411A1. Автор: Hasane Ratni,Beat Frei. Владелец: F Hoffmann La Roche AG. Дата публикации: 2021-10-20.

Beta-secretase inhibitors

Номер патента: RU2712272C2. Автор: Йенс-Уве Петерс,Вольфганг ХААП,Вольфганг ГУБА,ЗАНДЕР Ульрике ОБСТ,Томас Вольтеринг,Бьёрн Бартелс,Козимо Доленте. Владелец: Ф. Хоффманн-Ля Рош Аг. Дата публикации: 2020-01-28.

Malonamide derivatives as gamma-secretase inhibitors for treatment of alzheimer's disease

Номер патента: RU2402538C2. Автор: Александр Флор,Вольфганг ВОСТЛЬ,Роланд ЯКОБ-РОЭТНЕ. Владелец: Ф.Хоффманн-Ля Рош Аг. Дата публикации: 2010-10-27.

Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimer's disease

Номер патента: US09868725B2. Автор: Minoru Nakamura,Shinkichi Suzuki,Masami Yamada,Makoto Kamata,Hiroki Sakamoto,Takahiro Sugimoto. Владелец: Takeda Pharmaceutical Co Ltd. Дата публикации: 2018-01-16.

2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease

Номер патента: CA2714058A1. Автор: Craig A. Coburn,Hong Zhu,Philippe G. Nantermet,Hemaka A. Rajapakse,Keith P. Moore,Shawn J. Stachel,Ivory D. Hills,Samuel L. Graham. Владелец: Individual. Дата публикации: 2009-09-03.

Macrocyclic spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease

Номер патента: CA2667071A1. Автор: Philippe G. Nantermet,M. Katharine Holloway,Shaun R. Stauffer,Keith P. Moore. Владелец: Keith P. Moore. Дата публикации: 2008-04-17.

Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease

Номер патента: EP2063889A2. Автор: Craig A. Coburn,Wenjin Yang,Melissa S. Egbertson,Bruce Fahr,Wanli Lu,James C. Barrow,Lou Anne Neilson,Shaun R. Stauffer,Jenny M. Wai. Владелец: Sunesis Pharmaceuticals Inc. Дата публикации: 2009-06-03.

Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease

Номер патента: EP2091328A2. Автор: Shaun R. Stauffer,Ivory D. Hills,Ashley Nomland. Владелец: Merck and Co Inc. Дата публикации: 2009-08-26.

Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease

Номер патента: US20100069419A1. Автор: Shaun R. Stauffer,Ivory D. Hills,Ashley Nomland. Владелец: Individual. Дата публикации: 2010-03-18.

Compounds for the treatment of alzheimer's disease

Номер патента: AU2021366268A9. Автор: Ryoichi Kimura,Michael Houghton,James A. Nieman,D. Lorne Tyrrell,Bing Bai,Wen FU,Jack Jhamandas,Alexandr BELOVODSKIY,Mostofa HENA,Appan Srinivas Kandadai,Kamlesh Kumar Sahu. Владелец: University of Alberta. Дата публикации: 2024-08-01.

Thioflavin derivatives for use in the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition

Номер патента: US09833458B2. Автор: William E. Klunk,Chester A. Mathis, Jr.,Yanming Wang. Владелец: University of Pittsburgh. Дата публикации: 2017-12-05.

Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition

Номер патента: US09808541B2. Автор: William E. Klunk,Chester A. Mathis, Jr.,Yanming Wang. Владелец: University of Pittsburgh. Дата публикации: 2017-11-07.

Identification of novel benzothiazones as tau-sh3 interaction inhibitors for the treatment of alzheimer's disease

Номер патента: WO2023250002A1. Автор: Mark J. Suto,Corinne E. Augelli-Szafran,Vibha Pathak,Erik D. Roberson. Владелец: THE UAB RESEARCH FOUNDATION. Дата публикации: 2023-12-28.

New derivatives of propargylamine having neuroprotective capacity for the treatment of alzheimer's and parkinson's diseases

Номер патента: US20130012522A1. Автор: Jose Luis Marco Contelles,Mercedes Unzeta Lopez,Abdelouahid Samadi,Francisco Javier Luque Garriga,Irene Bolea Tomás. Владелец: Universitat de Barcelona UB. Дата публикации: 2013-01-10.

Derivatives of propargylamine having neuroprotective capacity for the treatment of Alzheimer's and Parkinson's diseases

Номер патента: US8999994B2. Автор: Jose Luis Marco Contelles,Mercedes Unzeta Lopez,Abdelouahid Samadi,Francisco Javier Luque Garriga,Irene Bolea Tomás. Владелец: Universitat de Barcelona UB. Дата публикации: 2015-04-07.

Substituted 1, 2, 3, 4-tetrahydroquinolin-7-yl carbamates as acetylcholinesterase inhibitors for treatment of alzheimer's disease

Номер патента: WO2012111021A1. Автор: Anil Kumar Saxena,Rakesh Shukla,Kuldeep Kumar ROY,Santoshkumar Tota,Chandishwar Nath. Владелец: Council Of Scientific & Industrial Research (An Indian Registered Body Incorporated Under The Registration Of Societies Act (Act Xxi Of 1860). Дата публикации: 2012-08-23.

Optimization and therapeutic valorization of the symptomatic treatment of alzheimer's disease with rivastigmine, galantamine or donepezil, by selected aminotetrahydrofurans acting as mixed sigma-1 / muscarinic ligands

Номер патента: US20150073046A1. Автор: Alexandre Vamvakides. Владелец: Individual. Дата публикации: 2015-03-12.

Compounds for treatment of alzheimer's disease

Номер патента: US09517232B2. Автор: Harry Ralph Howard,Dennis Michael Godek. Владелец: Medi Synergics LLC. Дата публикации: 2016-12-13.

Application of the piperazin derivatives for treatment of the alzheimer's disease and the alzheimer's type dementia with disturbed ventricular calcium signaling

Номер патента: RU2676100C1. Автор: Елена Александровна Попугаева,Дарья Павловна Чернюк,Илья Борисович Безпрозванный. Владелец: федеральное государственное автономное образовательное учреждение высшего образования "Санкт-Петербургский политехнический университет Петра Великого" (ФГАОУ ВО "СПбПУ"). Дата публикации: 2018-12-26.

2, 3, 4, 5-tetrahydrobenzo[f][1,4]oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of alzheimer's disease

Номер патента: CA2524640C. Автор: Guido Galley,Robert Alan Goodnow, Jr.,Jens Uwe Peters. Владелец: F Hoffmann La Roche AG. Дата публикации: 2011-10-11.

Malonamide derivatives as inhibitors of gamma-secretase for the treatment of alzheimer's disease

Номер патента: EP1828151A2. Автор: Alexander Flohr,Wolfgang Wostl,Roland Jakob-Roetne. Владелец: F Hoffmann La Roche AG. Дата публикации: 2007-09-05.

Thiophenyl sulfonamides for the treatment of alzheimer's disease

Номер патента: WO2010107997A1. Автор: John Edward Starrett. Владелец: BRISTOL-MYERS SQUIBB COMPANY. Дата публикации: 2010-09-23.

Pyrimidine derivatives for treatment of alzheimer's disease

Номер патента: EP2312946A1. Автор: Sean P. Ahearn,Alexey A. Rivkin,Stephanie M. Chichetti. Владелец: Merck Sharp and Dohme LLC. Дата публикации: 2011-04-27.

Thiophenyl sulfonamides for the treatment of alzheimer's disease

Номер патента: EP2408760A1. Автор: John Edward Starrett. Владелец: Bristol Myers Squibb Co. Дата публикации: 2012-01-25.

Novel pyrimidine derivatives and their application in therapy, as well as application of pyrimidine derivatives in manufacturing medication for prevention and/or treatment of alzheimer's disease

Номер патента: RU2433128C2. Автор: Карин СТААФ,Стефан БЕРГ,Ларс АНДЕРССОН,Эрван АРЗЕЛЬ,Джереми БАРРОУЗ,Свен ХЕЛЛЬБЕРГ,Фернандо ХУЭРТА,Торбен ПЕДЕРСЕН,Тобиас РЕЙН,Дидье РОТТИЧЧИ,Доминика ТУРЕК. Владелец: Астразенека Аб. Дата публикации: 2011-11-10.

Disubstituted piperidine derivatives as butyrylcholinesterase inhibitors for use in the treatment of alzheimer

Номер патента: EP3256128A1. Автор: Stanislav Gobec,Boris BRUS,Damijan KNEZ,Urban KOSAK,Nicolas COQUELLE,Jacques-Philippe COLLETIER. Владелец: UNIVERZA V LJUBLJANI. Дата публикации: 2017-12-20.

Disubstituted piperidine derivatives as butyrylcholinesterase inhibitors for use in the treatment of alzheimer

Номер патента: US20180086707A1. Автор: Stanislav Gobec,Boris BRUS,Damijan KNEZ,Urban KOSAK,Nicolas COQUELLE,Jacques-Philippe COLLETIER. Владелец: UNIVERZA V LJUBLJANI. Дата публикации: 2018-03-29.

Disubstituted piperidine derivatives as butyrylcholinesterase inhibitors for use in the treatment of alzheimer

Номер патента: WO2016151484A1. Автор: Stanislav Gobec,Boris BRUS,Damijan KNEZ,Urban KOSAK,Nicolas COQUELLE,Jacques-Philippe COLLETIER. Владелец: UNIVERZA V LJUBLJANI. Дата публикации: 2016-09-29.

Inhibition of ship1 as a therapeutic strategy for the treatment of alzheimer's disease

Номер патента: WO2024092205A1. Автор: Timothy Ivo Richardson,William Brent CLAYTON,Daniel Edward BECK. Владелец: The Trustees of Indiana University. Дата публикации: 2024-05-02.

AMYLOID-BINDING THIOFLAVIN DERIVATIVES, METHOD OF in vivo DETECTION OF AMYLOID DEPOSIT AND METHOD OF DIAGNOSTICS OF ALZHEIMER'S DISEASE

Номер патента: RU2324686C2. Автор: Яньмин ВАН,Уильям Э. КЛАНК,Честер Э. Мл. МАТИС,Уиль м Э. КЛАНК. Владелец: Юнивесити Оф Питсбэг. Дата публикации: 2008-05-20.

Tricyclic indole derivatives and their use in the treatment of alzheimer's disease

Номер патента: EP1620438A1. Автор: Emmanuel Hubert GlaxoSmithKline DEMONT,Sally GlaxoSmithKline REDSHAW,Daryl Simon GlaxoSmithKline WALTER. Владелец: Glaxo Group Ltd. Дата публикации: 2006-02-01.

Indazole derivatives for treatment of alzheimer's disease

Номер патента: EP1983981A1. Автор: Peter Hunt,Alan Nadin,Ian Churcher,Carmel B. Nanthakumar,Peter Brian Simpson,Richard Jelley,Hedaythul Choudhury,Neil Wilkie. Владелец: Merck Sharp and Dohme Ltd. Дата публикации: 2008-10-29.

Compositions for reducing Aβ 42 production and their use in treating alzheimer's disease (AD)

Номер патента: US09464053B2. Автор: Venkateswarlu Akella,Uday Saxena,Anji Reddy Kallam. Владелец: KAREUS THERAPEUTICS SA. Дата публикации: 2016-10-11.

Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition

Номер патента: CA2419420C. Автор: William E. Klunk,Chester A. Mathis, Jr.,Yanming Wang. Владелец: University of Pittsburgh. Дата публикации: 2011-08-02.

Mono-fluoro beta-secretase inhibitors

Номер патента: US09650336B2. Автор: Fredrik Rahm,Anna Minidis,Jenny Viklund. Владелец: AstraZeneca AB. Дата публикации: 2017-05-16.

Nlrp3 inflammasome small-molecule inhibitor for treatment of alzheimer's disease

Номер патента: EP4289830A1. Автор: Ho Chul Shin,Jee Yeon SEO,Muhammad Haseeb,Sangdun Choi,Javaid NASIR,Yasmeen FARZANA,Jae Kyung Heo. Владелец: Ajou University Industry Academic Cooperation Foundation. Дата публикации: 2023-12-13.

Substituted 1, 2, 3, 4-tetrahydroquinolin-7-yl carbamates as acetylcholinesterase inhibitors for treatment of Alzheimer's disease

Номер патента: US8946261B2. Автор: Anil Kumar Saxena,Rakesh Shukla,Kuldeep Kumar ROY,Santoshkumar Tota,Chandishwar Nath. Владелец: Council of Scientific and Industrial Research CSIR. Дата публикации: 2015-02-03.

Substituted 1, 2, 3, 4-tetrahydroquinolin-7-yl carbamates as acetylcholinesterase inhibitors for treatment of alzheimer's disease

Номер патента: EP2675790A1. Автор: Anil Kumar Saxena,Rakesh Shukla,Kuldeep Kumar ROY,Santoshkumar Tota,Chandishwar Nath. Владелец: Council of Scientific and Industrial Research CSIR. Дата публикации: 2013-12-25.

Substituted 1, 2, 3, 4-tetrahydroquinolin-7-yl carbamates as acetylcholinesterase inhibitors for treatment of alzheimer's disease

Номер патента: WO2012111021A8. Автор: Anil Kumar Saxena,Rakesh Shukla,Kuldeep Kumar ROY,Santoshkumar Tota,Chandishwar Nath. Владелец: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH. Дата публикации: 2013-07-25.

Substituted 1, 2, 3, 4-tetrahydroquinolin-7-yl carbamates as acetylcholinesterase inhibitors for treatment of alzheimer's disease

Номер патента: US20130324573A1. Автор: Anil Kumar Saxena,Rakesh Shukla,Kuldeep Kumar ROY,Santoshkumar Tota,Chandishwar Nath. Владелец: Council of Scientific and Industrial Research CSIR. Дата публикации: 2013-12-05.

3,5-diarylazaindoles as DYRK1A protein inhibitors for the treatment of cognitive deficiencies associated with Down's syndrome and with Alzheimer's disease

Номер патента: US09447093B2. Автор: Kevin Cariou,Stephanie Gourdain,Jean Maurice Delabar,Nathalie Janel,Julien Dairou,Clement Denhez,Robert Dobb,Fernando Rodrigues Lima. Владелец: Universite de Reims Champagne Ardenne URCA. Дата публикации: 2016-09-20.

Optimization and therapeutic valorization of the symptomatic treatment of alzheimer's disease with rivastigmine, galantamine or donepezil, by selected aminotetrahydrofurans acting as mixed sigma-1 / muscarinic ligands

Номер патента: WO2014155138A1. Автор: Alexandre Vamvakides. Владелец: Alexandre Vamvakides. Дата публикации: 2014-10-02.

Nlrp3 inflammasome small-molecule inhibitor for treatment of alzheimer's disease

Номер патента: US20240132458A1. Автор: Ho Chul Shin,Jee Yeon SEO,Muhammad Haseeb,Sangdun Choi,Javaid NASIR,Yasmeen FARZANA,Jae Kyung Heo. Владелец: Ajou University Industry Academic Cooperation Foundation. Дата публикации: 2024-04-25.

Lactams as beta secretase inhibitors

Номер патента: WO2012172449A1. Автор: Michael Aaron Brodney. Владелец: PFIZER INC.. Дата публикации: 2012-12-20.

Imidazopyridine derivatives and their use as agents for diagnosis of alzheimer's disease

Номер патента: IL198995A. Автор: . Владелец: Nihon Mediphysics Co Ltd. Дата публикации: 2012-10-31.

Triazole derivatives for treatment of alzheimer's disease

Номер патента: EP2378879A1. Автор: Christian Fischer,Hua Zhou,Matthew Christopher,Benito Munoz,Adam J. Schell,Chaomin Li,Joey Methot,Rachel N. Maccoss,Sean P. Ahearn,William Colby Brown,Alexey A. Rivkin,Stephanie Chichetti,Andrew Rosenau,Sam D. Kattar. Владелец: Merck Sharp and Dohme LLC. Дата публикации: 2011-10-26.

Tetrahydroindole Derivatives for Treatment of Alzheimer's Disease

Номер патента: US20100016308A1. Автор: Frank Burkamp,Stephen Robert Fletcher,Stephen John Lewis,Martin Richard Teall,Graham David Checksfield,Paul Joseph Oakley,Edward Giles Meiver. Владелец: Individual. Дата публикации: 2010-01-21.

Tetrahydroindole derivatives for treatment of alzheimer's disease

Номер патента: EP1948603A1. Автор: Frank Burkamp,Stephen Robert Fletcher,Edward Giles Mciver,Stephen John Lewis,Martin Richard Teall,Graham David Checksfield,Paul Joseph Oakley. Владелец: Merck Sharp and Dohme Ltd. Дата публикации: 2008-07-30.

Tetrahydroindole derivatives for treatment of alzheimer's disease

Номер патента: CA2628934A1. Автор: Frank Burkamp,Stephen Robert Fletcher,Edward Giles Mciver,Stephen John Lewis,Martin Richard Teall,Graham David Checksfield,Paul Joseph Oakley. Владелец: Individual. Дата публикации: 2007-05-18.

Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use

Номер патента: US09611261B2. Автор: Jennifer R. Allen,Michael J. Frohn,Paul E. Harrington,Robert M. Rzasa,Nobuko Nishimura,James Brown,Angel Guzman-Perez,Wenyuan Qian,Albert Amegadzie,Jonathan D. Low,Patricia Lopez,Ana Elena Minatti,Qiufen Xue,Vu Van Ma,Kelvin Sham,Adrian L. Smith,Shannon Rumfelt,Ryan White. Владелец: AMGEN INC. Дата публикации: 2017-04-04.

Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use

Номер патента: US09550762B2. Автор: Yuan Cheng,Jennifer R. Allen,Michael J. Frohn,Paul E. Harrington,Alexander J. Pickrell,Robert M. Rzasa,James Manning,Qingyian Liu,Mark H. Norman,Nobuko Nishimura,Angel Guzman-Perez,Matthew P. Bourbeau,James A. Brown,Longbin Liu,Liping H. Pettus,Wenyuan Qian,Aaron C. Siegmund,Albert Amegadzie,Jian J. Chen,Jonathan D. Low,Thomas T. Nguyen,Ana Elena Minatti,Qiufen Xue,Vu Van Ma,Markian M. STEC,Shannon Rumfelt,Ryan D. WHITE. Владелец: AMGEN INC. Дата публикации: 2017-01-24.

Acyl guanidines as beta-secretase inhibitors

Номер патента: WO2007002214A3. Автор: Lorin A Thompson Iii,Andrew C Good,Shuhao Shi,Shirong Zhu,Samuel Gerritz,Weixu Zhai. Владелец: Weixu Zhai. Дата публикации: 2007-04-12.

Oxime-containing macrocyclic acyl guanidines as beta-secretase inhibitors

Номер патента: US20080139523A1. Автор: Yong-Jin Wu,Shuhao Shi,Shirong Zhu,Samuel Gerritz. Владелец: Bristol Myers Squibb Co. Дата публикации: 2008-06-12.

Novel isophthalates as beta-secretase inhibitors

Номер патента: US20100222581A1. Автор: John E. Macor,Jianliang Shi,Kenneth M. Boy,Lorin A. Thompson, Iii. Владелец: Bristol Myers Squibb Co. Дата публикации: 2010-09-02.

Oxazine derivatives as beta-secretase inhibitors and methods of use

Номер патента: US20200207747A1. Автор: Ning Chen,Jennifer R. Allen,Michael J. Frohn,Paul E. Harrington,Qingyian Liu,Matthew P. Bourbeau,Corey REEVES. Владелец: AMGEN INC. Дата публикации: 2020-07-02.

Mono-fluoro beta-secretase inhibitors

Номер патента: US20140288091A1. Автор: Fredrik Rahm,Anna Minidis,Jenny Viklund. Владелец: AstraZeneca AB. Дата публикации: 2014-09-25.

Compounds derived from 3,4-dihydropyrrolo [1,2-a] pyrazin-1-ylamine, inhibitors of (bace); pharmaceutical composition that includes them; Preparation process; Useful for the treatment or prevention of Alzheimer's disease, dementia, down syndrome and other dementias associated with beta-amyloids.

Номер патента: CL2013002511A1. Автор: Andrés Avelino Trabanco-Suárez,Francisca Delgado-Jiménez. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2014-01-24.

Compounds and methods for the diagnosis and treatment of amyloid associated diseases

Номер патента: US8741883B2. Автор: Jerry Yang,Petra Inbar. Владелец: University of California San Diego UCSD. Дата публикации: 2014-06-03.

Compounds and methods for the diagnosis and treatment of amyloid associated diseases

Номер патента: US20100178282A1. Автор: Jerry Yang,Petra Inbar. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2010-07-15.

Benzazole derivatives, compositions, and methods of use as .beta.-secretase inhibitors

Номер патента: CA2600570C. Автор: David Jones,Devi Reddy Gohimmukkula,Guoxiang Huang,Adnan M.M. Mjalli,Jeff Zhu,Mohan Rao,Robert C. Andrews,Tan Ren. Владелец: High Point Pharnaceuticals LLC. Дата публикации: 2011-12-06.

A pharmaceutical composition comprising an oxazine derivative and its use in the treatment or prevention of alzheimer's disease

Номер патента: CA3048346A1. Автор: Edgar John,Rita Ramos,Dragutin Knezic,Bruno Galli,Michael Juhnke,Miloud ACHOUR,Vishal Shamji KORADIA. Владелец: NOVARTIS AG. Дата публикации: 2018-07-26.

1, 3, 4, 5-Tetrahydro-2H-Pyrido[4,3-B]Indole Derivatives For The Treatment, Alleviation Or Prevention Of Disorders Associated With Tau Aggregates Like Alzheimer's Disease

Номер патента: AU2021203340A1. Автор: Sreenivasachary Nampally,Emanuele Gabellieri,Jérôme Molette. Владелец: AC IMMUNE SA. Дата публикации: 2021-06-24.

1, 3, 4, 5-tetrahydro-2H-pyrido(4,3-b)indole derivatives for the treatment, alleviation or prevention of disorders associated with Tau aggregates like Alzheimer's disease

Номер патента: AU2019205087A1. Автор: Sreenivasachary Nampally,Emanuele Gabellieri,Jérôme Molette. Владелец: AC IMMUNE SA. Дата публикации: 2020-07-02.

Metalloenzyme inhibitors for treating cancers, alzheimer's disease, hemochromatosis, and other disorders

Номер патента: US20230295125A1. Автор: Jonnie R. Williams, SR.. Владелец: Miralogx LLC. Дата публикации: 2023-09-21.

Metalloenzyme inhibitors for treating cancers, alzheimer's disease, hemochromatosis, and other disorders

Номер патента: EP4228628A1. Автор: Jonnie R. Williams. Владелец: Miralogx LLC. Дата публикации: 2023-08-23.

Substituted amide beta secretase inhibitors

Номер патента: US20060040994A1. Автор: Ying Huang,Andrew Stamford,Guoqing Li. Владелец: Individual. Дата публикации: 2006-02-23.

Methods and drug products for treating alzheimer's disease

Номер патента: US20160000769A1. Автор: Rajneesh Taneja,Allen D. Roses. Владелец: Zinfandel Pharmaceuticals Inc. Дата публикации: 2016-01-07.

Methods and drug products for treating alzheimer's disease

Номер патента: EP2665479A1. Автор: Rajneesh Taneja,Allen D. Roses. Владелец: Zinfandel Pharmaceuticals Inc. Дата публикации: 2013-11-27.

Methods and drug products for treating alzheimer's disease

Номер патента: WO2012096873A9. Автор: Rajneesh Taneja,Allen D. Roses. Владелец: Zinfandel Pharmaceuticals, Inc.. Дата публикации: 2013-09-12.

Methods and drug products for treating alzheimer's disease

Номер патента: US20170319565A1. Автор: Rajneesh Taneja,Allen D. Roses. Владелец: Zinfandel Pharmaceuticals Inc. Дата публикации: 2017-11-09.

Methods and drug products for treating alzheimer's disease

Номер патента: US09724339B2. Автор: Rajneesh Taneja,Allen D. Roses. Владелец: Zinfandel Pharmaceuticals Inc. Дата публикации: 2017-08-08.

Substituted Tetrahydroisoquinolines as Beta-secretase Inhibitors

Номер патента: US20080153868A1. Автор: Andrew C. Good,John E. Macor,Jianliang Shi,Kenneth M. Boy,Lawrence R. Marcin,Lorin A. Thompson. Владелец: Bristol Myers Squibb Co. Дата публикации: 2008-06-26.

Piperazine thiazole derivatives useful in the treatment of tauopathies such as Alzheimer's disease

Номер патента: US09808456B2. Автор: MATTHIAS Nettekoven,Hasane Ratni,Mark Rogers-Evans,Gerard Griffioen,Giuseppe Cecere,Katrien Princen,Walter Vifian. Владелец: REMYND NV. Дата публикации: 2017-11-07.

Macrocyclic diaminopropanes as beta-secretase inhibitors

Номер патента: US20070037868A1. Автор: Andrew Good,Lawrence MARCIN. Владелец: Bristol Myers Squibb Co. Дата публикации: 2007-02-15.

1, 3, 4, 5-tetrahydro-2h-pyrido[4,3-b]indole derivatives for the treatment, alleviation or prevention of disorders associated with tau aggregates like alzheimer's disease

Номер патента: CA3086759A1. Автор: Sreenivasachary Nampally,Emanuele Gabellieri,Jérôme Molette. Владелец: AC IMMUNE SA. Дата публикации: 2019-07-11.

1, 3, 4, 5-tetrahydro-2h-pyrido[4,3-b]indole derivatives for the treatment, alleviation or prevention of disorders associated with tau aggregates like alzheimer’s disease

Номер патента: NZ765495A. Автор: Sreenivasachary Nampally,Emanuele Gabellieri,Jérôme Molette. Владелец: AC IMMUNE SA. Дата публикации: 2024-02-23.

(3-fluoro-2-hydroxy)propyl-functionalized aryl derivatives or pharmaceutically acceptable salts thereof, method for preparing same, and pharmaceutical composition containing same as active ingredient for the diagnosis or treatment of neurodegenerative brain diseases

Номер патента: US20120214994A1. Автор: Dae-Hyuk Moon,Jin-Sook Ryu,Jae-Seung Kim,Seung-Jun Oh,Dae-Yoon Chi,Byoung-Se Lee,Chansoo Park,So-Young Chu,Yu-Jin Bae,Sirion Uthaiwan. Владелец: Individual. Дата публикации: 2012-08-23.

Inhibitors of two sites of binding acetylcholinesterase for treatment of the alzheimer's disease

Номер патента: RU2325379C2. Автор: ПАДИЛЬЯ Мигель МЕДИНА,УЭРТА Ана ФУЭРТЕС,ДИАС Исабель ДОРРОНСОРО,ГОРДИЛЬО Диана АЛОНСО,ПАЛОМЕРО Эстер ГАРСИА,ХИЛ Ана МАРТИНЕС,МОНТЕ МИЛЬЯН Мария ДЕЛЬ,ЭХЕА Паола УСАН,АРРЬЕТА Лаура РУБИО,Сусана МОРАЛЕС-АЛСЕЛАЙ,АУСТРИА Селия ДЕ,МОНТЕ МИЛЬЯН Мари ДЕЛЬ,АУСТРИА Сели ДЕ. Владелец: Неурофарма, С.А.. Дата публикации: 2008-05-27.

Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3

Номер патента: AU2002359164A8. Автор: James Empfield,Stefan Berg,Sven Hellberg,James Woods,Ratan Bhat,Michael Klimas. Владелец: AstraZeneca AB. Дата публикации: 2003-07-09.

Metalloenzyme inhibitors for treating cancers, alzheimer's disease, hemochromatosis, and other disorders

Номер патента: AU2021361997A9. Автор: Jonnie R. Williams. Владелец: Miralogx LLC. Дата публикации: 2024-02-08.

Piperazine thiazole derivatives useful in the treatment of tauopathies such as alzheimer's disease

Номер патента: CA2841037C. Автор: MATTHIAS Nettekoven,Hasane Ratni,Mark Rogers-Evans,Gerard Griffioen,Giuseppe Cecere,Katrien Princen,Walter Vifian. Владелец: REMYND NV. Дата публикации: 2020-03-31.

Compounds derived from imidazopyridine or imidazopyrimidine, inhibitors of pde10a; process of preparation of said compounds; pharmaceutical compositions; and its use for the therapeutic and / or preventive treatment of psychotic disorders, schizophrenia, Alzheimer's disease, solid tumors, among other diseases.

Номер патента: CL2012000708A1. Автор: Zbinden Katrin Groebke,Sánchez Rubén Alvarez,Alexander Flohr,Bernd Kuhn,Matthias Koerner,Markus Rudolph,Konrad Bleicher,Jens-Uwe Peters,Daniela Alberati. Владелец: Hoffmann La Roche. Дата публикации: 2012-09-07.

Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease

Номер патента: US20200071312A1. Автор: Chiung-Tong Chen,Chuan Shih,Chih-hao Chen,Hwei-Jiung Wang,Kai-Fa Huang. Владелец: National Health Research Institutes. Дата публикации: 2020-03-05.

Benzimidazole compounds and use thereof for treating Alzheimer's Disease or Huntington's Disease

Номер патента: US10584120B1. Автор: Chiung-Tong Chen,Chuan Shih,Chih-hao Chen,Hwei-Jiung Wang,Kai-Fa Huang. Владелец: National Health Research Institutes. Дата публикации: 2020-03-10.

Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease

Номер патента: CA3109623A1. Автор: Chiung-Tong Chen,Chuan Shih,Chih-hao Chen,Hwei-Jiung Wang,Kai-Fa Huang. Владелец: National Health Research Institutes. Дата публикации: 2020-03-05.

Dual Inhibitor Compounds for Use in the Treatment of Neurodegenerative Disorders and Alzheimer's Disease

Номер патента: US20170096406A1. Автор: Cavalli Andrea,Prati Federica,Bottegoni Giovanni,Favia Angelo Danilo,Pizzirani Daniela,Scarpelli Rita,Bolognesi Maria Laura. Владелец: . Дата публикации: 2017-04-06.

Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use

Номер патента: TWI614250B. Автор: 珍妮佛Ｒ艾倫,亞伯特艾葛茲,馬修Ｐ鮑比優,詹姆士Ａ布朗,將Ｊ陳,元鄭,麥可Ｊ佛朗,皮瑞茲安琪拉古茲曼,保羅Ｅ哈瑞登,羅彬呂,青延劉,強那森Ｄ洛,弗凡馬,詹姆士Ｒ曼寧,安娜艾蓮娜米那提,湯馬士Ｔ尼古元,西村信子,馬克Ｈ諾門,林平Ｈ皮特斯,亞力山德Ｊ皮克瑞爾,文遠錢,雪能倫菲特,羅勃特Ｍ拉薩,艾倫Ｃ席格蒙,馬克恩Ｍ史堤克,萊恩Ｄ懷特,曲芬徐. Владелец: 安美基公司. Дата публикации: 2018-02-11.

Piperazine thiazole derivatives useful in the treatment of tauopathies such as alzheimer's disease

Номер патента: CA2841037A1. Автор: MATTHIAS Nettekoven,Hasane Ratni,Mark Rogers-Evans,Gerard Griffioen,Giuseppe Cecere,Katrien Princen,Walter Vifian. Владелец: REMYND NV. Дата публикации: 2013-02-21.

Piperazine thiazole derivatives useful in the treatment of tauopathies such as alzheimer's disease

Номер патента: EP2744798A1. Автор: MATTHIAS Nettekoven,Hasane Ratni,Mark Rogers-Evans,Gerard Griffioen,Giuseppe Cecere,Katrien Princen,Walter Vifian. Владелец: REMYND NV. Дата публикации: 2014-06-25.

New imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases

Номер патента: WO2011045415A2. Автор: Sarah Catoen,Thierry Gautheret. Владелец: GUERBET. Дата публикации: 2011-04-21.

Cytochrome oxidase mutations aiding diagnosis of sporadic alzheimer's disease

Номер патента: US5565323A. Автор: Corinna Herrnstadt,W. Davis Parker. Владелец: MitoKor Inc. Дата публикации: 1996-10-15.

Targeting lysosomal lipid in alzheimer's disease

Номер патента: WO2024197271A1. Автор: Zibo Li,JR. Leon G. COLEMAN,Alexandra BARNETT,Saradhi KALARI,Xinrui Ma. Владелец: The University of North Carolina at Chapel Hill. Дата публикации: 2024-09-26.

Compositions and methods for treating Alzheimer's disease

Номер патента: US09427438B2. Автор: John Jahangir ALAM. Владелец: EIP PHARMA LLC. Дата публикации: 2016-08-30.

Preventives or remedies for alzheimer's disease or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound

Номер патента: CA2468948C. Автор: Kazuo Koyama,Yasuhiro Nakagami,Isao Kaneko,Shinji Marumoto,Masaki Meguro,Tomiichiro Oda. Владелец: BTG International Ltd. Дата публикации: 2012-04-17.

Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease

Номер патента: WO2020047360A8. Автор: Chiung-Tong Chen,Chuan Shih,Chih-hao Chen,Hwei-Jiung Wang,Kai-Fa Huang. Владелец: National Health Research Institutes. Дата публикации: 2021-09-10.

Novel imaging tracers for early detection and treatment of amyloid plaques caused by alzheimer's disease and related disorders

Номер патента: WO2008134618A3. Автор: David R Elmaleh,Timothy Shoup,Alan J Fischman. Владелец: Alan J Fischman. Дата публикации: 2008-12-24.

Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease

Номер патента: AU2019333295A1. Автор: Chiung-Tong Chen,Chuan Shih,Chih-hao Chen,Hwei-Jiung Wang,Kai-Fa Huang. Владелец: National Health Research Institutes. Дата публикации: 2021-03-04.

Novel Imaging Tracers for Early Detection and Treatment of Amyloid Plaques Caused by Alzheimer's Disease and Related Disorders

Номер патента: US20080267879A1. Автор: David R. Elmaleh,Alan J. Fischman,Timothy M. Shoup. Владелец: General Hospital Corp. Дата публикации: 2008-10-30.

Diagnosis and treatment of alzheimer's and other neurodementing diseases

Номер патента: CA2675340A1. Автор: Michael Bacher,Richard Dodel,Michael Przybylski,Raluca Stefanescu,Marilena Manea. Владелец: Individual. Дата публикации: 2008-07-17.

Diagnosis and treatment of alzheimer's and other neurodementing diseases

Номер патента: CA2675340C. Автор: Michael Bacher,Richard Dodel,Michael Przybylski,Raluca Stefanescu,Marilena Manea. Владелец: Individual. Дата публикации: 2018-07-31.

Agents inhibiting kallikrein-8 for use in the prevention or treatment of alzheimer's disease

Номер патента: EP3353214A1. Автор: Arne HERRING,Kathy KEYVANI. Владелец: Universitaet Duisburg Essen. Дата публикации: 2018-08-01.

Antibody molecules and peptide delivery systems for use in alzheimer's disease and related disorders

Номер патента: CA2975059C. Автор: Frederico Nuno Castanheira Aires Da Silva,Sofia Volker Cörte-Real,Vera Luísa SANTOS NEVES,Pedro Manuel CORREIA CANHÃO,Tiago FLEMING OUTEIRO,Miguel Augusto RICO BOTAS CASTANHO,Soraia Rafaela Santiago de Oliveira. Владелец: Technophage Investigacao e Desenvolvimento em Biotecnologia SA. Дата публикации: 2023-02-21.

Diagnosis and treatment of alzheimer's disease

Номер патента: US20150177261A1. Автор: Kaj Blennow,Jonas Nilsson,Henrik Zetterberg,Adnan Halim,Göran Larson,Gunnar Brinkmalm,Erik Portelius. Владелец: Individual. Дата публикации: 2015-06-25.

Alzheimer’s disease model

Номер патента: WO2003046172A3. Автор: Karl Peter Giese,Marco Angelo. Владелец: Marco Angelo. Дата публикации: 2003-07-17.

Protected amino acid derivatives for the treatment of alzheimer's disease

Номер патента: GB2392443A. Автор: Robert Gordon,Henriette Willems. Владелец: De Novo Pharmaceuticals Ltd. Дата публикации: 2004-03-03.

Compounds useful in the therapy of alzheimer's disease and formulations containing them

Номер патента: EP1638914A2. Автор: Ezio Bombardelli,Gabriele Fontana,Luisella Univers. degli Studi di Milano VEROTTA. Владелец: Indena SpA. Дата публикации: 2006-03-29.

Compounds useful in the therapy of alzheimer’s disease and formulations containing them

Номер патента: WO2004106275A2. Автор: Ezio Bombardelli,Gabriele Fontana,Luisella Verotta. Владелец: INDENA S.P.A.. Дата публикации: 2004-12-09.

Extracellular vesicles for the diagnosis of alzheimer's disease

Номер патента: WO2024108311A1. Автор: Stephen Pasternak,Hon LEONG. Владелец: Stephen Pasternak. Дата публикации: 2024-05-30.

Stable hyperforin salts, method for producing same and their use in the treatment of alzheimer's disease

Номер патента: AU2831299A. Автор: Christoph Schachtele,Clemens Erdelmeier,Klaus Klessing,Dieter Marme,Shyam Sunder Chatterjee. Владелец: Dr Willmar Schwabe GmbH and Co KG. Дата публикации: 1999-08-30.

Hyperforin derivatives and their use in Alzheimer's disease

Номер патента: US09556099B2. Автор: Paolo Morazzoni,Gabriele Fontana,Antonella Riva. Владелец: Indena SpA. Дата публикации: 2017-01-31.

Organosulfur compounds for the prevention and treatment of neurodegenerative diseases

Номер патента: US09562007B2. Автор: David Michael Ott. Владелец: Allium Vitalis Inc. Дата публикации: 2017-02-07.

Alzheimer's disease treatment and methods

Номер патента: US20240091376A1. Автор: Peter Butzloff. Владелец: Pharmzandia Corp. Дата публикации: 2024-03-21.

Alzheimer's disease treatment and methods

Номер патента: EP4301696A1. Автор: Peter Butzloff. Владелец: Pharmzandia Corp. Дата публикации: 2024-01-10.

Dna encoding for the precursor protein of apc polypeptide associated with alzheimer's disease

Номер патента: US5218100A. Автор: Hans-Georg Lemaire,Benno Muller-Hill,Jie Kang,Axel Unterbeck. Владелец: Bayer AG. Дата публикации: 1993-06-08.

Peptide for treatment of alzheimer's disease

Номер патента: RU2678987C2. Автор: Александр Александрович Колобов,Владимир Михайлович Шпень,Елена Артуровна КАМПЕ-НЕММ,Роман Данилович ДЕЙКО,Сергей Юрьевич Штрыголь. Владелец: Общество с ограниченной ответственностью "Научно-производственная фирма ВЕРТА". Дата публикации: 2019-02-05.

Human PEM as a target for birth contol and treatment of Alzheimer's disease

Номер патента: US20020048764A1. Автор: Bertram Weiss,Bernard Haendler,Christoph Geserick. Владелец: Schering AG. Дата публикации: 2002-04-25.

Human PEM as a target for birth control and treatment of Alzheimer's disease

Номер патента: US6825329B2. Автор: Bertram Weiss,Bernard Haendler,Christoph Geserick. Владелец: Schering AG. Дата публикации: 2004-11-30.

Tau vaccine for the treatment of alzheimer's disease

Номер патента: US20230302127A1. Автор: Robin Barbour,Wagner Zago,Tarlochan S. Nijjar,Gene Kinney. Владелец: Othair Prothena Ltd. Дата публикации: 2023-09-28.

Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease

Номер патента: US20230295254A1. Автор: Robin Barbour,Wagner Zago,Tarlochan S. Nijjar,Gene Kinney. Владелец: Othair Prothena Ltd. Дата публикации: 2023-09-21.

Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease

Номер патента: US20240343769A1. Автор: Robin Barbour,Wagner Zago,Tarlochan S. Nijjar,Gene Kinney. Владелец: Othair Prothena Ltd. Дата публикации: 2024-10-17.

Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease

Номер патента: US20230312662A1. Автор: Robin Barbour,Wagner Zago,Tarlochan S. Nijjar,Gene Kinney. Владелец: Othair Prothena Ltd. Дата публикации: 2023-10-05.

Method for diagnosis of alzheimer's disease and frontotemporal lobar degeneration, diagnostic agent, therapeutic agent, and screening method for said agents

Номер патента: EP4321165A3. Автор: Hitoshi Okazawa. Владелец: Tokyo Medical and Dental University NUC. Дата публикации: 2024-08-21.

BACE1 inhibitors for the treatment of Alzheimer's disease

Номер патента: US12043631B2. Автор: Arun K. Ghosh,Andrew Mesecar,Margherita Brindisi,Emilio Leal Cardenas. Владелец: PURDUE RESEARCH FOUNDATION. Дата публикации: 2024-07-23.

Modulating bone morphogenic protein (bmp) signaling in the treatment of alzheimer's disease

Номер патента: US20240102022A1. Автор: Robert C. Jones,Michael F. Clarke,Jane ANTONY,Elizabeth Yang Chen,Felicia Reinitz. Владелец: CZ Biohub SF LLC. Дата публикации: 2024-03-28.

Formulations for topic mucosal and/or oral systemic administrations containing a mixture based on lactoferrin, more effective in iron uptake, for the prevention and treatment of various pathologies

Номер патента: EP4216989A1. Автор: Piera Valenti,Rosalba Paesano. Владелец: Microbo Srl. Дата публикации: 2023-08-02.

Compositions and methods for treating alzheimer's disease

Номер патента: US20240238355A1. Автор: William L. Klein,Diana Jerusalinsky,Sergio T. Ferreira,Maria Clara Selles,Adriano S. Sebollela. Владелец: Universidade Federal do Rio de Janeiro UFRJ. Дата публикации: 2024-07-18.

Compositions and methods for treating alzheimer's disease

Номер патента: US20200289589A1. Автор: William L. Klein,Diana Jerusalinsky,Sergio T. Ferreira,Maria Clara Selles,Adriano S. Sebollela. Владелец: Universidade Federal do Rio de Janeiro UFRJ. Дата публикации: 2020-09-17.

BIVALENT MULTIFUNCTIONAL LIGANDS TARGETING Aβ OLIGOMERS AS TREATMENT FOR ALZHEIMER'S DISEASE

Номер патента: WO2012012257A3. Автор: Shijun Zhang,Tai Liang Guo. Владелец: Virginia Commonwealth University. Дата публикации: 2012-05-31.

Invention of protein pi4kiiia and related membrane protein complex in treatment of alzheimer's disease

Номер патента: RU2724493C2. Автор: Лэ ЧЖАН,Сяо ЧЖАН,Хайянь ЛЮ,Ян ХЭ,Фуде ХУАН,Венан ВАН,Лисян ЦЗЯН,Тонг ЧЖУ,Юдон ЧЖОУ,Ванго ВЭЙ. Владелец: Цзянсу Нуо-Бета Фармасьютикал Текнолоджи Ко., Лтд.. Дата публикации: 2020-06-23.

Treatment of alzheimer's disease subpopulations with pooled immunoglobulin g

Номер патента: AU2024201051A1. Автор: Hans-Peter Schwarz,David M. Gelmont,Julia Singer,Sandor Fritsch. Владелец: Takeda Pharmaceutical Co Ltd. Дата публикации: 2024-03-14.

Liposomes displaying a glycan ligand for cd33 and their use in the treatment of alzheimer's disease

Номер патента: US20240238442A1. Автор: Matthew Macauley,Abhishek BATTACHERJEE,Arjun Singh BAINS,Gour DASKHAN. Владелец: University of Alberta. Дата публикации: 2024-07-18.

Combination therapies for the treatment of Alzheimer's disease and related disorders

Номер патента: US09968618B1. Автор: David R. Elmaleh. Владелец: General Hospital Corp. Дата публикации: 2018-05-15.

Combination therapies for the treatment of Alzheimer's disease and related disorders

Номер патента: US09918992B2. Автор: David R. Elmaleh. Владелец: General Hospital Corp. Дата публикации: 2018-03-20.

Combination therapies for the treatment of alzheimer's disease and related disorders

Номер патента: US09913847B2. Автор: David R. Elmaleh. Владелец: General Hospital Corp. Дата публикации: 2018-03-13.

Application of elapidae snake postsynaptic neurotoxin monomer molecule in treatment of alzheimer's disease

Номер патента: EP4046648A1. Автор: Hyatt QI,Zhankai QI. Владелец: Qi Zhankai. Дата публикации: 2022-08-24.

Combination therapies for the treatment of Alzheimer's disease and related disorders

Номер патента: US09855276B2. Автор: David R. Elmaleh. Владелец: General Hospital Corp. Дата публикации: 2018-01-02.

Sorla mini-receptor for treatment of alzheimer's disease

Номер патента: CA3219014A1. Автор: Olav Michael Andersen,Anne Mette GISSEL JENSEN. Владелец: AARHUS UNIVERSITET. Дата публикации: 2023-01-05.

Diagnostic test and treatment/prevention of alzheimer's disease

Номер патента: EP3142708A1. Автор: Arthur P. Bollon,Baoxi Qu. Владелец: Vitruvian Biomedical Inc. Дата публикации: 2017-03-22.

Diagnostic Test and Treatment/Prevention of Alzheimer's Disease

Номер патента: US20160206714A1. Автор: Arthur P. Bollon,Baoxi Qu. Владелец: Vitruvian Biomedical Inc. Дата публикации: 2016-07-21.

Diagnostic test and treatment/prevention of alzheimer's disease

Номер патента: WO2015175898A1. Автор: Arthur P. Bollon,Baoxi Qu. Владелец: Vitruvian Biomedical, Inc.. Дата публикации: 2015-11-19.

Sorla mini-receptor for treatment of alzheimer's disease

Номер патента: AU2022305119A1. Автор: Olav Michael Andersen,Anne Mette GISSEL JENSEN. Владелец: AARHUS UNIVERSITET. Дата публикации: 2024-02-01.

Immunotherapeutic compositions for the treatment of alzheimer'S disease

Номер патента: US09498522B2. Автор: Stephen Grimes,Peter Blackburn. Владелец: MERCIA PHARMA Inc. Дата публикации: 2016-11-22.

Method of treating alzheimer's disease

Номер патента: RU2385161C2. Автор: БАРРИО Мануэль САРАСА. Владелец: Араклон Байотек, С.Л.. Дата публикации: 2010-03-27.

Use of stat4 inhibitors for prevention and treatment of alzheimer's disease

Номер патента: US20230233595A1. Автор: Jerry L. Nadler,Patric K. Stanton. Владелец: New York Medical College. Дата публикации: 2023-07-27.

Scyllo-inositol in combination with immunotherapeutics for the treatment of alzheimer's disease

Номер патента: WO2024054416A1. Автор: Phillip Frost,Antonio Cruz,John K. CHOE. Владелец: Eirgen Pharma, Ltd.. Дата публикации: 2024-03-14.

INHIBITORS OF β-SECRETASE, AND THEIR USE FOR THE PREVENTION OR TREATMENT OF ALZHEIMER’S DISEASE OR MILD COGNITIVE IMPAIRMENT

Номер патента: WO2004041211A3. Автор: Pavel Petukhov,Alan P Kozikowski,Paul S Aisen. Владелец: Paul S Aisen. Дата публикации: 2004-09-10.

Alzheimer's disease treatment method comprising a beta-amyloid peptide

Номер патента: CA2524571C. Автор: Manuel Sarasa Barrio. Владелец: Araclon Biotech SL. Дата публикации: 2017-01-10.

Use of a peptide for the production of antibodies for the treatment of alzheimer's disease

Номер патента: IL171651A. Автор: . Владелец: Univ Zaragoza. Дата публикации: 2011-11-30.

Application of zn7mt3 and its derivatives in the prevention and treatment of alzheimer's disease

Номер патента: US20180371061A1. Автор: Wei Xu,Xiangshi TAN,Daofeng XIANG,Yingxuan TAN,Yueru ZHANG. Владелец: Liaocheng City Orient Biomedical Technology Co Ltd. Дата публикации: 2018-12-27.

Methods of treating alzheimer's disease with apo a-1 milano

Номер патента: WO2012109469A2. Автор: Prediman K. Shah. Владелец: CEDARS-SINAI MEDICAL CENTER. Дата публикации: 2012-08-16.

Multiepitope vaccine for the treatment of alzheimer's disease

Номер патента: US20230355729A1. Автор: Robin Barbour,Wagner Zago,Gene Kinney. Владелец: Individual. Дата публикации: 2023-11-09.

Multi-epitope vaccine for the treatment of Alzheimer's disease

Номер патента: US11945849B2. Автор: Robin Barbour,Wagner Zago,Tarlochan S. Nijjar,Gene Kinney. Владелец: Othair Prothena Ltd. Дата публикации: 2024-04-02.

ß-AMYLOID VACCINE FOR THE TREATMENT OF ALZHEIMER’S DISEASE

Номер патента: US20230364210A1. Автор: Robin Barbour,Wagner Zago,Gene Kinney. Владелец: Othair Prothena Ltd. Дата публикации: 2023-11-16.

Multi-epitope vaccine for the treatment of Alzheimer's disease

Номер патента: US11965005B2. Автор: Robin Barbour,Wagner Zago,Tarlochan S. Nijjar,Gene Kinney. Владелец: Othair Prothena Ltd. Дата публикации: 2024-04-23.

Multi-epitope vaccine for the treatment of Alzheimer's disease

Номер патента: US11952406B2. Автор: Robin Barbour,Wagner Zago,Tarlochan S. Nijjar,Gene Kinney. Владелец: Othair Prothena Ltd. Дата публикации: 2024-04-09.

Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease

Номер патента: US20230322876A1. Автор: Robin Barbour,Wagner Zago,Tarlochan S. Nijjar,Gene Kinney. Владелец: Othair Prothena Ltd. Дата публикации: 2023-10-12.

Tau vaccine for the treatment of alzheimer's disease

Номер патента: WO2022031342A1. Автор: Robin Barbour,Wagner Zago,Tarlochan S. Nijjar,Gene Kinney. Владелец: Othair Prothena Limited. Дата публикации: 2022-02-10.

INHIBITORS OF THE NITRATION OF AMYLOID ß PEPTIDES AND THEIR USES IN THE DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE

Номер патента: EP2454599A1. Автор: Michael Thomas Heneka,Markus Peter Kummer. Владелец: Rheinische Friedrich Wilhelms Universitaet Bonn. Дата публикации: 2012-05-23.

Intranasal immunotherapy for the treatment of alzheimer's disease

Номер патента: EP4236988A1. Автор: Kalipada PAHAN. Владелец: RUSH UNIVERSITY MEDICAL CENTER. Дата публикации: 2023-09-06.

Intranasal immunotherapt for the treatment of alzheimer's disease

Номер патента: US20240018231A1. Автор: Kalipada PAHAN. Владелец: RUSH UNIVERSITY MEDICAL CENTER. Дата публикации: 2024-01-18.

Protein-based therapy and diagnosis of tau-mediated pathology in Alzheimer's disease

Номер патента: US09845352B2. Автор: Eva Kontsekova,Michal Novak,Branislav Kováce{hacek over (c)}h,Norbert {hacek over (Z)}ilka. Владелец: Axon NeuroScience SE. Дата публикации: 2017-12-19.

Protein-based therapy and diagnosis of tau-mediated pathology in Alzheimer's disease

Номер патента: US09828421B2. Автор: Eva Kontsekova,Michal Novak,Branislav Kováce{hacek over (c)}h,Norbert {hacek over (Z)}ilka. Владелец: Axon NeuroScience SE. Дата публикации: 2017-11-28.

Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease

Номер патента: US09518101B2. Автор: Eva Kontsekova,Norbert ZILKA,Michal Novak,Branislav Kovacech. Владелец: Axon NeuroScience SE. Дата публикации: 2016-12-13.

Method for diagnosis of alzheimer's disease and frontotemporal lobar degeneration, diagnostic agent, therapeutic agent, and screening method for said agents

Номер патента: EP4321165A2. Автор: Hitoshi Okazawa. Владелец: Tokyo Medical and Dental University NUC. Дата публикации: 2024-02-14.

Methylated peptides derived from tau protein and their antibodies for diagnosis and therapy of alzheimer's disease

Номер патента: US09738709B2. Автор: Jeffrey A. Kuret,Kristen E. Funk,Jyanyu Austin Yang,Stefani Thomas. Владелец: University of Maryland at Baltimore. Дата публикации: 2017-08-22.

Activator peptides of the enzyme adam 10 and related uses in the treatment of alzheimer's disease

Номер патента: WO2019123413A1. Автор: Elena Marcello,Stefano Musardo,Sebastien Michel Therin,Fabrizio Gardoni,Monica Maria Grazia DI LUCA,Daniele DI MARINO. Владелец: Universita' Degli Studi Di Milano. Дата публикации: 2019-06-27.

Activator peptides of the enzyme adam 10 and related uses in the treatment of alzheimer's disease

Номер патента: EP3727588A1. Автор: Elena Marcello,Stefano Musardo,Sebastien Michel Therin,Fabrizio Gardoni,Monica Maria Grazia DI LUCA,Daniele DI MARINO. Владелец: Universita degli Studi di Milano. Дата публикации: 2020-10-28.

Biomarkers and treatments of alzheimer’s disease and mild cognitive impairment

Номер патента: ZA202201230B. Автор: Eva Kontsekova,Norbert ZILKA,Michal Novak,Branislav Kovacech. Владелец: Axon NeuroScience SE. Дата публикации: 2024-09-25.

Methods of treating alzheimer's disease

Номер патента: RU2724190C2. Автор: Майкл Уорд,Уилльям ЧО,Мишель ФРИЗЕНХАН,Роберт ПОЛ. Владелец: Дженентек, Инк.. Дата публикации: 2020-06-23.

Immunological methods and compositions for the treatment of Alzheimer's disease

Номер патента: US20030232758A1. Автор: Joanne Mclaurin,Peter St. George-Hyslop. Владелец: Hospital for Sick Children HSC. Дата публикации: 2003-12-18.

Compositions and method for the diagnosis, prevention and treatment of alzheimer's disease

Номер патента: US20120114669A1. Автор: Sungmin Song,Yong-Keun Jung. Владелец: SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION. Дата публикации: 2012-05-10.

Prevention and treatment of alzheimer's disease by genome editing using the crispr/cas system

Номер патента: CA2948429A1. Автор: Jacques P. Tremblay,Pierre Chapdelaine,Joël ROUSSEAU. Владелец: UNIVERSITE LAVAL. Дата публикации: 2015-11-12.

Use of inositol-tripyrophosphate in treating Alzheimer's disease, stroke or osteoporosis

Номер патента: EP2251013A3. Автор: Jean-Marie Lehn,Ruth Greferath,Claude Nicolau,Konstantina C Fylaktakidou. Владелец: OxyPlus Inc. Дата публикации: 2011-03-23.

Adeno-associated virus vector for alzheimer's disease treatment, its application for reception of therapeutic agents, and also method of alzheimer's disease treatment by means of given vector

Номер патента: RU2335542C2. Автор: Хидео ХАРА,Такеси ТАБИРА. Владелец: Нэшнл Инститьют Оф Байомедикал Инновэйшн. Дата публикации: 2008-10-10.

Method for in vitro diagnosis of alzheimer's disease using monoclonal antibody

Номер патента: RU2416619C2. Автор: Энрике МЕНДЕС. Владелец: Консехо Супериор Де Инвестигасионес Сьентификас. Дата публикации: 2011-04-20.

Method of in-vitro diagnosis of alzheimer's disease by means of a monoclonal antibody

Номер патента: CA2601550C. Автор: Enrique Mendez. Владелец: Consejo Superior de Investigaciones Cientificas CSIC. Дата публикации: 2014-11-18.

Sorla mini-receptor for treatment of alzheimer's disease

Номер патента: EP4363440A1. Автор: Olav Michael Andersen,Anne Mette GISSEL JENSEN. Владелец: AARHUS UNIVERSITET. Дата публикации: 2024-05-08.

Methods for the treatment of alzheimer's disease and compositions therefore

Номер патента: EP1565202A2. Автор: Larry Alexander Gaither,Dalia Cohen. Владелец: Novartis Pharma Gmbh. Дата публикации: 2005-08-24.

Bace1 inhibitors for the treatment of alzheimer's disease

Номер патента: US20220389030A1. Автор: Arun K. Ghosh,Andrew Mesecar,Margherita Brindisi,Emilio Leal Cardenas. Владелец: PURDUE RESEARCH FOUNDATION. Дата публикации: 2022-12-08.

New targets for diagnosing and treating alzheimer's disease and use thereof

Номер патента: EP4450973A1. Автор: Shisong Jiang,Wenshu LU,Aili Jian,Renying ZHU. Владелец: Shanghai Jw Inflinhix Co Ltd. Дата публикации: 2024-10-23.

Combination therapies for the treatment of Alzheimer's disease and related disorders

Номер патента: AU2013334874A1. Автор: David R. Elmaleh. Владелец: General Hospital Corp. Дата публикации: 2015-05-14.

Preparation and use of a specific gaba-a.alpha.5 receptor ligand for treatment of alzheimer's disease

Номер патента: CA2212058C. Автор: Gerard Raphael Dawson. Владелец: Merck Sharp and Dohme Ltd. Дата публикации: 2008-05-13.

N-terminal truncated protofibrils/oligomers for use in therapeutic and diagnostic methods for alzheimer's disease and related disorders

Номер патента: CA2765602C. Автор: Lars Lannfelt,Paer Gellerfors,Karin Tegerstedt,Linda Soederberg. Владелец: BioArctic AB. Дата публикации: 2021-05-25.

Formulations for topic mucosal and/or oral systemic administrations containing a mixture based on lactoferrin, more effective in iron uptake, for the prevention and treatment of various pathologies

Номер патента: WO2022064357A1. Автор: Piera Valenti,Rosalba Paesano. Владелец: Microbo S.R.L.. Дата публикации: 2022-03-31.

Methods and compositions for treating alzheimer's disease

Номер патента: WO2003086300A3. Автор: Dudley Strickland,Bradley T Hyman,William G Rebeck,Ayae Kinoshita,Christa Whelan. Владелец: Christa Whelan. Дата публикации: 2004-01-22.

Preparation and use of a specific gaba-a.alpha.5 receptor ligand for treatment of alzheimer's disease

Номер патента: CA2212058A1. Автор: Gerard Raphael Dawson. Владелец: Individual. Дата публикации: 1996-08-29.

Bispecific nanobodies as a therapeutic for alzheimer's disease

Номер патента: WO2011031720A1. Автор: Michael Sierks,Srinath Kasturirangan,Shanta Boddapati. Владелец: Arizona Board of Regents Acting for And on Behalf of Arizona State University. Дата публикации: 2011-03-17.

Compounds for use in the treatment of alzheimer's disease

Номер патента: WO2013042053A3. Автор: Uwe Reusch,Melvyn Little,Stefan Knackmuss,Marc Saul WEINBERG,Stefan Franz Thomas Weiss,Katarina Jovanovic,Danielle Gonsavles,Bianca Da Costa Dias. Владелец: University of the Witwatersrand, Johannesburg. Дата публикации: 2013-07-18.

Neuroactive steroid for the treatment of alzheimer's disease

Номер патента: AU2022291395A1. Автор: Albert Jean Robichaud,Michael C. Quirk,James J. Doherty,Aaron Michael KOENIG. Владелец: Sage Therapeutics Inc. Дата публикации: 2024-01-04.

Neuroactive steroid for the treatment of alzheimer's disease

Номер патента: EP4351588A1. Автор: Albert Jean Robichaud,Michael C. Quirk,James J. Doherty,Aaron Michael KOENIG. Владелец: Sage Therapeutics Inc. Дата публикации: 2024-04-17.

Compound and method for treatment of alzheimer's disease

Номер патента: EP4087860A1. Автор: Jan Johansson. Владелец: ALPHABETA AB. Дата публикации: 2022-11-16.

DNA sequence useful for the detection of Alzheimer's disease

Номер патента: US5220013A. Автор: Barbara Cordell,Phyllis A. Ponte. Владелец: Scios Nova Inc. Дата публикации: 1993-06-15.

Compounds for use in the treatment of alzheimer's disease

Номер патента: EP2758077A2. Автор: Uwe Reusch,Melvyn Little,Stefan Knackmuss,Marc Saul WEINBERG,Stefan Franz Thomas Weiss,Katarina Jovanovic,Danielle Gonsavles,Bianca Da Costa Dias. Владелец: University of the Witwatersrand, Johannesburg. Дата публикации: 2014-07-30.

Compounds for use in the treatment of alzheimer's disease

Номер патента: US20140220041A1. Автор: Uwe Reusch,Melvyn Little,Stefan Knackmuss,Marc Saul WEINBERG,Stefan Franz Thomas Weiss,Katarina Jovanovic,Danielle Gonsavles,Bianca Da Costa Dias. Владелец: University of the Witwatersrand, Johannesburg. Дата публикации: 2014-08-07.

Compounds for use in the treatment of alzheimer's disease

Номер патента: WO2013042053A2. Автор: Uwe Reusch,Melvyn Little,Stefan Knackmuss,Marc Saul WEINBERG,Stefan Franz Thomas Weiss,Katarina Jovanovic,Danielle Gonsavles,Bianca Da Costa Dias. Владелец: University of the Witwatersrand, Johannesburg. Дата публикации: 2013-03-28.

Compounds for use in the treatment of Alzheimer's disease

Номер патента: US9365647B2. Автор: Uwe Reusch,Melvyn Little,Stefan Knackmuss,Marc Saul WEINBERG,Stefan Franz Thomas Weiss,Katarina Jovanovic,Danielle Gonsavles,Bianca Da Costa Dias. Владелец: University of the Witwatersrand, Johannesburg. Дата публикации: 2016-06-14.

Neuroactive steroid for the treatment of alzheimer's disease

Номер патента: CA3223179A1. Автор: Albert Jean Robichaud,Michael C. Quirk,James J. Doherty,Aaron Michael KOENIG. Владелец: Sage Therapeutics Inc. Дата публикации: 2022-12-15.

Compounds for use in the treatment of alzheimer's disease

Номер патента: US20160361413A1. Автор: Uwe Reusch,Melvyn Little,Stefan Knackmuss,Marc Saul WEINBERG,Stefan Franz Thomas Weiss,Katarina Jovanovic,Danielle Gonsavles,Bianca Da Costa Dias. Владелец: University of the Witwatersrand, Johannesburg. Дата публикации: 2016-12-15.

Methods and system for detecting living, non-demented patients who have alzheimer's disease neuropathology for alzheimer's disease

Номер патента: WO2019099431A1. Автор: Gregory B. Mills. Владелец: Inspired Life Medical Inc.. Дата публикации: 2019-05-23.

Multiepitope vaccine for the treatment of alzheimer’s disease

Номер патента: TW202227464A. Автор: 羅賓巴柏,吉因金尼,瓦格奈薩果. Владелец: 愛爾蘭商歐薩爾普羅席納有限公司. Дата публикации: 2022-07-16.

Methods for treating alzheimer's disease

Номер патента: AU2021249050A1. Автор: Wilfred Jefferies,Chaahat SINGH. Владелец: Individual. Дата публикации: 2022-11-17.

Inhibitors of the Nitration of Amyloid Beta Peptides and Their Uses in the Diagnosis and Treatment of Alzheimer's Disease

Номер патента: US20120192294A1. Автор: Michael Thomas Heneka,Markus Peter Kummer. Владелец: Rheinische Friedrich Wilhelms Universitaet Bonn. Дата публикации: 2012-07-26.

Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, treatments and animal models produced therefrom

Номер патента: EP1481007B1. Автор: Paul Averback. Владелец: Nymox Corp. Дата публикации: 2007-01-24.

Therapeutic agent for alzheimer's disease

Номер патента: US20210162069A1. Автор: Fuyuki Mitsuyama. Владелец: Individual. Дата публикации: 2021-06-03.

Methods for diagnosing and treating alzheimer's disease by administering an anti-angiogenic agent

Номер патента: US20140294726A1. Автор: Wilfred Jefferies,Kaan E. Biron,Dara L. Dickstein. Владелец: Individual. Дата публикации: 2014-10-02.

Methods for diagnosing and treating alzheimer’s disease

Номер патента: AU2020204610A1. Автор: Wilfred Jefferies,Kaan E. Biron,Dara L. Dickstein. Владелец: Cava Healthcare Inc. Дата публикации: 2020-07-30.

Methods for diagnosing and treating alzheimer's disease

Номер патента: US20170224792A1. Автор: Wilfred Jefferies,Kaan E. Biron,Dara L. Dickstein. Владелец: Dara L. Dickstein. Дата публикации: 2017-08-10.

Methods for diagnosing and treating alzheimer's disease by administering an angiogenic agent

Номер патента: EP2734221A1. Автор: Kaan E. Biron,Dara L. Dickstein,Dr. Wilfred Jefferies. Владелец: Dickstein Dara L. Дата публикации: 2014-05-28.

Methods for diagnosing and treating alzheimer's disease

Номер патента: US20210100881A1. Автор: Wilfred Jefferies,Kaan E. Biron,Dara L. Dickstein. Владелец: Cava Healthcare Inc. Дата публикации: 2021-04-08.

Methods for diagnosing and treating alzheimer’s disease

Номер патента: AU2022202855A1. Автор: Wilfred Jefferies,Kaan E. Biron,Dara L. Dickstein. Владелец: Cava Healthcare Inc. Дата публикации: 2022-05-19.

Methods for diagnosing and treating Alzheimer's disease

Номер патента: US11925678B2. Автор: Wilfred Jefferies,Kaan E. Biron,Dara L. Dickstein. Владелец: Cava Healthcare Inc. Дата публикации: 2024-03-12.

Methods for diagnosing and treating alzheimer’s disease

Номер патента: AU2020204610B2. Автор: Wilfred Jefferies,Kaan E. Biron,Dara L. Dickstein. Владелец: Cava Healthcare Inc. Дата публикации: 2022-05-26.

Methods for diagnosing and treating Alzheimer's disease

Номер патента: US10792347B2. Автор: Wilfred Jefferies,Kaan E. Biron,Dara L. Dickstein. Владелец: Alternative Extracts Inc. Дата публикации: 2020-10-06.

Therapeutic agent for alzheimer's disease

Номер патента: EP3804766A1. Автор: Fuyuki Mitsuyama. Владелец: Individual. Дата публикации: 2021-04-14.

Zinc-charged peptides for the treatment of cancer and alzheimer's disease

Номер патента: US20240199712A1. Автор: Men Hwei Tsai. Владелец: Individual. Дата публикации: 2024-06-20.

Zinc-charged peptides for the treatment of cancer and alzheimer's disease

Номер патента: US12065470B2. Автор: Men Hwei Tsai. Владелец: Individual. Дата публикации: 2024-08-20.

Modulators of expression and function of lrp in alzheimer's disease

Номер патента: WO1997004794A1. Автор: Bradley T. Hyman,Dudley K. Strickland,Rudolph E. Tanzi,Maria Z. Kounnas,Robert D. Moir. Владелец: The American National Red Cross. Дата публикации: 1997-02-13.

Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

Номер патента: US09512191B2. Автор: Nazneen Dewji,S. Jonathan Singer. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2016-12-06.

Active immunization for treatment of alzheimer's disease

Номер патента: US6905686B1. Автор: Dale B. Schenk. Владелец: Neuralab Ltd. Дата публикации: 2005-06-14.

Neural thread protein gene expression and detection of alzheimer's disease

Номер патента: AU674581B2. Автор: Jack R. Wands,Suzanne M. De La Monte. Владелец: General Hospital Corp. Дата публикации: 1997-01-02.

Optical method for the detection of alzheimer's disease

Номер патента: CA2735869C. Автор: Keith L. Black,Yosef Koronyo,Maya Koronyo,Michal Schwartz,Daniel L. Farkas. Владелец: Yeda Research and Development Co Ltd. Дата публикации: 2020-08-18.

Neural thread protein gene expression and detection of Alzheimer's disease

Номер патента: US5948888A. Автор: Jack R. Wands,Suzanne De La Monte. Владелец: General Hospital Corp. Дата публикации: 1999-09-07.

Cd33 antibody compositions for treating alzheimer's disease

Номер патента: WO2024092001A1. Автор: David A. Scheinberg,Yue-ming LI,Wan Fung Eitan WONG,Manish MALVIYA,Kristen VOGT,George LIAO. Владелец: Memorial Hospital for Cancer and Allied Diseases. Дата публикации: 2024-05-02.

Phosphinic acid derivatives, beta-secretase inhibitors for treating alzheimer's disease

Номер патента: RU2367666C2. Автор: Ханс ХИЛЬПЕРТ,Роланд ХУММ,Петер ВАЙСС,Дитмар КНОПП,Ханс ХИЛЬПЕРТ (CH),Роланд ХУММ (DE),Дитмар КНОПП (CH),Петер ВАЙСС (CH). Владелец: Ф.Хоффманн-Ля Рош Аг. Дата публикации: 2009-09-20.

Transgenic mouse assay to determine the effect of Aβ antibodies and Aβ Fragments on alzheimer's disease characteristics

Номер патента: US6710226B1. Автор: Dale B. Schenk. Владелец: Neuralab Ltd. Дата публикации: 2004-03-23.

Compound and method for treatment of alzheimer's disease

Номер патента: US20230002458A1. Автор: Jan Johansson. Владелец: ALPHABETA AB. Дата публикации: 2023-01-05.

Methods of Prevention or Treatment of Alzheimer's Disease by Blocking or Decreasing STING Signaling Activation

Номер патента: US20230279100A1. Автор: Feng Xue. Владелец: Individual. Дата публикации: 2023-09-07.

Compositions and methods for treating alzheimer's disease

Номер патента: US11873321B2. Автор: Yi Zhou,Xin-Yuan Fu. Владелец: Generos Biopharma Ltd. Дата публикации: 2024-01-16.

Compositions and methods for treating Alzheimer's disease

Номер патента: AU2018270906B2. Автор: Xin-Yuan Fu. Владелец: Generos Biopharma Ltd. Дата публикации: 2024-02-29.

Oxime-Containing Acyl Guanidines as Beta-Secretase Inhibitors

Номер патента: US20070232581A1. Автор: Yong-Jin Wu,Shuhao Shi,Shirong Zhu,Samuel Gerritz. Владелец: Bristol Myers Squibb Co. Дата публикации: 2007-10-04.

AMYLOID-BETA-BINDING PEPTIDES AND THE USE THEREOF FOR THE TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE

Номер патента: US20200002379A9. Автор: Willbold Dieter. Владелец: . Дата публикации: 2020-01-02.

AMYLOID-BETA-BINDING PEPTIDES AND THE USE THEREOF FOR THE TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE

Номер патента: US20160297852A1. Автор: Willbold Dieter. Владелец: . Дата публикации: 2016-10-13.

AMYLOID-BETA-BINDING PEPTIDES AND THE USE THEREOF FOR THE TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE

Номер патента: US20200317734A1. Автор: Willbold Dieter. Владелец: . Дата публикации: 2020-10-08.

Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

Номер патента: CA2760519C. Автор: Nazneen Dewji,S. Jonathan Singer. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2020-10-27.

Alzheimer's disease secretase, APP substrates thereof, and uses thereof

Номер патента: US20050196398A1. Автор: Mark Gurney,Michael Bienkowski. Владелец: Pharmacia and Upjohn Co. Дата публикации: 2005-09-08.

Methods of delaying or preventing the onset of alzheimer's disease using crenezumab

Номер патента: WO2023245008A1. Автор: Nan Hu,Eric Reiman,Kaycee Michelle Sink,Shehnaaz SULIMAN,Carole HO,Pierre Tariot,Jessica LANGBAUM. Владелец: Banner Health. Дата публикации: 2023-12-21.

Methods for the Treatment and Diagnosis of Alzheimer's Disease and Traumatic Brain Injuries

Номер патента: US20180179259A1. Автор: Sahel Jose-Alain,Leveillard Thierry,Camara Hawa. Владелец: . Дата публикации: 2018-06-28.

Transgenic animals and cell lines for screening effective drugs for the treatment or prevention of Alzheimer's disease

Номер патента: JP4194664B2. Автор: ラモンテ，スザンヌデ,アール．ワンズ，ジャック. Владелец: ザジェネラルホスピタルコーポレイション. Дата публикации: 2008-12-10.

Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease

Номер патента: US20020129391A1. Автор: Suzanne De La Monte,Jack Wands. Владелец: Individual. Дата публикации: 2002-09-12.

Methods for the treatment and diagnosis of alzheimer's disease and traumatic brain injuries

Номер патента: EP3307392B1. Автор: Thierry Leveillard,José-Alain Sahel,Hawa Camara. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2019-05-29.

Poly-ga proteins in alzheimer's disease

Номер патента: EP4427049A1. Автор: Laura Ranum,Lien Nguyen. Владелец: University Of Florida. Дата публикации: 2024-09-11.

Peptides which bind to a specific a-beta-species for the therapy and/or diagnosis of alzheimer's disease

Номер патента: EP3271374B1. Автор: Dieter Willbold,Janine Kutzsche,Antonia Nicole KLEIN. Владелец: FORSCHUNGSZENTRUM JUELICH GMBH. Дата публикации: 2020-06-03.

Amyloid beta-binding peptides and their use for the treatment and diagnosis of alzheimer's dementia

Номер патента: CN105745219B. Автор: D.维尔博尔德. Владелец: FORSCHUNGSZENTRUM JUELICH GMBH. Дата публикации: 2020-10-09.

Monoclonal antibody to treat alzheimer's disease, prion disease, frontotemporal dementias and traumatic brain injury/chronic traumatic encephalopathy

Номер патента: US20190010238A1. Автор: Thomas Wisniewski,Allal BOUTAJANGOUT. Владелец: New York University NYU. Дата публикации: 2019-01-10.

Identification of genes involved in alzheimer's disease using drosophila melanogaster

Номер патента: US20020174446A1. Автор: Dalia Cohen,Mary Konsolaki,Felix Freuler,Susan Zusman,Uwe Dengler,Alyce Finelli,Mischa Reinhardt. Владелец: Individual. Дата публикации: 2002-11-21.

Methods to treat alzheimer's disease using apoe inhibitors

Номер патента: WO2013181618A3. Автор: Asa Abeliovich. Владелец: The Trustees of Columbia University in the City of New York. Дата публикации: 2014-03-27.

Be used for the treatment of neurodegenerative disorders and alzheimer's disease and improve the method and composition of normal memory

Номер патента: CN103282374B. Автор: 纳兹尼恩·德维基,S·乔纳森·辛格. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2016-02-03.

Specific A-beta Species-Binding Peptides for the Therapy and/or Diagnosis of Alzheimer's Dementia

Номер патента: US20180044398A1. Автор: Willbold Dieter,Kutzsche Janine,KLEIN Antonia. Владелец: . Дата публикации: 2018-02-15.

Treating alzheimer's disease utilizing extracorporeal radiofrequency

Номер патента: US20230048601A1. Автор: Qiang Chen,Mitchell Steven Felder. Владелец: Halberd Corp. Дата публикации: 2023-02-16.

Peptide with treatment action against alzheimer's disease

Номер патента: RU2626972C2. Автор: Александр Николаевич Самохин,Наталья Викторовна Бобкова,Ольга Марковна Вольпина,Анна Владимировна Камынина,Дмитрий Отарович Короев,Татьяна Данииловна Волкова,Маргарита Павловна Филатова. Владелец: Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН). Дата публикации: 2017-08-02.

Biofluid-based methods for diagnosing alzheimer's disease-associated conditions

Номер патента: EP4307988A1. Автор: Hugo Vanderstichele,Leyla ANDERSON,Steven R. Verdooner. Владелец: Neurovision Imaging Inc. Дата публикации: 2024-01-24.

Biofluid-Based Methods for Diagnosing Alzheimer’s Disease-Associated Conditions

Номер патента: US20240159777A1. Автор: Hugo Vanderstichele,Leyla ANDERSON,Steven R. Verdooner. Владелец: Neurovision Imaging Inc. Дата публикации: 2024-05-16.

Methods of using gm6 in diagnosing and treating alzheimer's disease

Номер патента: WO2018119018A1. Автор: Pui-Yuk Dorothy Ko,William Swindell. Владелец: Genervon Biopharmaceuticals, LLC. Дата публикации: 2018-06-28.

Methods of treating alzheimer's disease

Номер патента: RU2720468C2. Автор: Роберт Грэхэм. Владелец: Дженентек, Инк.. Дата публикации: 2020-04-30.

Methods for treating Alzheimer's disease

Номер патента: AU2021282448A1. Автор: Jeffrey Joseph Sevigny,Leslie Lugene Williams,James L. Ferrero. Владелец: Biogen International Neuroscience GmbH. Дата публикации: 2022-01-06.

Marker peptide for alzheimer's disease

Номер патента: US20110014635A1. Автор: Kazuo Yamamoto,Toshiharu Suzuki,Masaki Nishimura,Yoichi Araki,Haruyasu Yamaguchi,Naomi Miyagi. Владелец: Individual. Дата публикации: 2011-01-20.

Peptide for augmenting and expression of BDNF and pharmaceutical composition for prevention and treatment of neurodegenerative diseases including Alzheimer's disease or Parkinson's disease, comprising the same

Номер патента: US8557960B2. Автор: Hong Gi Kim,Kil Lyong Kim,Woo Ram Jung,Dong Ik Park,Min Kyoo Shin. Владелец: SUNGKYUNKWAN UNIVERSITY. Дата публикации: 2013-10-15.

Therapeutic Agent For Alzheimer's Disease

Номер патента: US20090246170A1. Автор: Hitoshi Iwasaki,Mamoru Hasegawa,Makoto Inoue,Hiroto Hara,Yumiko Tokusumi,Toshiaki Tabata. Владелец: Dnavec Corp. Дата публикации: 2009-10-01.

Peptide therapeutics for treating alzheimer's disease and related conditions

Номер патента: EP3802568A1. Автор: Heloise Anne Pereira,Anne Kasus-Jacobi,Amanda J. STOCK. Владелец: University of Oklahoma . Дата публикации: 2021-04-14.

Methods of Treating Alzheimer's Disease

Номер патента: US20230070758A1. Автор: Xue Hua,William Walker,Hans J. MOEBIUS,Leen Kawas,Kevin Church. Владелец: Athira Pharma Inc. Дата публикации: 2023-03-09.

Assay method for Alzheimer's disease

Номер патента: US09453069B2. Автор: David M. Holtzman,Ronald Demattos,Kelly R. Bales,Steven M. Paul,David J. Cummins. Владелец: Washington University in St Louis WUSTL. Дата публикации: 2016-09-27.

Method of treating alzheimer's disease

Номер патента: RU2526155C2. Автор: БАРРИО Мануэль САРАСА. Владелец: Араклон Байотек, С.Л.. Дата публикации: 2014-08-20.

Gene therapy for alzheimer's disease

Номер патента: EP3976637A1. Автор: Jie Shen,Raymond J. KELLEHER III. Владелец: Brigham and Womens Hospital Inc. Дата публикации: 2022-04-06.

Method for treating alzheimer’s disease

Номер патента: NZ731520A. Автор: James Ferrero,Jeffrey SEVIGNY,Leslie Williams. Владелец: Biogen Int Neuroscience Gmbh. Дата публикации: 2021-08-27.

Methods for treating alzheimer's disease

Номер патента: US20180333487A1. Автор: Jeffrey Joseph Sevigny,Leslie Lugene Williams,James L. Ferrero. Владелец: Biogen International Neuroscience GmbH. Дата публикации: 2018-11-22.

Method for treating Alzheimer's disease

Номер патента: AU2015356773B2. Автор: Jeffrey Joseph Sevigny,Leslie Lugene Williams,James L. Ferrero. Владелец: Biogen International Neuroscience GmbH. Дата публикации: 2021-09-09.

Method for treating alzheimer's disease

Номер патента: EP3227329A2. Автор: Jeffrey Joseph Sevigny,Leslie Lugene Williams,James L. Ferrero. Владелец: BIOGEN IDEC INTERNATIONAL NEUROSCIENCE GMBH. Дата публикации: 2017-10-11.

Peptide therapeutics for treating alzheimer's disease and related conditions

Номер патента: US20210115426A1. Автор: Heloise Anne Pereira,Anne Kasus-Jacobi,Amanda J. STOCK. Владелец: University of Oklahoma . Дата публикации: 2021-04-22.

Peptide therapeutics for treating alzheimer's disease and related conditions

Номер патента: EP4259188A2. Автор: Heloise Anne Pereira,Anne Kasus-Jacobi,Amanda J. STOCK. Владелец: University of Oklahoma . Дата публикации: 2023-10-18.

Method for treating alzheimer's disease

Номер патента: NZ731520B2. Автор: Jeffrey Joseph Sevigny,Leslie Lugene Williams,James L Ferrero. Владелец: Biogen International Neuroscience GmbH. Дата публикации: 2021-11-30.

Biomarkers for alzheimer's disease treatment

Номер патента: EP4367516A1. Автор: Robert Gordon,David Verbel,Pallavi SACHDEV,Michael Irizarry,Larisa Reyderman,Akihiko Koyama,June Kaplow,Lynn Kramer,Shobha DHADDA,Chad SWANSON,Michio KANEKIYO,Seiichi HAYATO,Ishani LANDRY. Владелец: Eisai R&D Management Co Ltd. Дата публикации: 2024-05-15.

Methods for treating alzheimer's disease

Номер патента: US20240270830A1. Автор: Karen SMIRNAKIS,Patrick Ryland BURKETT,Kimberly UMANS. Владелец: Biogen MA Inc. Дата публикации: 2024-08-15.

Method for treating Alzheimer's disease and method for downregulating protein aggregation in brain

Номер патента: US20190161525A1. Автор: Nan-Shan CHANG,Yu-Min Kuo. Владелец: National Cheng Kung University NCKU. Дата публикации: 2019-05-30.

Novel blood cell biomarker for late onset alzheimer's disease

Номер патента: EP3345000A1. Автор: Christopher Wheeler. Владелец: Cedars Sinai Medical Center. Дата публикации: 2018-07-11.

Nucleic acids for diagnosing and modeling Alzheimer's disease

Номер патента: US5455169A. Автор: Michael J. Mullan. Владелец: Alzheimers Institute of America Inc. Дата публикации: 1995-10-03.

Methods of treating alzheimer's disease

Номер патента: AU2022312384A1. Автор: Xue Hua,William Walker,Hans J. MOEBIUS,Leen Kawas,Kevin Church. Владелец: Athira Pharma Inc. Дата публикации: 2024-01-04.

Agglutination of gangliosides for treating alzheimer's disease

Номер патента: US20200017578A1. Автор: Eugene Ponomarev,Marina Dukhinova,Tatyana Veremeyko,Andrew L.M. Chan. Владелец: Chinese University of Hong Kong CUHK. Дата публикации: 2020-01-16.

Method of treating alzheimer's disease with expanded natural killer cells

Номер патента: WO2024036005A1. Автор: Sang Woo Park,Yong Man Kim,Paul Y. Song. Владелец: LOOTS, Eli. Дата публикации: 2024-02-15.

Methods for treating Alzheimer's disease

Номер патента: US11781135B2. Автор: C. Frank Bennett,Timothy M. Miller,Frank Rigo,Sarah Devos. Владелец: Biogen MA Inc. Дата публикации: 2023-10-10.

Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease

Номер патента: EP1153036A1. Автор: Rudolph E. Tanzi,Dora M. Kovacs,Aleister J. Saunders. Владелец: General Hospital Corp. Дата публикации: 2001-11-14.

Application Of PI4KIIIA Protein And Related Membrane Protein Complex In Treating Alzheimer's Disease

Номер патента: US20240173287A1. Автор: YANG He,Tong Zhu,Le Zhang,Xiao Zhang,Haiyan Liu,Yudong Zhou,Fude HUANG,Wenan WANG,Wanguo Wei,Lixiang Jiang. Владелец: Jiangsu Nuo-Beta Pharmaceutical Technology Co Ltd. Дата публикации: 2024-05-30.

Method for treating alzheimer's disease by targeting mapt gene

Номер патента: EP4179082A1. Автор: Tetsuya Yamagata,Iain Robert Thompson,Talha AKBULUT. Владелец: Modalis Therapeutics Corp. Дата публикации: 2023-05-17.

Blood-based diagnostic assays for alzheimer's disease

Номер патента: CA3226615A1. Автор: Ian Pike,George Thornton,Michael BREMANG. Владелец: Cassava Sciences Inc. Дата публикации: 2023-03-30.

Novel gamma-lactams as beta-secretase inhibitors

Номер патента: US20060046984A1. Автор: John Macor,Jianliang Shi,Lorin Thompson,Kenneth Boy. Владелец: Individual. Дата публикации: 2006-03-02.

PIPERAZINE THIAZOLE DERIVATIVES USEFUL IN THE TREATMENT OF TAUOPATHIES SUCH AS ALZHEIMER'S DISEASE

Номер патента: US20140206699A1. Автор: Nettekoven Matthias,Ratni Hasane,Cecere Giuseppe,Vifian Walter,Princen Katrien,Griffioen Gerard,Rogres-Evans Mark. Владелец: REMYND NV. Дата публикации: 2014-07-24.

Method for selecting a transgenic mouse model of alzheimer's disease

Номер патента: US6717031B2. Автор: Kate Dora Games,Russell E. Rydel,Dale Bernard Schenk,Lisa Claire McConlogue,Peter Andrew Seubert. Владелец: Athena Neurosciences Inc. Дата публикации: 2004-04-06.

Method for identifying alzheimer's disease therapeutics using transgenic animal models

Номер патента: WO1996040896A1. Автор: Dale B. Schenk,Peter A. Seubert,Russell E. Rydel,Kate D. Games,Lisa Claire McConlogue. Владелец: Athena Neurosciences, Inc.. Дата публикации: 1996-12-19.

Transgenic animal models for alzheimer's disease

Номер патента: CA2127450C. Автор: Vermuri B. Reddy,Samuel Wadsworth,Benjamin Snyder,Chamer Wei. Владелец: Elan Pharmaceuticals LLC. Дата публикации: 2007-04-17.

Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease

Номер патента: CA2085127C. Автор: Barbara Cordell. Владелец: Scios Nova Inc. Дата публикации: 2002-12-10.

Wild-derived mouse models of alzheimer's disease

Номер патента: AU2023232109A1. Автор: Gareth Howell,Gregory Carter,Michael SASNER,Kristen ONOS. Владелец: Jackson Laboratory. Дата публикации: 2024-10-10.

Models of Alzheimer's Disease

Номер патента: GB2295395A. Автор: Brian Anderton,Christopher Charles Joh Miller. Владелец: INST OF PSYCHIATRY. Дата публикации: 1996-05-29.

Non-human primate alzheimer's disease model animal and method for producing same

Номер патента: US20230027317A1. Автор: Takashi Yamamoto,Kenichi Nagata,Kenya Sato,Tetsushi Sakuma,Takaomi Saido,Erika Sasaki,Wakako KUMITA,Hiroki SASAGURI. Владелец: Central Institute for Experimental Animals. Дата публикации: 2023-01-26.

Non-human primate alzheimer's disease model animal and method for producing same

Номер патента: EP4079852A1. Автор: Takashi Yamamoto,Kenichi Nagata,Kenya Sato,Tetsushi Sakuma,Takaomi Saido,Erika Sasaki,Wakako KUMITA,Hiroki SASAGURI. Владелец: Central Inst for Experimental Animals. Дата публикации: 2022-10-26.

Wild-derived mouse models of alzheimer's disease

Номер патента: WO2023173009A2. Автор: Gareth Howell,Gregory Carter,Michael SASNER,Kristen ONOS. Владелец: THE JACKSON LABORATORY. Дата публикации: 2023-09-14.

Wild-derived mouse models of alzheimer's disease

Номер патента: WO2023173009A3. Автор: Gareth Howell,Gregory Carter,Michael SASNER,Kristen ONOS. Владелец: THE JACKSON LABORATORY. Дата публикации: 2023-10-26.

Alzheimer's disease animal model, method for obtaining same and uses thereof

Номер патента: CA2638983A1. Автор: Lluis Montoliu Jose,Fernando Valdivieso Amate,Julio Pozueta Larios. Владелец: Individual. Дата публикации: 2007-06-07.

Non-human alzheimer's disease model animal and method for producing same

Номер патента: EP4043568A1. Автор: Hiroyuki Yamazaki,Yuko Sekino,Kenji HANAMURA,Tomoaki Shirao,Noriko Koganezawa. Владелец: Alzmed Inc. Дата публикации: 2022-08-17.

Non-human alzheimer's disease model animal and method for producing same

Номер патента: US20230138759A1. Автор: Hiroyuki Yamazaki,Yuko Sekino,Kenji HANAMURA,Tomoaki Shirao,Noriko Koganezawa. Владелец: Alzmed Inc. Дата публикации: 2023-05-04.

Use of the ornithine transcarbamylase (otc), as a marker for diagnosing a brain alteration including alzheimer's disease or non-alzheimer's dementia

Номер патента: CA2649462A1. Автор: Philippe Amouyel,Stephanie Ferreira,Jean-Charles Lambert. Владелец: Individual. Дата публикации: 2007-10-25.

USE OF Aß34 TO ASSESS ALZHEIMER’S DISEASE PROGRESSION

Номер патента: US20210285971A1. Автор: Gerhard MULTHAUP,Adeola Shobo. Владелец: Royal Institution for the Advancement of Learning. Дата публикации: 2021-09-16.

Methods for treating and diagnosing a cancer secreting cath-d or alzheimer's disease

Номер патента: WO2009043858A9. Автор: Emmanuelle Liaudet,Christine Prebois,Danielle Derocq,Mélanie Beaujoin. Владелец: Mélanie Beaujoin. Дата публикации: 2009-07-09.

Diagnostic tests for alzheimer's disease

Номер патента: WO1999058981A2. Автор: Daniel L. Alkon,Maurizio Grimaldi,Antonella R. Favit. Владелец: The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services. Дата публикации: 1999-11-18.

Diagnostic tests for alzheimer's disease

Номер патента: EP1078259A2. Автор: Daniel L. Alkon,Maurizio Grimaldi,Antonella R. Favit. Владелец: US Department of Health and Human Services. Дата публикации: 2001-02-28.

Methods for diagnosing and treating alzheimer's disease and parkinson's disease

Номер патента: CA2493718A1. Автор: Paul F. Good,D. Stave Kohtz. Владелец: Individual. Дата публикации: 2003-01-30.

Biological devices and methods of use thereof for the study and control of alzheimer's disease

Номер патента: US09890201B2. Автор: Raul CUERO RENGIFO,Diana Marcela VASQUEZ FORERO. Владелец: INTERNATIONAL PARK OF CREATIVITY Co. Дата публикации: 2018-02-13.

Cell test for alzheimer's disease

Номер патента: WO1994025872A1. Автор: Ito Etsuro,Daniel L. Alkon,Gary E. Gibson,Rene Etcheberrigaray. Владелец: Conell Research Foundation, Inc.. Дата публикации: 1994-11-10.

Cell test for Alzheimer's disease

Номер патента: AU689776B2. Автор: Ito Etsuro,Daniel L. Alkon,Rene Etcheberrigaray,Gary E Gibson. Владелец: Cornell Research Foundation Inc. Дата публикации: 1998-04-09.

Synaptic protein biomarkers and differential diagnosis of alzheimer's disease and other neurodegenerative disorders

Номер патента: EP3452828A1. Автор: Edward J. Goetzl. Владелец: Nanosomix Inc. Дата публикации: 2019-03-13.

Benfotiamine derivatives in the treatment of alzheimer's disease

Номер патента: US11820787B2. Автор: Huan ZHANG,Chunjiu Zhong. Владелец: Shanghai Raising Pharmaceutical Co Ltd. Дата публикации: 2023-11-21.

Methods for treating and diagnosing a cancer secreting cath-d or alzheimer's disease

Номер патента: WO2009043858A2. Автор: Emmanuelle Liaudet,Christine Prebois,Danielle Derocq,Mélanie Beaujoin. Владелец: Inserm (Institut National de la Sante et de la Recherche Medicale). Дата публикации: 2009-04-09.

Compositions and methods for diagnosing alzheimer's disease

Номер патента: US6495335B2. Автор: Mario Chojkier,Martina Buck. Владелец: Individual. Дата публикации: 2002-12-17.

Methods for treating and diagnosing a cancer secreting cath-d or alzheimer's disease

Номер патента: WO2009043858A3. Автор: Emmanuelle Liaudet,Christine Prebois,Danielle Derocq,Mélanie Beaujoin. Владелец: Mélanie Beaujoin. Дата публикации: 2009-05-28.

p53 Peptides as Markers in the Diagnosis and Prognosis of Alzheimer's Disease

Номер патента: US20240060994A1. Автор: Maurizio Memo,Daniela Letizia UBERTI. Владелец: Diadem Spa. Дата публикации: 2024-02-22.

Negative correlation between irp-2 and transferrin receptor expression as a diagnostic of alzheimer's disease

Номер патента: US20100143924A1. Автор: Wolff M. Kirsch. Владелец: LOMA LINDA UNIVERSITY. Дата публикации: 2010-06-10.

Cell test for alzheimer's disease

Номер патента: AU6778494A. Автор: Ito Etsuro,Daniel L. Alkon,Rene Etcheberrigaray,Gary E Gibson. Владелец: US Department of Health and Human Services. Дата публикации: 1994-11-21.

Methods for the diagnosis of alzheimer's disease

Номер патента: WO1995005604A3. Автор: Carl R Merril,Ginger Johnson,Hossein A Ghanbari,Benjamin Wolozin. Владелец: Molecular Geriatrics Corp. Дата публикации: 2001-09-13.

Diagnostic method for alzheimer's disease

Номер патента: CA2782432C. Автор: Maria Zellner,Ellen Umlauf. Владелец: Randox Laboratories Ltd. Дата публикации: 2019-01-08.

Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41)

Номер патента: US6114133A. Автор: Robin Barbour,Dale B. Schenk,Peter A. Seubert,Carmen Vigo-Pelfrey. Владелец: Eli Lilly and Co. Дата публикации: 2000-09-05.

Biomarkers for diagnosing alzheimer's disease

Номер патента: CA2746000C. Автор: Denis François HOCHSTRASSER,Jean-Charles Sanchez,Gerhard Koenig,Oezkan Yalkinoglu,Odile Carrette. Владелец: Bayer Schering Pharma AG. Дата публикации: 2014-10-21.

Biomarkers comprising peptide sequence vnhvtlsqpk for diagnosing alzheimer's disease

Номер патента: CA2745724C. Автор: Denis François HOCHSTRASSER,Jean-Charles Sanchez,Gerhard Koenig,Oezkan Yalkinoglu,Odile Carrette. Владелец: Bayer Schering Pharma AG. Дата публикации: 2015-06-02.

Biomarkers for diagnosing alzheimer's disease

Номер патента: CA2496321E. Автор: Denis François HOCHSTRASSER,Jean-Charles Sanchez,Gerhard Koenig,Oezkan Yalkinoglu,Odile Carrette. Владелец: Odile Carrette. Дата публикации: 2004-03-04.

Alzheimer's disease, secretase, APP substrates therefor, and uses therefor

Номер патента: US6790610B2. Автор: Mark E. Gurney,Luis A. Parodi,Michael J. Bienkowski,Robert L. Heinrikson,Riqiang Yan. Владелец: Pharmacia and Upjohn Co. Дата публикации: 2004-09-14.

Alzheimer's disease secretase, APP substrates therefor, and uses therefor

Номер патента: US20010018208A1. Автор: Mark Gurney,Riqiang Yan,Robert Heinrikson,Luis Parodi,Michael Bienkowski. Владелец: Pharmacia and Upjohn Co. Дата публикации: 2001-08-30.

CDNA clone encoding brain amyloid of alzheimer's disease

Номер патента: US4912206A. Автор: Dmitry Y. Goldgaber,Michael Lerman,D. Carleton Gajdusek. Владелец: US Department of Health and Human Services. Дата публикации: 1990-03-27.

Process for differential diagnosis of alzheimer's dementia in patients exhibiting mild cognitive impairment

Номер патента: NZ538669A. Автор: Miyoko Takahashi,George Jackowski. Владелец: Syn X Pharma Inc. Дата публикации: 2007-01-26.

Process for differential diagnosis of alzheimer's dementia and device therefor

Номер патента: GB2380546B. Автор: Miyoko Takahashi,George Jackowski. Владелец: Syn X Pharma Inc. Дата публикации: 2003-11-19.

Method for the detection of a neurological or psychiatric, demential disease, especially alzheimer's disease by use of cholecystokinin (cck) -molecules, corresponding substances and detection reagents

Номер патента: WO2005038463A8. Автор: Hans-Dieter Zucht,Hartmut Selle,Jens Lamerz,Thomas Moehring. Владелец: Thomas Moehring. Дата публикации: 2006-02-16.

Diagnostic agent and method for alzheimer's disease

Номер патента: WO2024049357A1. Автор: Chin Tong ONG,Zhen Kai NGIAN,Yow Yong TAN. Владелец: TEMASEK LIFE SCIENCES LABORATORY LIMITED. Дата публикации: 2024-03-07.

Amyloid beta aggregates in cerebro spinal fluid as biomarkers for alzheimer's disease

Номер патента: CA2781952A1. Автор: Alice Yam,Xuemei Wang,David Peretz,Man Gao (Carol),Sophie Allauzen,Joseph Fedynyshyn. Владелец: NOVARTIS AG. Дата публикации: 2011-06-03.

Diagnostic methods for alzheimer's disease

Номер патента: US6287793B1. Автор: Dale B. Schenk,Robin M. Barbour,Kelly L. Johnson. Владелец: Elan Pharmaceuticals LLC. Дата публикации: 2001-09-11.

Diagnostic drug and diagnostic method for alzheimer's disease

Номер патента: CA2823286C. Автор: Hiroyuki Nakagawa,Mikio Aoki,Masakazu Hashimoto,Lars O. Tjernberg,Bengt Winblad. Владелец: Sumitomo Dainippon Pharma Co Ltd. Дата публикации: 2020-01-28.

Polypeptide marker for alzheimer's disease and its use for diagnosis

Номер патента: CA1268131A. Автор: George G. Glenner,Caine W. Wong. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 1990-04-24.

The application of antibodies for detecting protein biomarker group in the preparation of kits for diagnosing Alzheimer's disease, mild cognitive impairment and other senile dementia

Номер патента: LU503936B1. Автор: Zhengqian DAI,Bojun Gu. Владелец: Hunan Qiankang Tech Co Ltd. Дата публикации: 2024-07-05.

Polypeptide marker for Alzheimer's disease and its use for diagnosis

Номер патента: US4666829A. Автор: George G. Glenner,Caine W. Wong. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 1987-05-19.

Protein and its use in diagnosing alzheimer's disease

Номер патента: WO2006089422A1. Автор: Paul Averback,Jack Gemmell. Владелец: NYMOX CORPORATION. Дата публикации: 2006-08-31.

Lateral flow device for diagnosing alzheimer's disease using the t14 peptide

Номер патента: WO2024052650A1. Автор: Susan Greenfield,Sara GARCIA-RATES. Владелец: NEURO-BIO LTD. Дата публикации: 2024-03-14.

Method for detecting mild cognitive impairment and mild alzheimer's disease

Номер патента: US20230417774A1. Автор: Yoshiya Oda,Suzumi TOKUOKA,Fumie HAMANO. Владелец: University of Tokyo NUC. Дата публикации: 2023-12-28.

Compositions, kits, and methods for detecting preclinical alzheimer's disease

Номер патента: CA3228621A1. Автор: Xin Huang,James Doecke,Yihan Li,Baijun GU. Владелец: NEUROQUEST Ltd. Дата публикации: 2023-02-16.

Therapeutic targets for Alzheimer's disease

Номер патента: US09944986B2. Автор: Zsuzsanna Nagy. Владелец: UNIVERSITY OF BIRMINGHAM. Дата публикации: 2018-04-17.

Alzheimer's disease-specific alterations of protein kinase c epsilon (pkc-epsilon) protein levels

Номер патента: CA2790680C. Автор: Daniel L. Alkon,Tapan K. Khan. Владелец: Blanchette Rockefeller Neuroscience Institute. Дата публикации: 2019-02-19.

Therapeutic targets for alzheimer's disease

Номер патента: EP2872529A2. Автор: Zsuzsanna Nagy. Владелец: UNIVERSITY OF BIRMINGHAM. Дата публикации: 2015-05-20.

Inhibitors of src kinase for use in alzheimer's disease

Номер патента: EP1556703A2. Автор: Nicola Zambrano,Luc Mercken,Tommaso Russo. Владелец: AVENTIS PHARMA SA. Дата публикации: 2005-07-27.

Inhibitors of src kinase for use in alzheimer's disease

Номер патента: EP1556703B1. Автор: Nicola Zambrano,Luc Mercken,Tommaso Russo. Владелец: AVENTIS PHARMA SA. Дата публикации: 2008-10-22.

Inhibitors of src kinase for use in alzheimer's disease

Номер патента: AU2003286144A1. Автор: Nicola Zambrano,Luc Mercken,Tommaso Russo. Владелец: AVENTIS PHARMA SA. Дата публикации: 2004-05-13.

Use of the cyp46a1 gene for the treatment of alzheimer's disease

Номер патента: EP2187898A1. Автор: Patrick Aubourg,Nathalie Cartier-Lacave,Eloise Hudry. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2010-05-26.

Transgenic models of alzheimer"s disease and uses thereof in the treatment of a variety of neurodegenerative diseases

Номер патента: EP1744762A2. Автор: Veronica Galvan,Dale E. Bredesen. Владелец: BUCK INSTITUTE FOR RESEARCH ON AGING. Дата публикации: 2007-01-24.

Inhibitors of src kinase for use in alzheimer's disease

Номер патента: WO2004038422A2. Автор: Nicola Zambrano,Luc Mercken,Tommaso Russo. Владелец: AVENTIS PHARMA S.A.. Дата публикации: 2004-05-06.

Inhibitors of Src kinase for use in alzheimer's disease

Номер патента: US20040176313A1. Автор: Nicola Zambrano,Luc Mercken,Tommaso Russo. Владелец: AVENTIS PHARMA SA. Дата публикации: 2004-09-09.

Transgenic models of alzheimer’s disease and uses thereof in the treatment of a variety of neurodegenerative diseases

Номер патента: WO2005115136A3. Автор: Dale E Bredesen,Veronica Galvan. Владелец: Buck Inst. Дата публикации: 2006-09-14.

Transgenic models of alzheimer’s disease and uses thereof in the treatment of a variety of neurodegenerative diseases

Номер патента: WO2005115136A2. Автор: Veronica Galvan,Dale E. Bredesen. Владелец: Buck Institute. Дата публикации: 2005-12-08.

Inhalation-type pharmaceutical composition for the treatment of Alzheimer's disease and preparation method thereof

Номер патента: US09463157B2. Автор: Hsin-Yung Lin. Владелец: Individual. Дата публикации: 2016-10-11.

Composition for prevention or treatment of alzheimer's disease comprising lactobacillus sakei probio-65

Номер патента: US20230381250A1. Автор: Yong-Ha Park,Min-Tze Liong. Владелец: Probionic Corp. Дата публикации: 2023-11-30.

Instant diagnostic test for alzheimer's disease

Номер патента: RU2426130C2. Автор: Томас АРЕНДТ,Дженс СТИЛЕР. Владелец: Лейпцигский Университет. Дата публикации: 2011-08-10.

Extracellular targets for alzheimer's disease

Номер патента: WO2009043922A2. Автор: Bart De Strooper,Tomoko Wakabayashi. Владелец: Katholieke Universiteit Leuven, K.U. Leuven R & D. Дата публикации: 2009-04-09.

Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of alzheimer's disease

Номер патента: EP3810142A1. Автор: William J. ROMANOW,Ming-Hsiang Lee,Jerold Chun,Victoria BLAHO. Владелец: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE. Дата публикации: 2021-04-28.

Biomarkers for the progression of alzheimer's disease

Номер патента: CA2657980A1. Автор: Yunsheng He,Baltazar Gomez-Mancilla,Joanne Meyer,Giorgio Rovelli,Rainer R. Kuhn,Graeme Bilbe. Владелец: Individual. Дата публикации: 2007-12-27.

Compositions and methods for treating alzheimer's disease

Номер патента: EP4376824A1. Автор: Li Ouyang,Kit Yu Fu,Nancy Yuk Yu Ip,Fanny Chui Fun Ip,Yuanbing JIANG,Xiaopu ZHOU,Hiu Yi WONG,Yangyang DUAN. Владелец: Hong Kong University of Science and Technology HKUST. Дата публикации: 2024-06-05.

Method for manifestation of alzheimer's disease

Номер патента: RU2380423C2. Автор: Лоран Прадье,Жан-Франсуа ДЕЛЕЗ,Сильвен РИКАР,Сандрин МАС,Эмманюэль КУЗЕН,Хесус Бенавидес. Владелец: Авентис Фарма С.А.. Дата публикации: 2010-01-27.

MiRNA marker for diagnosis and/or treatment of alzheimer's disease

Номер патента: US12006551B1. Автор: LI Zeng,Rui Liu,Ting Sun,Junxia ZHANG,Zhuorong Li,Mimin LIU. Владелец: Institute Of Medicinal Biotechnology Chinese Academy Of Medical Sciences And Peking University. Дата публикации: 2024-06-11.

Association between the acid phosphatase (ACP1) gene and Alzheimer's disease

Номер патента: US20030110523A1. Автор: David Comings,James MacMurray. Владелец: Individual. Дата публикации: 2003-06-12.

Microrna biomarkers indicative of alzheimer's disease

Номер патента: US09771617B2. Автор: Pavan Kumar,Zoltan Dezso. Владелец: Eisai R&D Management Co Ltd. Дата публикации: 2017-09-26.

Composition for preventing or treating alzheimer's disease comprising inhibitor of atlastin 2, and method for diagnosing alzheimer's disease by determining atlastin 2

Номер патента: US20230227828A1. Автор: Dong Gyu Jo,Ji Hoon Han. Владелец: Sungkyunkwan University Research and Business Foundation. Дата публикации: 2023-07-20.

Animal model for alzheimer's disease

Номер патента: WO2004064768A3. Автор: Tadeusz Wieloch. Владелец: Tadeusz Wieloch. Дата публикации: 2004-09-30.

Diagnosis of alzheimer's disease using ldl receptor protein-1

Номер патента: EP1290451A2. Автор: Berislav V. Zlokovic. Владелец: University of Southern California USC. Дата публикации: 2003-03-12.

Diagnosis of alzheimer's disease using ldl receptor protein-1

Номер патента: EP1290451B1. Автор: Berislav V. Zlokovic. Владелец: University of Southern California USC. Дата публикации: 2005-12-07.

Antisense oligonucleotides for use in treating alzheimer's disease

Номер патента: AU2022271491A1. Автор: Thomas Petrus Gerardus DE VLAAM,Tsinatkeab Tadesse HAILU,Zhana KARNEVA. Владелец: Academisch Ziekenhuis Leiden Also Acting Under Name Leiden University Medical Centre Lum. Дата публикации: 2023-02-09.

Compositions and methods of detecting and treating alzheimer's disease

Номер патента: AU2024205163A1. Автор: Evan C. Unger,Iman Daryaei,Emmanuelle Joelle MEUILLET. Владелец: Microvascular Therapeutics LLC. Дата публикации: 2024-08-15.

Quick test for the diagnosis of alzheimer's disease

Номер патента: RS52875B. Автор: Thomas Arendt,Jens Stieler. Владелец: Universität Leipzig. Дата публикации: 2013-12-31.

Screening platform to identify therapeutic drugs or agents for treatment of alzheimer's disease

Номер патента: ZA202000409B. Автор: QUINTI Luisa,E Tanzi Rudolph,Yeon Kim Doo. Владелец: Massachusetts Gen Hospital. Дата публикации: 2023-10-25.

Methods of treating alzheimer's disease

Номер патента: WO2023275376A1. Автор: Olav Michael Andersen. Владелец: AARHUS UNIVERSITET. Дата публикации: 2023-01-05.

Methods of treating alzheimer's disease

Номер патента: EP4363578A1. Автор: Olav Michael Andersen. Владелец: AARHUS UNIVERSITET. Дата публикации: 2024-05-08.

Methods of treating alzheimer's disease

Номер патента: US20240279666A1. Автор: Olav Michael Andersen. Владелец: AARHUS UNIVERSITET. Дата публикации: 2024-08-22.

Vaccines for protection from and treatment of alzheimer's disease

Номер патента: US20170042990A1. Автор: Bira Arya,Richard Markham. Владелец: Cyvax Inc. Дата публикации: 2017-02-16.

Rapid high throughput screening system to assess potential treatments for sporadic alzheimer's disease

Номер патента: WO2022170072A1. Автор: David L. Kaplan,Dana Cairns. Владелец: TRUSTEES OF TUFTS COLLEGE. Дата публикации: 2022-08-11.

Vaccines for protection from and treatment of alzheimer's disease

Номер патента: US09937248B2. Автор: Bira Arya. Владелец: Cyvax Inc. Дата публикации: 2018-04-10.

Vaccines for protection from and treatment of alzheimer's disease

Номер патента: US09433665B2. Автор: Bira Arya,Richard Markham. Владелец: Cyvax Inc. Дата публикации: 2016-09-06.

Quick test for the diagnosis of alzheimer's disease

Номер патента: CA2540841A1. Автор: Thomas Arendt,Jens Stieler. Владелец: Jens Stieler. Дата публикации: 2005-06-02.

Transgenic invertebrate model of alzheimer's disease and utilization thereof

Номер патента: EP3626074A1. Автор: Katsuhiko Yanagisawa,Yasutoyo YAMASAKI,Leo TSUDA. Владелец: NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY. Дата публикации: 2020-03-25.

Vaccines for protection from and treatment of alzheimer's disease

Номер патента: US20140199338A1. Автор: Bira Arya,Richard Markham. Владелец: Cyvax Inc. Дата публикации: 2014-07-17.

Rapid high throughput screening system to assess potential treatments for sporadic alzheimer’s disease

Номер патента: US20240093236A1. Автор: David L. Kaplan,Dana Cairns. Владелец: TUFTS UNIVERSITY. Дата публикации: 2024-03-21.

Compositions and methods for treating alzheimer's disease

Номер патента: WO2023005959A1. Автор: Li Ouyang,Kit Yu Fu,Nancy Yuk Yu Ip,Fanny Chui Fun Ip,Yuanbing JIANG,Xiaopu ZHOU,Hiu Yi WONG,Yangyang DUAN. Владелец: THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY. Дата публикации: 2023-02-02.

Variants of clu/apoj, picalm, abca7, cr1 and bin1 gene loci and the ms4a gene cluster for the diagnosis of alzheimer's disease

Номер патента: CA2766876C. Автор: Julie Williams,Michael John Owen. Владелец: University College Cardiff Consultants Ltd. Дата публикации: 2020-01-28.

Treatment of alzheimer's disease

Номер патента: US20230348978A1. Автор: Roman Urfer,Anne URFER-BUCHWALDER. Владелец: Selonterra Inc. Дата публикации: 2023-11-02.

Use of apoe4 motif-mediated genes for diagnosis and treatment of alzheimer's disease

Номер патента: EP3555629A2. Автор: Roman Urfer,Anne URFER-BUCHWALDER. Владелец: Selonterra Inc. Дата публикации: 2019-10-23.

Treatment of alzheimer's disease

Номер патента: WO2021142163A1. Автор: Roman Urfer,Anne URFER-BUCHWALDER. Владелец: Selonterra, Inc.. Дата публикации: 2021-07-15.

Methods of diagnosis alzheimer's disease

Номер патента: EP3488013A1. Автор: Manel Esteller Badosa,Johannes Gräff,Holger Heyn,Jose Vicente SANCHEZ MUT. Владелец: Ecole Polytechnique Federale de Lausanne EPFL. Дата публикации: 2019-05-29.

Methods of diagnosis alzheimer's disease

Номер патента: US20190233894A1. Автор: Manuel Esteller Badosa,Johannes Gräff,Holger Heyn,Jose Vicente SACHEZ MUT. Владелец: Ecole Polytechnique Federale de Lausanne EPFL. Дата публикации: 2019-08-01.

Methods of diagnosis alzheimer's disease

Номер патента: WO2018015291A1. Автор: Manel Esteller Badosa,Johannes Gräff,Holger Heyn,Jose Vicente SACHEZ MUT. Владелец: Fundació Institució Catalana De Recerca I Estudis Avançats (Icrea). Дата публикации: 2018-01-25.

Ntrk1 genetic markers associated with age of onset of alzheimer's disease

Номер патента: WO2005037204A2. Автор: Richard S. Judson,Jeroen Aerssens,Maria Athanasiou,Carlos Brain,Nadine Cohen,Bradley Dain,R. Rex Denton,Vural Ozdemir,Carol R. Reed. Владелец: Genaissance Pharmaceuticals, Inc.. Дата публикации: 2005-04-28.

Biotin complexes for treatment and diagnosis of alzheimer's disease

Номер патента: US09655977B2. Автор: David R. Elmaleh. Владелец: General Hospital Corp. Дата публикации: 2017-05-23.

Compositions and methods of detecting and treating alzheimer's disease

Номер патента: WO2019191518A1. Автор: Evan C. Unger,Iman Daryaei,Emmanuelle Joelle MEUILLET. Владелец: Microvascuar Therapeutics Llc. Дата публикации: 2019-10-03.

Compositions and methods of detecting and treating alzheimer's disease

Номер патента: EP3773500A1. Автор: Evan C. Unger,Iman Daryaei,Emmanuelle Joelle MEUILLET. Владелец: Microvascular Therapeutics LLC. Дата публикации: 2021-02-17.

Compositions and methods of detecting and treating Alzheimer's disease

Номер патента: AU2019243579B2. Автор: Evan C. Unger,Iman Daryaei,Emmanuelle Joelle MEUILLET. Владелец: Microvascular Therapeutics LLC. Дата публикации: 2024-05-09.

Treatment with cytokines for alzheimer's disease

Номер патента: CA2487734C. Автор: Mario Clerici,Giorgio Annoni. Владелец: Immunoclin Ltd. Дата публикации: 2012-03-06.

Methods of diagnosis and treatment of alzheimer's disease

Номер патента: US20200088724A1. Автор: Xinhua Zhan,Boryana S. Stamova-Kiossepacheva,Frank R. Sharp. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2020-03-19.

Methods of diagnosis and treatment of Alzheimer's Disease

Номер патента: US11598774B2. Автор: Xinhua Zhan,Boryana S. Stamova-Kiossepacheva,Frank R. Sharp. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2023-03-07.

Methods for treating alzheimer's disease with donepezil transdermal system

Номер патента: US20240156747A1. Автор: Eun Soo Lee,Amit K. Jain,Parminder Singh. Владелец: Corium LLC. Дата публикации: 2024-05-16.

Treatment of alzheimer's disease with vascular progenitor-derived exosomes enriched with micrornas or thioredoxin

Номер патента: WO2024039760A2. Автор: Peixin Yang,Wei-bin SHEN. Владелец: University of Maryland, Baltimore. Дата публикации: 2024-02-22.

Treatment of alzheimer's disease with vascular progenitor-derived exosomes enriched with micrornas or thioredoxin

Номер патента: WO2024039760A3. Автор: Peixin Yang,Wei-bin SHEN. Владелец: University of Maryland, Baltimore. Дата публикации: 2024-04-04.

Biotin complexes for treatment and diagnosis of Alzheimer's disease

Номер патента: AU2019203874A1. Автор: David R. Elmaleh. Владелец: General Hospital Corp. Дата публикации: 2019-06-20.

Clonal hematopoiesis of indeterminate potential and protection from alzheimer's disease

Номер патента: WO2023034096A1. Автор: Siddhartha Jaiswal,Hind BOUZID. Владелец: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY. Дата публикации: 2023-03-09.

Screening Assays Using Stem Cells and Stem Cell-Derived Neurons from Mouse Models of Alzheimer's Disease

Номер патента: US20140171380A1. Автор: Tae-Wan Kim,Natalie Landman,Laura Beth Johnson MCINTIRE,Gina FINAN. Владелец: Columbia University in the City of New York. Дата публикации: 2014-06-19.

Neural-derived human exosomes for alzheimer's disease and co-morbidities thereof

Номер патента: WO2021096929A1. Автор: Rene ANAND,Susan MCKAY. Владелец: Anand Rene. Дата публикации: 2021-05-20.

Small molecule immunomodulators for alzheimer's disease

Номер патента: CA2746273C. Автор: John R. Cashman,Kenneth J. Abel. Владелец: HUMAN BIOMOLECULAR RESEARCH INSTITUTE. Дата публикации: 2019-04-09.

Methods for the detection and treatment of proteinopathies

Номер патента: WO2022155322A1. Автор: Surendra Sharma. Владелец: Women & Infants Hospital Of Rhode Island. Дата публикации: 2022-07-21.

Process for treatment of amyotrophic lateral sclerosis,rheumatoid arthritis,tremors/parkinson's disease,multiple sclerosis,non-viral based cancers,alzheimer's disease,muscular dystrophy,attention deficit disorder,attention deficit hyperactivity disorder,complex regional pain syndrome,diabetes,neuropathic pain,spider arthritis,west nile virus,fibromyalgia,shingles,gout,migraine headaches,senile dementia,post polio syndrome,central virus deafness,asthma,chronic pain of unknown origin and hepatitis c

Номер патента: SG184564A1. Автор: George Nelson. Владелец: Salubrious Pharmaceutical LLC. Дата публикации: 2012-11-29.

Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for preparing therapeutic agents for alzheimer's disease

Номер патента: RU2472513C2. Автор: Сигфридо СКАРПА,Андреа ФУСО,Розеллина ДАМЬЯНИ,Мауро РОССИНИ. Владелец: Гносис С.п.А.. Дата публикации: 2013-01-20.

Devices, kits, and methods for determining increased susceptibility to and treatment and prevention of periodontitis, alzheimer's disease, and other conditions

Номер патента: WO2023283021A9. Автор: Martin Levine,Zsolt M. LOHINAI. Владелец: Martin Levine. Дата публикации: 2023-11-02.

Methods of diagnosing alzheimer's disease and risk of progression to alzheimer's disease

Номер патента: EP3551051A1. Автор: Salvador Soriano,Michael Castello. Владелец: LOMA LINDA UNIVERSITY. Дата публикации: 2019-10-16.

Methods of diagnosing alzheimer's disease and risk of progression to alzheimer's disease

Номер патента: US20190300960A1. Автор: Salvador Soriano,Michael Castello. Владелец: LOMA LINDA UNIVERSITY. Дата публикации: 2019-10-03.

Methods of diagnosing Alzheimer's disease and risk of progression to Alzheimer's disease

Номер патента: AU2017371071B2. Автор: Salvador Soriano,Michael Castello. Владелец: LOMA LINDA UNIVERSITY. Дата публикации: 2023-06-15.

Method for diagnosing alzheimer's disease spectrum neurocognitive disorders from tear sample, and solution and diagnostic kit useful in the method

Номер патента: WO2021130508A3. Автор: János KÁLMÁN,Magdolna PÁKÁSKI,Zsolt Datki. Владелец: SZEGEDI TUDOMÁNYEGYETEM. Дата публикации: 2021-08-05.

Method for diagnosing alzheimer's disease spectrum neurocognitive disorders from tear sample, and solution and diagnostic kit useful in the method

Номер патента: EP4081797A2. Автор: János KÁLMÁN,Magdolna PÁKÁSKI,Zsolt Datki. Владелец: SZEGEDI TUDOMÁNYEGYETEM. Дата публикации: 2022-11-02.

Method for diagnosing alzheimer's disease spectrum neurocognitive disorders from tear sample, and solution and diagnostic kit useful in the method

Номер патента: WO2021130508A2. Автор: János KÁLMÁN,Magdolna PÁKÁSKI,Zsolt Datki. Владелец: SZEGEDI TUDOMÁNYEGYETEM. Дата публикации: 2021-07-01.

Apoe promoter single nucleotide polymorphism associated with alzheimer's disease risk and use thereof

Номер патента: EP3626830A1. Автор: Jang Jae Lee,Kun Ho Lee,Kyu Yeong Choi. Владелец: Infomeditech Co ltd. Дата публикации: 2020-03-25.

Method for the detection and treatment of proteinopathies

Номер патента: US20240077500A1. Автор: Surendra Sharma. Владелец: WOMEN AND INFANTS HOSPITAL OF RHODE ISLAND. Дата публикации: 2024-03-07.

Micro-rna-biomarkers indicating alzheimer's disease

Номер патента: RU2639509C2. Автор: Золтан ДЕЗСО,Паван КУМАР. Владелец: Эйсай Ар Энд Ди Менеджмент Ко., Лтд.. Дата публикации: 2017-12-21.

Agents, compositions and methods for treating and preventing alzheimer's disease

Номер патента: US20210085692A1. Автор: Roberta Diaz Brinton,Kathleen E. ROGERS. Владелец: University of Southern California USC. Дата публикации: 2021-03-25.

Agents, compositions and methods for treating and preventing alzheimer's disease

Номер патента: WO2019178230A1. Автор: Roberta Diaz Brinton,Kathleen E. ROGERS. Владелец: UNIVERSITY OF SOUTHERN CALIFORNIA. Дата публикации: 2019-09-19.

Devices, kits, and methods for determining increased susceptibility to and treatment and prevention of periodontitis, alzheimer's disease, and other conditions

Номер патента: EP4367261A1. Автор: Martin Levine,Zsolt M. LOHINAI. Владелец: Individual. Дата публикации: 2024-05-15.

A transgenic invertebrate model for alzheimer's disease and use thereof

Номер патента: US20210227814A1. Автор: Katsuhiko Yanagisawa,Yasutoyo YAMASAKI,Leo TSUDA. Владелец: NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY. Дата публикации: 2021-07-29.

ErbB2 REGULATES AUTOPHAGIC FLUX TO MODULATE THE PROTEOSTASIS OF APP-CTFs IN ALZHEIMER'S DISEASE

Номер патента: US20190209565A1. Автор: Yung-Feng Liao,Bo-Jeng WANG. Владелец: Academia Sinica. Дата публикации: 2019-07-11.

ErbB2 REGULATES AUTOPHAGIC FLUX TO MODULATE THE PROTEOSTASIS OF APP-CTFs IN ALZHEIMER'S DISEASE

Номер патента: WO2018048755A1. Автор: Yung-Feng Liao,Bo-Jeng WANG. Владелец: Shih, Ming-Che. Дата публикации: 2018-03-15.

Methods of diagnosing alzheimer's disease and risk of progression to alzheimer's disease

Номер патента: US20240026452A1. Автор: Salvador Soriano,Michael Castello. Владелец: LOMA LINDA UNIVERSITY. Дата публикации: 2024-01-25.

Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof

Номер патента: CA2626086A1. Автор: Yonghong Li,Andrew Grupe. Владелец: Individual. Дата публикации: 2007-05-03.

Methods of using miRNA from bodily fluids for early detection and monitoring of mild cognitive impairment (MCI) and alzheimer's disease (AD)

Номер патента: US09556487B2. Автор: Samuil R. Umansky,Kira S. Sheinerman,Vladimir Tsivinsky. Владелец: DiamiR LLC. Дата публикации: 2017-01-31.

Method for detecting and treating Alzheimer's disease

Номер патента: US5535760A. Автор: Huntington Potter. Владелец: Harvard College. Дата публикации: 1996-07-16.

Methods for detecting alzheimer's disease

Номер патента: IL195288A. Автор: . Владелец: ExonHit Therapeutics SA. Дата публикации: 2013-10-31.

Compositions and methods for preparing an alzheimer's disease animal model using microrna

Номер патента: US20230256119A1. Автор: Hyo Jin Lee,Sang Moo Lee,Jin-Hyeob Ryu,Hyun Su Min. Владелец: Biorchestra Co Ltd. Дата публикации: 2023-08-17.

Methods of diagnosing alzheimer's disease and risk of progression to alzheimer's disease

Номер патента: WO2018107059A1. Автор: Salvador Soriano,Michael Castello. Владелец: LOMA LINDA UNIVERSITY HEALTH. Дата публикации: 2018-06-14.

Method For Diagnosing Alzheimer's Disease Spectrum Neurocognitive Disorders From Tear Sample, And Solution And Diagnostic Kit Useful In The Method

Номер патента: US20230024661A1. Автор: János KÁLMÁN,Magdolna PÁKÁSKI,Zsolt Datki. Владелец: SZEGEDI TUDOMÁNYEGYETEM. Дата публикации: 2023-01-26.

Method for identifying carbohydrate drug-sensitive patient in patients having alzheimer's disease

Номер патента: US20220280541A1. Автор: Jing Zhang,Teng FENG,Meiyu Geng,Guangqiang Sun,Xinyi Wang. Владелец: Shanghai Green Valley Pharmaceutical Co Ltd. Дата публикации: 2022-09-08.

Method for identifying carbohydrate drug-sensitive patient in patients having Alzheimer's disease

Номер патента: AU2020327258A1. Автор: Jing Zhang,Teng FENG,Meiyu Geng,Guangqiang Sun,Xinyi Wang. Владелец: Shanghai Green Valley Pharmaceutical Co Ltd. Дата публикации: 2022-03-10.

Abnormalities of phosphatase 2a (pp2a) for diagnosis and treatment of alzheimer's disease

Номер патента: CA2582270A1. Автор: Daniel L. Alkon,Wei-Qin Zhao. Владелец: Wei-Qin Zhao. Дата публикации: 2006-05-26.

Transgenic animals exhibiting major disorders related to Alzheimer's disease

Номер патента: US20050076400A1. Автор: Laurent Pradier,Patrick Benoit,Gunter Tremp,Veronique Blanchard-Bregeon,Jean-Michel Itier,Caty Casas Louzao. Владелец: AVENTIS PHARMA SA. Дата публикации: 2005-04-07.

Transgenic pig as a model of alzheimer's disease

Номер патента: US20100138940A1. Автор: Arne Lund JØRGENSEN,Ida Elisabeth Holm,Anders Lade Nielsen,Marianne Gregers Johansen,Jannik Ejnar Jakobsen. Владелец: AARHUS UNIVERSITET. Дата публикации: 2010-06-03.

Transgenic pig as a model of alzheimer's disease

Номер патента: WO2008106981A1. Автор: Arne Lund JØRGENSEN,Ida Elisabeth Holm,Anders Lade Nielsen,Marianne Gregers Johansen,Jannik Ejnar Jakobsen. Владелец: AARHUS UNIVERSITET. Дата публикации: 2008-09-12.

Transgenic pig as a model of alzheimer's disease

Номер патента: EP2134846A1. Автор: Arne Lund JØRGENSEN,Ida Elisabeth Holm,Anders Lade Nielsen,Marianne Gregers Johansen,Jannik Ejnar Jakobsen. Владелец: AARHUS UNIVERSITET. Дата публикации: 2009-12-23.

Model animal of alzheimer's disease and use thereof

Номер патента: US20070294779A1. Автор: Takashi Saito,Jiro Takano,Takaomi Saido,Nobuhisa Iwata,Takahiro Suemoto. Владелец: RIKEN Institute of Physical and Chemical Research. Дата публикации: 2007-12-20.

S-adenosylmethionine and derivatives thereof for the treatment and prevention of alzheimer's disease

Номер патента: EP1326620A1. Автор: Sigfrido Scarpa,Andrea Fuso. Владелец: Universita degli Studi di Roma La Sapienza. Дата публикации: 2003-07-16.

Use of calcilytic drugs as a pharmacological approach to the treatment and prevention of alzheimer's disease, alzheimer's disease-related disorders, and down's syndrome neuropathies

Номер патента: EP2797591A1. Автор: Ubaldo Armato,Ilaria Pierpaola DAL PRA',Anna Maria CHIARINI. Владелец: Individual. Дата публикации: 2014-11-05.

Lachnospiraceae spp and ruminococcus lactaris strains for the treatment and prevention of alzheimer's disease and aging

Номер патента: WO2023222924A1. Автор: Christiane Bouchier,Damien REI,Dominique CLERMONT,Gérald TOUAK. Владелец: INSTITUT PASTEUR. Дата публикации: 2023-11-23.

Treatment of mild and moderate Alzheimer's disease

Номер патента: US09717710B2. Автор: Matthew J. Kostura,Maria Carmen Valcarce Lopez,David J. Clark,Cesare Orlandi,Imogene M. Dunn. Владелец: vTv Therapeutics LLC. Дата публикации: 2017-08-01.

Multi-component formulations for the treatment of cognitive decline including Alzheimer's disease

Номер патента: US09682048B1. Автор: Gene S. Rosen. Владелец: Individual. Дата публикации: 2017-06-20.

Treatment of mild and moderate alzheimer's disease

Номер патента: WO2014055588A1. Автор: Matthew J. Kostura,Maria Carmen Valcarce Lopez,David J. Clark,Cesare Orlandi,Imogene M. GRIMES. Владелец: TransTech Pharma, LLC. Дата публикации: 2014-04-10.

Micro device of nerve signal recording and stimulating for diagnosis and treatment of chronic pain or alzheimer's disease

Номер патента: US20220184398A1. Автор: Jae Suk Sung,Heon Jin Choi,Youngcheol Chae. Владелец: Nformare Inc. Дата публикации: 2022-06-16.

Micro device of nerve signal recording and stimulating for diagnosis and treatment of chronic pain or alzheimer's disease

Номер патента: US11813455B2. Автор: Jae Suk Sung,Heon Jin Choi,Youngcheol Chae. Владелец: Nformare Inc. Дата публикации: 2023-11-14.

Peripheral blood mononuclear cells (pbmc) phenotypes as biomarkers for patients with alzheimer's disease and/or mild cognitive impairment (mci)

Номер патента: US20240327913A1. Автор: Philip DENNER,Anja Schneider,Eugenio FAVA,Wera ROTH,Pranjal DHOLE,Josephine BLERSCH. Владелец: Deutsches Zentrum fuer Neurodegenerative Erkrankungen eV. Дата публикации: 2024-10-03.

Set of oligonucleotide primers and probes for genetic typing of polymorphous dna loci associated with a risk of progression of sporadic form of alzheimer's disease in russian populations

Номер патента: RU2600874C2. Автор: Александр Сергеевич Заседателев,Татьяна Васильевна Наседкина,Ольга Алексеевна Гра,Игорь Игоревич Низамутдинов. Владелец: Федеральное государственное бюджетное учреждение науки Российской академии наук Институт молекулярной биологии им. В.А. Энгельгардта Российской академии наук (ИМБ РАН). Дата публикации: 2016-10-27.

Methods and compositions for pre-symptomatic or post-symptomatic diagnosis of alzheimer's disease and other neurodegenerative disorders

Номер патента: EP1769089A2. Автор: Douglas C. Wallace,Pinar E. Coskun. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2007-04-04.

Methods and compositions for pre-symptomatic or post-symptomatic diagnosis of alzheimer's disease and other neurodegenerative disorders

Номер патента: US20090111093A1. Автор: Douglas C. Wallace,Pinar E. Coskun. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2009-04-30.

Methods and compositions for diagnosis of alzheimer's disease and other neurodegenerative disorders

Номер патента: WO2007011322A2. Автор: Douglas C. Wallace,Pinar E. Coskun. Владелец: The Regents of the University of California. Дата публикации: 2007-01-25.

Method for diagnosis of Alzheimer's disease using microrna

Номер патента: US12084718B2. Автор: Jin-Hyeob Ryu,Hyun-Jeong CHO. Владелец: Biorchestra Co Ltd. Дата публикации: 2024-09-10.

Composition for predicting clinical stage of Alzheimer's disease and kit using the same

Номер патента: US20220091138A1. Автор: Myeong Ok Kim. Владелец: Industry Academic Cooperation Foundation of GNU. Дата публикации: 2022-03-24.

Compositions and methods for assessing risk factors in Alzheimer's disease

Номер патента: US6136530A. Автор: Shirley E. Poduslo. Владелец: Texas Tech University Health Sciences Center. Дата публикации: 2000-10-24.

Circulating miRNAs as biomarkers for diagnosis of mild cognitive impairment and Alzheimer's disease

Номер патента: US12054779B2. Автор: Jose Rodriguez Alvarez,Alfredo Jesus Miñano Molina,Dolores Siedlecki Wullich. Владелец: Centro Investigacion Biomedica En Red Enfermedades Neurodegenerativas (ciberned). Дата публикации: 2024-08-06.

Prediction of alzheimer's disease

Номер патента: WO2023225004A1. Автор: Uppala RadhaKrishna,Ray BAHADO-SINGH,Stewart F. GRAHAM,Sangeetha VISHWESWARAIAH. Владелец: Bioscreening & Diagnostics LLC. Дата публикации: 2023-11-23.

U-p53 peptides as markers in the rate of progression of cognitive decline to alzheimer's disease

Номер патента: WO2024148357A2. Автор: Paul Kinnon,Simona Piccirella. Владелец: Diadem Spa. Дата публикации: 2024-07-11.

U-p53 peptides as markers in the rate of progression of cognitive decline to alzheimer's disease

Номер патента: WO2024148357A3. Автор: Paul Kinnon,Simona Piccirella. Владелец: Diadem Spa. Дата публикации: 2024-08-08.

Olfactory receptor copy number association with age at onset of alzheimer's disease

Номер патента: WO2011163607A3. Автор: Kinga Szigeti,Chad A. Shaw,Joanna Wiszniewska. Владелец: Baylor College of Medicine. Дата публикации: 2013-09-06.

Method for determining the risk of occurrence of alzheimer's disease

Номер патента: WO2011024082A3. Автор: Philippe Amouyel,Jean-Charles Lambert,Mark Lathrop. Владелец: Institut National De La Sante Et De La Recherche Medicale (Inserm) (Epst). Дата публикации: 2011-04-21.

Method for determining the risk of occurrence of alzheimer's disease

Номер патента: US20120238461A1. Автор: Philippe Amouyel,Jean-Charles Lambert,Mark Lathrop. Владелец: Universite Lille 2 Droit et Sante. Дата публикации: 2012-09-20.

Drug targets for alzheimer's disease and other diseases associated with decreased neuronal metabolism

Номер патента: US20030059824A1. Автор: Samuel Henderson. Владелец: Accera Inc. Дата публикации: 2003-03-27.

Method for diagnosis of alzheimer's disease using microrna

Номер патента: US20220170095A1. Автор: Jin-Hyeob Ryu,Hyun-Jeong CHO. Владелец: Biorchestra Co Ltd. Дата публикации: 2022-06-02.

Cortical neuron cell model of alzheimer's disease based on bmi1 deficiency, and uses thereof

Номер патента: EP3494212A1. Автор: Gilbert Bernier,Anthony Flamier. Владелец: 9636137 Canada Inc. Дата публикации: 2019-06-12.

Biosensor for diagnosing alzheimer's disease using rayleigh scattering and colorimetric assay of gold nanoparticle and multi-detection method using the biosensor

Номер патента: US20190338360A1. Автор: SangJun SIM. Владелец: Pharmaworks Co Ltd. Дата публикации: 2019-11-07.

Method for determining the risk of occurrence of alzheimer's disease

Номер патента: WO2011024082A2. Автор: Philippe Amouyel,Jean-Charles Lambert,Mark Lathrop. Владелец: Institut National De La Sante Et De La Recherche Medicale (Inserm) (Epst). Дата публикации: 2011-03-03.

Cortical neuron cell model of alzheimer's disease based on bmi1 deficiency, and uses thereof

Номер патента: US20190203254A1. Автор: Gilbert Bernier,Anthony Flamier. Владелец: 9636137 Canada Inc. Дата публикации: 2019-07-04.

Cortical neuron cell model of alzheimer's disease based on bmi1 deficiency, and uses thereof

Номер патента: WO2018025098A1. Автор: Gilbert Bernier,Anthony Flamier. Владелец: 9636137 Canada Inc.. Дата публикации: 2018-02-08.

Biomarkers for alzheimer's disease

Номер патента: CA2718392A1. Автор: Philippe Amouyel,Stephanie Ferreira,Jean-Charles Lambert. Владелец: Genoscreen. Дата публикации: 2009-09-17.

Methods for assessing risk of alzheimer's disease in a patient

Номер патента: US20130102692A1. Автор: Craig S. Atwood. Владелец: WISCONSIN ALUMNI RESEARCH FOUNDATION. Дата публикации: 2013-04-25.

Methods for Assessing Risk of Alzheimer's Disease in a Patient

Номер патента: US20100035266A1. Автор: Craig S. Atwood. Владелец: WISCONSIN ALUMNI RESEARCH FOUNDATION. Дата публикации: 2010-02-11.

Methods for assessing risk of alzheimer's disease in a patient

Номер патента: US20170016072A1. Автор: Craig S. Atwood. Владелец: WISCONSIN ALUMNI RESEARCH FOUNDATION. Дата публикации: 2017-01-19.

Screening method for agents suitable for therapy of alzheimer's disease

Номер патента: EP2222869A1. Автор: Gerd Multhaup,Lisa-Marie MÜNTER. Владелец: FREIE UNIVERSITAET BERLIN. Дата публикации: 2010-09-01.

Methods for diagnosing and/or treating alzheimer's disease

Номер патента: WO2023129531A2. Автор: Sarah S. Bacus. Владелец: Seq Biomarque, Llc.. Дата публикации: 2023-07-06.

Screening method for agents suitable for therapy of alzheimer's disease

Номер патента: WO2009068269A1. Автор: Gerd Multhaup,Lisa-Marie MÜNTER. Владелец: Fu Berlin. Дата публикации: 2009-06-04.

Detection of alzheimer's disease (ad), frontotemporal lobar degeneration (ftld), amyotrophic lateral schlerosis (als), parkinson's disease (pd), and dementia with lewy bodies (dlb) indicated by phosphorylation of marcks

Номер патента: EP3764102A1. Автор: Hitoshi Okazawa. Владелец: Tokyo Medical and Dental University NUC. Дата публикации: 2021-01-13.

Methods for diagnosing and/or treating alzheimer's disease

Номер патента: AU2022429793A1. Автор: Sarah S. Bacus. Владелец: Seq Biomarque LLC. Дата публикации: 2024-06-27.

Methods for diagnosing and/or treating alzheimer's disease

Номер патента: WO2023129531A3. Автор: Sarah S. Bacus. Владелец: Seq Biomarque, Llc.. Дата публикации: 2023-08-10.

Microrna biomarkers in blood for diagnosis of alzheimer's disease

Номер патента: EP3449009A1. Автор: Urszula Wojda,Katarzyna Laskowska-Kaszub,Tomasz Gabryelewicz,Jacek Kuznicki. Владелец: Instytut Biologii Doswiadczalnej Pan Im M Nenckiego. Дата публикации: 2019-03-06.

Diagnostics for determining the onset of alzheimer's disease

Номер патента: US20180057879A1. Автор: William P. Macconnell,Harold Amogan. Владелец: Macconnell Research Corp. Дата публикации: 2018-03-01.

Microrna biomarkers in blood for diagnosis of alzheimer's disease

Номер патента: US20190136320A1. Автор: Urszula Wojda,Katarzyna Laskowska-Kaszub,Tomasz Gabryelewicz,Jacek Kuznicki. Владелец: Biotech Innovations Spolka Z Ograniczona Odpowiedziainoscia. Дата публикации: 2019-05-09.

Methods of Diagnosis of Alzheimer's Disease by Monitoring STING Signaling Activation

Номер патента: US20230313306A1. Автор: Feng Xue. Владелец: Individual. Дата публикации: 2023-10-05.

Reagents and methods for alzheimer's disease and comorbidities thereof

Номер патента: WO2020227084A2. Автор: Rene ANAND,Susan MCKAY. Владелец: Anand Rene. Дата публикации: 2020-11-12.

Human induced pluripotent stem cell lines for modeling Alzheimer's disease and usage thereof

Номер патента: US11834648B2. Автор: BO Yang,Min Zhou,Jian Fu,Yuqing Liu,Lixiang Jiang,Yubo YAN,Jiayin YANG. Владелец: Shenzhen Cell Inspire Biotechnology Co ltd. Дата публикации: 2023-12-05.

Olfactory receptor copy number association with age at onset of alzheimer's disease

Номер патента: WO2011163607A2. Автор: Kinga Szigeti,Chad A. Shaw,Joanna Wiszniewska. Владелец: Baylor College of Medicine. Дата публикации: 2011-12-29.

Diagnostic test for alzheimer's disease

Номер патента: EP1017845A4. Автор: David Henry Small,Javier Saez-Valero,Gian Sberna. Владелец: University of Melbourne. Дата публикации: 2003-07-02.

Diagnostic test for alzheimer's disease

Номер патента: EP1017845A1. Автор: David Henry Small,Javier Saez-Valero,Gian Sberna. Владелец: University of Melbourne. Дата публикации: 2000-07-12.

Diagnostic test for alzheimer's disease

Номер патента: EP1017845B1. Автор: David Henry Small,Javier Saez-Valero,Gian Sberna. Владелец: MONASH UNIVERSITY. Дата публикации: 2006-04-19.

Reagents and methods for alzheimer's disease and comorbidities thereof

Номер патента: WO2020227084A3. Автор: Rene ANAND,Susan MCKAY. Владелец: Anand Rene. Дата публикации: 2020-12-17.

Method for determining a predisposition to or prognosis of alzheimer's disease based on angiotensin-converting enzyme dna polymorphisms

Номер патента: WO2000000640A3. Автор: Julie Williams,Michael John Owen,Patrick Gavin Kehoe. Владелец: Patrick Gavin Kehoe. Дата публикации: 2000-05-25.

Method for diagnosis of alzheimer's disease

Номер патента: US20180113129A1. Автор: Chai-Ching Lin,Chen-Wei Tsai. Владелец: Dr Power Stem Biomedicai Research Inc Ltd. Дата публикации: 2018-04-26.

Novel human induced pluripotent stem cell lines for modeling alzheimer's disease and usage thereof

Номер патента: EP3707263A1. Автор: BO Yang,Min Zhou,Jian Fu,Yuqing Liu,Lixiang Jiang,Yubo YAN,Jiayin YANG. Владелец: Shenzhen Cell Inspire Biotechnology Co ltd. Дата публикации: 2020-09-16.

Screening and treatment of alzheimer's disease

Номер патента: WO2006129058A2. Автор: Michael O'donovan,Lesley Jones,Stephen Mcllroy. Владелец: Mcllroy, Esther. Дата публикации: 2006-12-07.

Screening and treatment of alzheimer's disease

Номер патента: WO2006129058A3. Автор: Michael O'donovan,Lesley Jones,Stephen Mcllroy. Владелец: Mcllroy Esther. Дата публикации: 2007-02-01.

Biomarker panels, systems, and methods for risk stratification of a subject for alzheimer's disease

Номер патента: US20230340597A1. Автор: Sasidhar Venkata MANDA,Sai Krishnaveni CHEVOORU,Subhashani PRABHAKAR,Anusha TUMMALA. Владелец: Urvogelbio Private Ltd. Дата публикации: 2023-10-26.

Alzheimer's disease early diagnosis and/or prognosis in circulating immune cells based on heparan sulfates and/or of heparan sulfate sulfotransferases

Номер патента: EP3430408A1. Автор: Bruno Dubois,Patricia Albanese,Dulce PAPY-GARCIA,Alexandre FIFRE,Sandrine CHANTEPIE-LABORDE,Mohand Ouidir OUIDJA,Francis NYASSE. Владелец: Universite Paris Est Creteil Paris 12. Дата публикации: 2019-01-23.

Specialized excitatory synaptic protein biomarkers of plasma neuronal exosomes for prediction and staging of alzheimer's disease

Номер патента: US20190011460A1. Автор: Edward J. Goetzl. Владелец: Individual. Дата публикации: 2019-01-10.

Stimulus-elicited genomic profile markers of alzheimer's disease

Номер патента: EP2326729A1. Автор: Daniel L. Alkon,Tapan Kumar Khan. Владелец: Blanchette Rockefeller Neuroscience Institute. Дата публикации: 2011-06-01.

Plasma cell-free rna and methods of use thereof as non-invasive biomarkers for alzheimer's disease

Номер патента: US20240167096A1. Автор: Carlos Cruchaga,Laura IBANEZ,Alejandro Cisterna Garcia. Владелец: Washington University in St Louis WUSTL. Дата публикации: 2024-05-23.

Mitochondrial preproteins as markers for alzheimer's disease

Номер патента: EP3114486A2. Автор: Caroline Graff,Chris MEISINGER,Nora VÖGTLE,Dirk MOSSMANN,Elzbieta GLASER,René P. ZAHEDI. Владелец: Albert Ludwigs Universitaet Freiburg. Дата публикации: 2017-01-11.

Methods for detection of cell-free dna (cfdna) and uses thereof for diagnosing, treating, and/or monitoring alzheimer's disease

Номер патента: WO2024098003A1. Автор: Victor Velculescu,Sarah Bacus,Jillian PHALLEN,Christopher A. Hamm,Robert Scharpf,Akshaya ANNAPRAGADA. Владелец: Seq Biomarque, Llc. Дата публикации: 2024-05-10.

Composition and method of using mir-302 precursors as drugs for treating alzheimer's diseases

Номер патента: US20170218362A1. Автор: Shi-Lung Lin,Hsin-Hua Li,Chih-Li LIN,Te-Jen LAI. Владелец: MELLO BIOTECHNOLOGY Inc. Дата публикации: 2017-08-03.

Gene expression profiling of endothelium in alzheimer's disease

Номер патента: WO2002057496A3. Автор: Howard J Federoff,Berislav V Zlokovic. Владелец: Berislav V Zlokovic. Дата публикации: 2004-03-25.

Biomarkers and diagnostic methods for Alzheimer's disease and other neurodegenerative disorders

Номер патента: US09958460B2. Автор: Edward J. Goetzl. Владелец: Nanosomix Inc. Дата публикации: 2018-05-01.

Method of determining alzheimer's disease risk using apolipoprotein e4 genotype analysis in combination with decreased estrogen levels

Номер патента: US20020098481A1. Автор: Donald E. Schmechel,Gillian Einstein,Laura W. Shaughnessy. Владелец: Individual. Дата публикации: 2002-07-25.

Methods and compositions for treating alzheimer's disease

Номер патента: US20150247857A1. Автор: Henry W. Querfurth. Владелец: Individual. Дата публикации: 2015-09-03.

Screening for alzheimer's disease

Номер патента: WO2004005534A2. Автор: Margaret A. Pericak-Vance,Jeffrey M. Vance,Jonathan L. Haines. Владелец: Duke University. Дата публикации: 2004-01-15.

Composition for diagnosing Alzheimer's disease using methylation status of HMOX1 gene and method for diagnosing Alzheimer's disease using the same

Номер патента: US20140162252A1. Автор: Jung-Hyuck AHN,Hye-Youn Sung. Владелец: Industry Collaboration Foundation of Ewha University. Дата публикации: 2014-06-12.

tRNA-Derived Fragments as Disease Biomarkers and Neuropathological Regulators in Alzheimer's Disease

Номер патента: US20220195508A1. Автор: Xiang Fang,Xiaoyong Bao. Владелец: University of Texas System. Дата публикации: 2022-06-23.

Mirnas as biomarkers for alzheimer's disease

Номер патента: WO2019081497A1. Автор: Andreas Keller,Markus Beier. Владелец: Universität des Saarlandes. Дата публикации: 2019-05-02.

Differentially expressed biomarkers for alzheimer's disease

Номер патента: EP2992111A2. Автор: Graham Ball. Владелец: NOTTINGHAM TRENT UNIVERSITY. Дата публикации: 2016-03-09.

Composition and method of using mir-302 precursors as drugs for treating alzheimer's diseases

Номер патента: US20200071700A1. Автор: Shi-Lung Lin,Hsin-Hua Li,Chih-Li LIN,Te-Jen LAI. Владелец: Individual. Дата публикации: 2020-03-05.

LYMPHOCYTE-BASED PKCepsilon TEST FOR ALZHEIMER'S DISEASE

Номер патента: EP3601601A1. Автор: Daniel L. Alkon,Florin Valentin Chirila. Владелец: NeuroDiagnostics LLC. Дата публикации: 2020-02-05.

Methods and compositions for diagnosing, preventing, and treating Alzheimer's disease

Номер патента: US20040219610A1. Автор: Rudolph Tanzi,Giuseppina Tesco,Young Koh. Владелец: General Hospital Corp. Дата публикации: 2004-11-04.

Treatment of vascular dysfunction and alzheimer's disease

Номер патента: EP1532258A1. Автор: Berislav V. Zlokovic. Владелец: Socratech LLC. Дата публикации: 2005-05-25.

Alzheimer's disease-specific alterations of the erk1/erk2 phosphorylation ratio - alzheimer's disease-specific molecular biomarkers (adsmb)

Номер патента: CA2625300C. Автор: Daniel L. Alkon,Tapan Kumar Khan. Владелец: Blanchette Rockefeller Neuroscience Institute. Дата публикации: 2018-01-02.

Use of low volume plasma exchange for treating the early and middle stages of alzheimer's disease

Номер патента: US20240115665A1. Автор: Victor Grifols Roura,Antonio Manuel Paez Regadera,Laura Nunez Domenech. Владелец: Grifols Worldwide Operations Ltd. Дата публикации: 2024-04-11.

Combination therapy of donepezil and sildenafil for the treatment of alzheimer's disease or cognitive impairment

Номер патента: EP4240359A1. Автор: Sukchan Lee,Yong Ha Chi,Hyun-Hee RYU,Miso JEONG. Владелец: Neurorive Inc. Дата публикации: 2023-09-13.

Combination therapy of donepezil and tadalafil for the treatment of alzheimer's disease or cognitive impairment

Номер патента: US20230405004A1. Автор: Sukchan Lee,Yong Ha Chi,Hyun-Hee RYU,Miso JEONG. Владелец: Neurorive Inc. Дата публикации: 2023-12-21.

Combination therapy of donepezil and sildenafil for the treatment of alzheimer's disease or cognitive impairment

Номер патента: US20230398106A1. Автор: Sukchan Lee,Yong Ha Chi,Hyun-Hee RYU,Miso JEONG. Владелец: Neurorive Inc. Дата публикации: 2023-12-14.

Method For Prevention And Treatment Of Alzheimer's Disease

Номер патента: US20100221239A1. Автор: Tzu-Ming Pan. Владелец: Individual. Дата публикации: 2010-09-02.

Formulation and method for treatment of alzheimer's disease, stroke and diabetic retinopathy

Номер патента: WO2024110993A1. Автор: Krishnakumar Menon,Gopi Mohan CHETHAMPADI,Sunitha SUBHRAMANIAN. Владелец: AMRITA VISHWA VIDYAPEETHAM. Дата публикации: 2024-05-30.

Biomarkers for alzheimer's disease progression

Номер патента: WO2008024677A1. Автор: Jonathan Bejamin Singer. Владелец: Novartis Pharma Gmbh. Дата публикации: 2008-02-28.

Pharmaceutical composition for prevention or treatment of alzheimer's disease, comprising mountain-cultivated ginseng extract

Номер патента: US20210113639A1. Автор: Sang Il Lee,Hyoung Chun Kim,Eun Joo Shin,Sung Kwon KO. Владелец: University Industry Cooperation Foundation of Kangwon National University. Дата публикации: 2021-04-22.

Memantine therapy for alzheimer's disease of low and low to moderate severity

Номер патента: RU2371173C2. Автор: Скотт МАКДОНАЛЬД,Айван ГЕРГЕЛ,Альбрехт ШТЕФФЛЕР,Ханс-Йорг МЕБИУС,Ивонне ВИРТ,Стивен ПОТКИН. Владелец: Мерц Фарма Гмбх Унд Ко. Кгаа. Дата публикации: 2009-10-27.

Pharmaceutical composition for prevention or treatment of alzheimer's disease, comprising mountain-cultivated ginseng extract

Номер патента: EP3616704A1. Автор: Sang Il Lee,Hyoung Chun Kim,Eun Joo Shin,Sung Kwon KO. Владелец: University Industry Cooperation Foundation of Kangwon National University. Дата публикации: 2020-03-04.

Masitinib for the treatment of alzheimer's disease

Номер патента: AU2021399925A9. Автор: Alain Moussy,Colin Mansfield. Владелец: AB Science SA. Дата публикации: 2024-10-10.

Methods for treating alzheimer's disease and pharmaceutical compositions

Номер патента: RU2675786C2. Автор: Эллен ШМИДТ,Джохан АРЕБЕРГ. Владелец: Х. Лундбекк А/С. Дата публикации: 2018-12-25.

A traditional chinese medicine composition for the treatment of alzheimer's disease

Номер патента: NL2035374B1. Автор: ZHANG Wei,Shao Hui,HUANG PENG,PENG Can,Yang Xuan,LI Junying,Zhang Caiyun,Nian Lizhong,Shan Xiaoxiao,Jin Chuanshan,Du Mingsong. Владелец: Univ Anhui Chinese Medicine. Дата публикации: 2024-06-10.

Anavex2-73 for the treatment of alzheimer's disease

Номер патента: WO2018231216A1. Автор: Marco Cecchi. Владелец: ANAVEX LIFE SCIENCES CORP.. Дата публикации: 2018-12-20.

ANAVEX2-73 for the treatment of Alzheimer's disease

Номер патента: AU2017418247B2. Автор: Marco Cecchi. Владелец: Anavex Life Sciences Corp. Дата публикации: 2023-12-14.

Anavex2-73 for the treatment of alzheimer's disease

Номер патента: US11103478B2. Автор: Marco Cecchi. Владелец: Anavex Life Sciences Corp. Дата публикации: 2021-08-31.

Pharmaceutical composition of naphthalene derivatives as multi-targeted therapeutic agents for the treatment of alzheimer's disease

Номер патента: US20240299334A1. Автор: Laura GARCIA PUPO,Leonora Gonzalez Mesa,Giselle Pentón Rol,Majel Cervantes Llanos,Marquiza Sablon Carrazana,Chryslaine Rodriguez-Tanty,Suchitil Rivera Marrero,Rafaela Perez Perera,Samila Leon Chaviano,Alberto BENCOMO MARTINEZ,Kathleen CASTRO-PALOMINO ANTELA,Miriam DORESTE BROWN,Orestes de Jesús DÍAZ GARCÍA,Roberto MENÉNDEZ SOTO DEL VALLE,Laura OTAÑO TAMAYO,Adriana ÁGUILA CORDOVA. Владелец: Centro De Neurociencias De Cuba Cneuro. Дата публикации: 2024-09-12.

Systems and methods for moving and circulating fluid to treat alzheimer's disease

Номер патента: US09421348B2. Автор: Tim Lenihan,Bruce Meadows. Владелец: Ecole Polytechnique Federale de Lausanne EPFL. Дата публикации: 2016-08-23.

Pharmaceutical composition for the treatment of alzheimer's disease or dementia

Номер патента: US20240165097A1. Автор: Tim TASKER. Владелец: Allergan Pharmaceuticals International Ltd. Дата публикации: 2024-05-23.

Diagnosis and treatment of alzheimer's disease

Номер патента: EP1817050A2. Автор: Suzanne Marie De La Monte,Jack Raymond Wands. Владелец: RHODE ISLAND HOSPITAL. Дата публикации: 2007-08-15.

Pharmaceutical composition for the treatment of alzheimer's disease, method for producing same and use thereof

Номер патента: EP2556833A4. Автор: Sousa Buck Hudson De,Nunes Marielza Andrade. Владелец: Fundação Arnaldo Vieira De Carvalho. Дата публикации: 2013-09-04.

Unconjugated plga nanoparticles in the treatment of alzheimer's disease

Номер патента: US20230087306A1. Автор: QI Wu,Satyabrata Kar,Bibin Gnanadhason ANAND,Karthivashan GOVINDARAJAN. Владелец: University of Alberta. Дата публикации: 2023-03-23.

Methods and compositions relating to Alzheimer's disease

Номер патента: AU2005288689A1. Автор: Stefan Kienle,Richard Joubert,Helen Byers,Karsten Kuhn,Juergen Schaefer,Christian Baumann,Malcolm Ward,Simon Lovestone,Jules Westbrook,Petra Prefot,Abdul Hye,Stephen Lynham,Thorsten Prinz. Владелец: Proteome Sciences PLC. Дата публикации: 2006-04-06.

Methods and compositions relating to alzheimer's disease

Номер патента: CA2580532A1. Автор: Stefan Kienle,Richard Joubert,Helen Byers,Karsten Kuhn,Juergen Schaefer,Christian Baumann,Malcolm Ward,Simon Lovestone,Jules Westbrook,Petra Prefot,Abdul Hye,Stephen Lynham,Thorsten Prinz. Владелец: Individual. Дата публикации: 2006-04-06.

Methods and compositions relating to Alzheimer`s disease

Номер патента: EP2354795B1. Автор: Richard Joubert,Malcom Ward,Helen Byers,Karsten Kuhn,Juergen Schaefer,Christian Baumann,Simon Lovestone,Jules Westbrook,Petra Prefot,Abdul Hye,Stephen Lynham,Thorsten Prinz,Stefan Kielne. Владелец: Proteome Sciences PLC. Дата публикации: 2014-12-17.

Methods and compositions relating to alzheimer's disease

Номер патента: EP1794594B1. Автор: Malcolm Proteome Sciences plc Ward,Helen Proteome Sciences plc BYERS,Jules Proteome Sciences plc WESTBROOK,Simon King's College London LOVESTONE,Abdul King's College London HYE,Stephen King's College London LYNHAM,Richard Proteome Sciences R&D GmbH&Co.KG JOUBERT,Petra Proteome Sciences R&D GmbH&Co. KG PREFOT,Karsten Proteome Sciences R&D GmbH&Co. KG KUHN,Christian Proteome Sci. R&D GmbH&Co KG BAUMANN,Juergen Proteome Sci. R&D GmbH&CO KG SCHAEFER,Thorsten Proteome Sciences R&D GmbH&Co. KG PRINZ,Stefan Proteome Sciences R&D GmbH&Co. KG KIENLE. Владелец: Proteome Sciences PLC. Дата публикации: 2011-01-12.

Bambuterol for the treatment of alzheimer's disease

Номер патента: CA3095859C. Автор: Patrick Dallemagne,Christophe Rochais,Anne-Claire GROO,Aurelie Malzert-Freon. Владелец: Université de Caen Normandie. Дата публикации: 2024-04-30.

Diagnosis and treatment of alzheimer's disease

Номер патента: CA2587601A1. Автор: Suzanne Marie De La Monte,Jack Raymond Wands. Владелец: Individual. Дата публикации: 2006-06-08.

Method of upregulating sorla for the treatment of alzheimer's disease

Номер патента: US20110104165A1. Автор: Thomas Willnow. Владелец: H Lundbeck AS. Дата публикации: 2011-05-05.

Preventative treatment of alzheimer's disease

Номер патента: US20180133186A1. Автор: Carol A. Colton. Владелец: Duke University. Дата публикации: 2018-05-17.

Method of upregulating sorla for the treatment of alzheimer's disease

Номер патента: WO2010028651A3. Автор: Thomas Willnow. Владелец: H. Lundbeck A/S. Дата публикации: 2010-05-06.

Method of upregulating sorla for the treatment of alzheimer's disease

Номер патента: EP2323687A2. Автор: Thomas Willnow. Владелец: H Lundbeck AS. Дата публикации: 2011-05-25.

Application of protein yb-1 and its fragments for production of medications in treatment of alzheimer's disease

Номер патента: RU2561050C2. Автор: Александр Николаевич Самохин,Наталья Викторовна Бобкова,Ирина Юрьевна Александрова,Лев Павлович Овчинников,Наталия Игоревна Медвинская,Сергей Георгиевич Гурьянов,Инна Владимировна Нестерова,Ирина Александровна Елисеева,Павел Валерьевич Некрасов. Владелец: Федеральное государственное бюджетное учреждение науки Институт биофизики клетки Российской академии наук (ИБК РАН). Дата публикации: 2015-08-20.

Combination of a nmda receptor channel blocker and a pkc activator for treatment of alzheimer's disease

Номер патента: WO2009099563A3. Автор: Daniel L. Alkon,Changhai Cui. Владелец: BLANCHETTE ROCKEFELLER NEUROSCIENCES INSTITUTE. Дата публикации: 2009-10-15.

Compositions of peptide conjugate and methods for prevention and treatment of alzheimer's disease

Номер патента: RU2406529C2. Автор: Джин КИННИ,Джон В. ШИВЕР,Джозеф Дж. ДЖОЙС,Виктор М. ГАРСКИ,Пол М. КЕЛЛЕР,Сяопин ЛЯН. Владелец: Мерк Шарп Энд Домэ Корп.. Дата публикации: 2010-12-20.

Method of treatment of central nervous system diseases such as alzheimer's disease and parkinson's disease and method of diagnosing alzheimer's disease

Номер патента: CA1323294C. Автор: Chaovanee Aroonsakul. Владелец: Individual. Дата публикации: 1993-10-19.

Component assay for alzheimer's disease in a living subject

Номер патента: CA3227341A1. Автор: Hoau-Yan Wang,George B. Thornton. Владелец: Cassava Sciences Inc. Дата публикации: 2023-01-26.

Component assay for alzheimer's disease in a living subject

Номер патента: AU2022313196A1. Автор: Hoau-Yan Wang,George B. Thornton. Владелец: Cassava Sciences Inc. Дата публикации: 2024-02-15.

Component assay for alzheimer's disease in a living subject

Номер патента: EP4374175A1. Автор: Hoau-Yan Wang,George B. Thornton. Владелец: Cassava Sciences Inc. Дата публикации: 2024-05-29.

Assays for inhibitors of neuronal transport of alzheimer's amyloid precursor protein

Номер патента: WO2002041839A2. Автор: Lawrence S. B. Goldstein,Adeela Kamal,Gorazd Stokin. Владелец: The Regents of the University of California. Дата публикации: 2002-05-30.

Masitinib for the treatment of alzheimer's disease

Номер патента: EP4262801A1. Автор: Alain Moussy,Colin Mansfield. Владелец: AB Science SA. Дата публикации: 2023-10-25.

Non-productive angiogenesis inhibitor for use in the treatment of alzheimer's disease

Номер патента: EP3900788A1. Автор: Alberto Pascual Bravo,Alicia Elena ROSALES NIEVES,María Isabel ÁLVAREZ VERGARA. Владелец: Consejo Superior de Investigaciones Cientificas CSIC. Дата публикации: 2021-10-27.

Masitinib for the treatment of alzheimer's disease

Номер патента: US20240058328A1. Автор: Alain Moussy,Colin Mansfield. Владелец: AB Science SA. Дата публикации: 2024-02-22.

Dosing regimen for the treatment of alzheimer's disease with sulfonyl fluorides

Номер патента: WO2010115177A1. Автор: Federica Pericle,Enrico Braglia. Владелец: The Board of Regents of the University of Texas System. Дата публикации: 2010-10-07.

Therapeutic agent for Alzheimer's disease

Номер патента: US09980937B2. Автор: Takashi Tanaka,Keiro Shirotani,Nobuhisa Iwata,Masashi Asai. Владелец: Nagasaki University NUC. Дата публикации: 2018-05-29.

Therapeutic agent containing carbostiryl derivative and donepezil for treating alzheimer's disease

Номер патента: RU2469723C2. Автор: Хейи АРАИ. Владелец: Дзунтендо Юниверсити. Дата публикации: 2012-12-20.

A use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease

Номер патента: CA2310926C. Автор: Wim Louis Julien Parys,Michael Pontecorvo. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2002-10-15.

Liquid-state fermentation broth of Ganoderma lucidum to prepare a combination for amelioration, prevention or treatment of Alzheimer’s disease or other relevant symptoms induced by Alzheimer’s disease

Номер патента: AU2021102478A4. Автор: Wei-Jen Chen,Yu-Shan WEI,Hsin-I Lo,Hui-Fang Chu. Владелец: Syngen Biotech Co Ltd. Дата публикации: 2021-09-30.

Method of treating alzheimer's disease, progressive multiple sclerosis, severe stroke, cerebral and birth brain injury, parkinsonism and other neurodegenerative diseases

Номер патента: RU2737995C1. Автор: Наталья Вениаминовна Казанцева. Владелец: Наталья Вениаминовна Казанцева. Дата публикации: 2020-12-07.

Agent For Prevention And/Or Treatment Of Alzheimer's Disease

Номер патента: US20070218031A1. Автор: Toshinori Ozaki,Akira Nakagawara. Владелец: Chiba Prefectural Government. Дата публикации: 2007-09-20.

A composition comprising an extract of red mold rice for treatment of alzheimer's disease

Номер патента: CA2616971C. Автор: Tzu-Ming Pan,Chun-Lin Lee. Владелец: Sunway Biotech Co Ltd. Дата публикации: 2012-11-20.

H3 receptor antagonist for use in the treatment of alzheimer's disease

Номер патента: US09789102B2. Автор: Thomas Rooney,Veronique Mary,Veronique Blanchard-Bregeon,Pascal Barneoud,Philippe Delay-Goyet,Jean Menager,Nathalie SCHUSSLER,Mathilde LOPEZ-GRANCHA. Владелец: SANOFI SA. Дата публикации: 2017-10-17.

Noble gas treatment of alzheimer's disease and taupathies

Номер патента: US20170196906A1. Автор: Thomas Ichim,Vlad Bogin. Владелец: Noblis Therapeutics Inc. Дата публикации: 2017-07-13.

Astrocytic trpa1 channel inhibition as a novel neuroprotective therapeutic target in the prodromal phases of alzheimer's disease

Номер патента: US20230372350A1. Автор: Alain Buisson,Mireille Albrieux,Adrien Paumier,Anthony Bosson,Sylvie Boisseau. Владелец: Institut National de la Sante et de la Recherche Medicale INSERM. Дата публикации: 2023-11-23.

Pimavanserin alone or in combination for use in the treatment of alzheimer's disease psychosis

Номер патента: US20200237739A1. Автор: James M. Youakim,Srdjan R. STANKOVIC,James Randall OWEN,Bruce Duane Coate,Mark Donald Knowles. Владелец: Acadia Pharmaceuticals Inc. Дата публикации: 2020-07-30.

Composition for the treatment of alzheimer's disease and process for preparing the same

Номер патента: WO1992000737A1. Автор: Peter Literati Nagy,Sziveszter Vizi,Jeno^' SZILBEREKY. Владелец: Biorex Kutató-Fejleszto^' Kft.. Дата публикации: 1992-01-23.

Composition for the treatment of alzheimer's disease and¹process for preparing the same

Номер патента: IE912431A1. Автор: . Владелец: Biorex Kutato Fejleszto Kft. Дата публикации: 1992-01-15.

Compositions and methods for the diagnosis and treatment of alzheimer's disease

Номер патента: WO2021016551A8. Автор: Rima F. KADDURAH-DAOUK,Rebecca BAILLIE,Xianlin Han,Kwangsik Nho,Andrew J. Saykin,Siamak MAHMOUDIANDEHKORDI,Shahzad AHMAD,Cornelia van Duijin. Владелец: Indiana University School of Medicine. Дата публикации: 2022-01-20.

Compositions and methods for the diagnosis and treatment of alzheimer's disease

Номер патента: WO2021016466A1. Автор: Matthias Arnold,John Q. Trojanowski,Leslie M. Shaw,Rima F. KADDURAH-DAOUK,Xianlin Han,Kwangsik Nho,Andrew J. Saykin,Gregory Louie,Gabi KASTENMÜLLER,Siamak MAHMOUDIANDEHKORDI,Shahzad AHMAD,Cornelia van Duijin,Shannon L. RISACHER,Colette BLACH,Rebecca BALLIE,Michael W WEINER,P. Murali DORAISWAMY. Владелец: Indiana University School of Medicine. Дата публикации: 2021-01-28.

Compositions and methods for treating Alzheimer's disease and related disorders and promoting a healthy nervous system

Номер патента: US20150150828A1. Автор: Giulio Maria Pasinetti. Владелец: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. Дата публикации: 2015-06-04.

Compositions and methods for treating alzheimer`s disease and related disorders and promoting a healthy nervous system

Номер патента: US20160151301A1. Автор: Giulio Maria Pasinetti. Владелец: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. Дата публикации: 2016-06-02.

Compositions and methods for treating alzheimer’s disease and related disorders and promoting a healthy nervous system

Номер патента: WO2006047544A2. Автор: Giulio Mario Pasinetti. Владелец: Mount Sinai School Of Medecine Of New York University. Дата публикации: 2006-05-04.

Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II

Номер патента: US09603823B2. Автор: Samuel T. Henderson. Владелец: Accera Inc. Дата публикации: 2017-03-28.

Use of mnk inhibitors for the treatment of alzheimer's disease

Номер патента: US20100247517A1. Автор: Martin Schneider,Matthias Austen,Marcus Geese. Владелец: BOEHRINGER INGELHEIM INTERNATIONAL GMBH. Дата публикации: 2010-09-30.

Nadh and nadph as drugs for treating alzheimer's disease

Номер патента: CA2105912C. Автор: Jorg Birkmayer. Владелец: Individual. Дата публикации: 2000-11-14.

Compositions and methods for the treatment of alzheimer's disease and other neurogenerative disease

Номер патента: WO2024044355A2. Автор: Christine Ann DENNY,Briana K. Chen,Holly HUNSBERGER. Владелец: 1/1The Trustees Of Columbia University In The City Of New York. Дата публикации: 2024-02-29.

Use of artemether in the prevention and treatment of alzheimer's disease

Номер патента: US20210205265A1. Автор: Wenhua Zheng. Владелец: UNIVERSITY OF MACAU. Дата публикации: 2021-07-08.

Method for selectively inhibiting the activity of acat1 in the treatment of alzheimer's disease

Номер патента: WO2014039138A1. Автор: Ta-Yuan Chang,Maximillian A. ROGERS,Elena Bryleva,Stephanie Murphy,Catherine C.Y. Chang. Владелец: Trustees of Dartmouth College. Дата публикации: 2014-03-13.

Method for selectively inhibiting the activity of acat1 in the treatment of alzheimer's disease

Номер патента: EP2892618A1. Автор: Ta-Yuan Chang,Maximillian A. ROGERS,Elena Bryleva,Stephanie Murphy,Catherine C.Y. Chang. Владелец: Dartmouth College. Дата публикации: 2015-07-15.

Method for selectively inhibiting the activity of acat1 in the treatment of alzheimer's disease

Номер патента: WO2010042292A8. Автор: Ta-Yuan Chang,Catherine C. Y. Chang. Владелец: Trustees of Dartmouth College. Дата публикации: 2010-07-15.

Compositions and methods for the treatment and/or prevention of alzheimer's disease

Номер патента: US20240293431A1. Автор: Chuanhai Cao. Владелец: UNIVERSITY OF SOUTH FLORIDA. Дата публикации: 2024-09-05.

Anavex2-73 for the Treatment of Alzheimer's Disease

Номер патента: US20200022943A1. Автор: Marco Cecchi. Владелец: Anavex Life Sciences Corp. Дата публикации: 2020-01-23.

ANAVEX2-73 for the treatment of Alzheimer's disease

Номер патента: AU2024201661A1. Автор: Marco Cecchi. Владелец: Anavex Life Sciences Corp. Дата публикации: 2024-04-04.

Anavex2-73 for the Treatment of Alzheimer's Disease

Номер патента: US20180360796A1. Автор: Marco Cecchi. Владелец: Anavex Life Sciences Corp. Дата публикации: 2018-12-20.

Treatment of alzheimer's disease with allogeneic mesenchymal stem cells

Номер патента: EP4210719A1. Автор: Joshua M. Hare,Anthony A. OLIVA. Владелец: Longeveron Inc. Дата публикации: 2023-07-19.

Prevention and treatment of alzheimer's disease through electromagnetic field exposure

Номер патента: US20120065456A1. Автор: Chuanhai Cao,Jun Tan,Gary W. Arendash. Владелец: UNIVERSITY OF SOUTH FLORIDA. Дата публикации: 2012-03-15.

Pharmaceutical composition of naphthalene derivatives as multi-target therapeutic agents for the treatment of alzheimer's disease

Номер патента: CA3200071A1. Автор: Laura GARCIA PUPO,Leonora Gonzalez Mesa,Giselle Pentón Rol,Majel Cervantes Llanos,Marquiza Sablon Carrazana,Chryslaine Rodriguez-Tanty,Suchitil Rivera Marrero,Rafaela Perez Perera,Samila Leon Chaviano,Alberto BENCOMO MARTINEZ,Kathleen CASTRO-PALOMINO ANTELA,Miriam DORESTE BROWN,Orestes de Jesús DÍAZ GARCÍA,Roberto MENÉNDEZ SOTO DEL VALLE,Laura OTAÑO TAMAYO,Adriana ÁGUILA CORDOVA. Владелец: Centro de Neurociencias de Cuba. Дата публикации: 2022-06-02.

Application of Lactoferrin in Prevention and Treatment of Alzheimer's Disease

Номер патента: US20240316163A1. Автор: GUO CHENG,LIN Zhang,Lingli Zhang. Владелец: Hainan Xingzheng Nutrition Engineering Co Ltd. Дата публикации: 2024-09-26.

Agents for use in the treatment of Alzheimer's disease

Номер патента: US6323218B1. Автор: Xudong Huang,Ashley I. Bush,Craig S. Atwood,Rudolph E. Tanzi. Владелец: General Hospital Corp. Дата публикации: 2001-11-27.

Use of alpha 2B or 2B/2C adrenoceptor agonists for the treatment of Alzheimer's or Parkinson's disease

Номер патента: NZ539328A. Автор: John E Donello,Daniel W Gil,Larry A Wheeler. Владелец: Allergan Inc. Дата публикации: 2007-01-26.

Compounds for the treatment of alzheimer's disease

Номер патента: CA2652164C. Автор: Jeremy Turnbull,Edwin Yates,Susannah Patey. Владелец: Ulive Enterprises Ltd. Дата публикации: 2015-09-01.

Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction

Номер патента: US20130011468A1. Автор: Morten Bryhn. Владелец: Pronova Biopharma Norge AS. Дата публикации: 2013-01-10.

Treatment of Alzheimer's Disease with Allogeneic Mesenchymal Stem Cells

Номер патента: US20230310509A1. Автор: Joshua M. Hare,Anthony A. OLIVA. Владелец: Longeveron Inc. Дата публикации: 2023-10-05.

Pharmaceutical composition for the treatment of alzheimer's disease or dementia

Номер патента: EP4304591A1. Автор: Tim TASKER. Владелец: Heptares Therapeutics Ltd. Дата публикации: 2024-01-17.

Pharmaceutical composition of naphthalene derivatives as multi-target therapeutic agents for the treatment of alzheimer's disease

Номер патента: EP4252749A1. Автор: Laura GARCIA PUPO,Leonora Gonzalez Mesa,Giselle Pentón Rol,Majel Cervantes Llanos,Marquiza Sablon Carrazana,Chryslaine Rodriguez-Tanty,Suchitil Rivera Marrero,Rafaela Perez Perera,Samila Leon Chaviano,Alberto BENCOMO MARTINEZ,Kathleen CASTRO-PALOMINO ANTELA,Miriam DORESTE BROWN,Orestes de Jesús DÍAZ GARCÍA,Roberto MENÉNDEZ SOTO DEL VALLE,Laura OTAÑO TAMAYO,Adriana ÁGUILA CORDOVA. Владелец: Centro de Neurociencias de Cuba. Дата публикации: 2023-10-04.

Synthesis of amino thiol nutraceutical linked antioxidant conjugates for treatment of Alzheimer’s disease

Номер патента: AU2021107264A4. Автор: Dileep Kumar,Neha Vithal Bhilare. Владелец: Bhilare Neha Vithal Dr. Дата публикации: 2021-12-23.

Prevention and treatment of alzheimer's disease by amyloid beta peptide and sphin-gosine-1-phosphate

Номер патента: US09757398B2. Автор: Ramon Cacabelos,Carmen Vigo. Владелец: Euroespes Biotecnologia SL. Дата публикации: 2017-09-12.

Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease

Номер патента: CA2264097C. Автор: Panayotis Nikolas Gerolymatos. Владелец: PN Gerolymatos SA. Дата публикации: 2007-11-27.

Use Of 2-Phenyl-6-(1H-Imidazol-1-YL) Quinazoline For Treating Neurodegenerative Diseases, Preferably Alzheimer's Disease

Номер патента: US20240091227A1. Автор: Lucio Claudio Rovati,Gianfranco Caselli,Emanuele SALA. Владелец: Rottapharm Biotech SRL. Дата публикации: 2024-03-21.

Apparatus and method for detecting amyloid in a retina in a diagnosis, advancement, and prognosing of alzheimer's disease, traumatic brain injury, macular degeneration and a plurality of neurodegenerative dissorders, and ocular diseases

Номер патента: US09730580B2. Автор: Steven Roger Verdooner. Владелец: Neurovision Imaging Inc. Дата публикации: 2017-08-15.

Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of alzheimer's disease (ad)

Номер патента: WO2010005581A4. Автор: Venkateswarlu Akella,Uday Saxena. Владелец: Kareus Therapeutics, Llc. Дата публикации: 2010-03-04.

Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of alzheimer's disease (ad)

Номер патента: US20110097347A1. Автор: Uday Saxena,Venkateswarulu Akella. Владелец: Venkateswarulu Akella. Дата публикации: 2011-04-28.

Agent for preventing or treating alzheimer's disease

Номер патента: US20200108048A1. Автор: Hiroshi Kobayashi,Yoshihiko Matsumoto. Владелец: Fujifilm Toyama Chemical Co Ltd. Дата публикации: 2020-04-09.

Prophylactic and therapeutic treatment of alzheimer's disease using phytic acid and phytate to reduce amyloid beta plaque and tau protein

Номер патента: US11510932B2. Автор: Robert Sabin. Владелец: Individual. Дата публикации: 2022-11-29.

Pharmaceutical preservation of creb activation in the treatment of alzheimer's disease

Номер патента: EP4252750A1. Автор: Guilherme Gomes,Michael Kreutz,Carsten Reissner,Katarzyna Grochowska,Anja Oelschlegel,Anna Karpova. Владелец: Leibniz Institut fuer Neurobiologie. Дата публикации: 2023-10-04.

6-Substituted Estradiol Derivatives for the Treatment of Alzheimer's Disease

Номер патента: US20150265630A1. Автор: James G. Yarger,Steven H. Nye. Владелец: Endece LLC. Дата публикации: 2015-09-24.

Prophylactic and therapeutic treatment of alzheimer's disease

Номер патента: WO2010110923A3. Автор: Robert Sabin. Владелец: Robert Sabin. Дата публикации: 2011-02-24.

Prophylactic and therapeutic treatment of alzheimer's disease using phytic acid and phytate to reduce amyloid beta plaque and tau protein

Номер патента: US20200078380A1. Автор: Robert Sabin. Владелец: Individual. Дата публикации: 2020-03-12.

Prophylactic and therapeutic treatment of alzheimer's disease using phytic acid and phytate to reduce amyloid beta plaque and tau protein

Номер патента: US20230048403A1. Автор: Robert Sabin. Владелец: Individual. Дата публикации: 2023-02-16.

Prophylactic and therapeutic treatment of alzheimer's disease using phytic acid and phytate to reduce amyloid beta plaque and tau protein

Номер патента: US20210038618A1. Автор: Robert Sabin. Владелец: Individual. Дата публикации: 2021-02-11.

Polytherapy Modulating Cathelicidin Gene Expression Modulation for The Treatment of Alzheimer's Disease and Other Conditions

Номер патента: US20230063416A1. Автор: Annelise E. Barron,Mehrdad Shamloo,Joshua Mcclure,Andrew K. Evans,Jennifer S. Lin. Владелец: Maxwell Biosciences Inc. Дата публикации: 2023-03-02.

Biomarkers for the diagnosis and characterization of alzheimer's disease

Номер патента: WO2018049268A8. Автор: Therese Koal,Matthias Arnold,Will THOMPSON,Rima F. KADDURAH-DAOUK,Xianlin Han,Rebecca A. Baillie,Kwangsik Nho,Andrew J. Saykin,Jon B. TOLEDO,Gabi KASTEMULLER,Lisa ST. JOHN-WILLIAMS,M. Arthur MOSELEY,Pudugramam Murali DORAISWAMY. Владелец: Rosa & Co Llc. Дата публикации: 2019-04-25.

Use of R-(Z) -alpha-(methoxyimino)-alpha-(1-azabicyclo 2.2.2 oct-3-yl) acetonitrile to reduce amyloid beta A4 formation in Alzheimer's disease

Номер патента: AU698695B2. Автор: Roger Edward Markwell,Carol Wendy Gray,Julie Hawkins. Владелец: SmithKline Beecham Ltd. Дата публикации: 1998-11-05.

N'-(2-chloro-6-methylbenzoyl)-4-methyl-3-[2-(3-quinolyl)ethynyl]-benzohydrazide for treatment of alzheimer's disease

Номер патента: US20230301982A1. Автор: Nitin Krishnaji Damle,Vikram Krishna Ramanathan,Sanjay Nandlalji MANDHANE,Shakti Kamalchand JAIN,Durgesh Ashok Kumar SONI. Владелец: Sun Pharma Advanced Research Co Ltd. Дата публикации: 2023-09-28.

New approach to treatment of alzheimer's disease

Номер патента: RU2106864C1. Автор: Сергей Евгеньевич Ткаченко,Светлана Васильевна Афанасьева,Сергей Олегович Бачурин,Марина Абрамовна Юровская,Николай Серафимович Зефиров,Владимир Викторович Григорьев,Валерий Павлович Четвериков,Андрей Захарович Афанасьев,Елизавета Евгеньевна Букатина,Ирина Владимировна Григорьева. Владелец: Ирина Владимировна Григорьева. Дата публикации: 1998-03-20.

Clomipramine for the treatment of alzheimer's disease

Номер патента: US20230372356A1. Автор: Pushkar SHARMA,Monika CHAUHAN. Владелец: National Institute of Immunology. Дата публикации: 2023-11-23.

Clomipramine for the treatment of Alzheimer's Disease

Номер патента: US11957692B2. Автор: Pushkar SHARMA,Monika CHAUHAN. Владелец: National Institute of Immunology. Дата публикации: 2024-04-16.

Valacyclovir and celecoxib for the treatment of alzheimer's disease and covid-19

Номер патента: WO2024059247A2. Автор: William Langley PRIDGEN. Владелец: Virios Therapeutics, Inc. Дата публикации: 2024-03-21.

Clomipramine for the treatment of alzheimer's disease

Номер патента: WO2023228204A1. Автор: Pushkar SHARMA,Monika CHAUHAN. Владелец: National Institute of Immunology. Дата публикации: 2023-11-30.

Valacyclovir and celecoxib for the treatment of alzheimer's disease and covid-19

Номер патента: WO2024059247A3. Автор: William Langley PRIDGEN. Владелец: Virios Therapeutics, Inc. Дата публикации: 2024-05-10.

Intranasal dantrolene administration for treatment of alzheimer's disease

Номер патента: CA3145528A1. Автор: Ge Liang,Huafeng Wei,Qing Cheng Meng,Maryellen FAZEN ECKENHOLL. Владелец: University of Pennsylvania Penn. Дата публикации: 2020-12-30.

Use of R-(Z) -alpha-(methoxyimino)-alpha-(1-azabicyclo 2.2.2 oct-3-yl) acetonitrile to reduce amyloid beta A4 formation in Alzheimer's disease

Номер патента: AU3843195A. Автор: Roger Edward Markwell,Carol Wendy Gray,Julie Hawkins. Владелец: SmithKline Beecham Ltd. Дата публикации: 1996-05-15.

Diagnosing and treating alzheimer's disease

Номер патента: US11719708B2. Автор: Steven William Graves. Владелец: BRIGHAM YOUNG UNIVERSITY. Дата публикации: 2023-08-08.

Accelerated evaluation of treatments to prevent clinical onset of alzheimer's disease

Номер патента: US09492114B2. Автор: Eric M. Reiman. Владелец: Banner Health Systems Inc. Дата публикации: 2016-11-15.

Upregulation of Adamts4 Protease Activity for the Treatment of Alzheimer's Disease

Номер патента: US20090305314A1. Автор: Dirk Beher,Jonathon Wrigley. Владелец: Individual. Дата публикации: 2009-12-10.

Pharmaceutical composition of naphthalene derivatives as multi-target therapeutic agents for the treatment of alzheimer's disease

Номер патента: AU2021388673A1. Автор: Laura GARCIA PUPO,Leonora Gonzalez Mesa,Giselle Pentón Rol,Majel Cervantes Llanos,Marquiza Sablon Carrazana,Chryslaine Rodriguez-Tanty,Suchitil Rivera Marrero,Rafaela Perez Perera,Samila Leon Chaviano,Alberto BENCOMO MARTINEZ,Kathleen CASTRO-PALOMINO ANTELA,Miriam DORESTE BROWN,Orestes de Jesús DÍAZ GARCÍA,Roberto MENÉNDEZ SOTO DEL VALLE,Laura OTAÑO TAMAYO,Adriana ÁGUILA CORDOVA. Владелец: Centro de Neurociencias de Cuba. Дата публикации: 2024-03-28.

Upregulation of adamts4 protease activity for the treatment of alzheimer's disease

Номер патента: CA2640955A1. Автор: Dirk Beher,Jonathan David Wrigley. Владелец: Individual. Дата публикации: 2007-08-09.

Upregulation of adamts4 protease activity for the treatment of alzheimer's disease

Номер патента: EP1981542A1. Автор: Dirk Beher,Jonathan David Wrigley. Владелец: Merck Sharp and Dohme Ltd. Дата публикации: 2008-10-22.

Compounds for treatment of alzheimer's disease

Номер патента: ZA202206837B. Автор: Krenning Guido,Henk Henning Robert,Cornelis Van Der Graaf Adrianus,Henri Swart Daniël,Françoise De Veij Mestdagh Christina,Cornelis Vogelaar Pieter. Владелец: Sulfateq Bv. Дата публикации: 2023-11-29.

Electrical treatment of alzheimer's disease

Номер патента: US09775996B2. Автор: Yossi Gross. Владелец: Rainbow Medical Ltd. Дата публикации: 2017-10-03.

Electrical substance clearance from the brain for treatment of Alzheimer's disease

Номер патента: US09724515B2. Автор: Yossi Gross,Gideon Fostick. Владелец: Rainbow Medical Ltd. Дата публикации: 2017-08-08.

Method of treating, delaying and/or preventing Alzheimer's Disease

Номер патента: US09717704B2. Автор: Janne Sande Mathisen,Henrik Mathisen. Владелец: SMARTFISH AS. Дата публикации: 2017-08-01.

Electrical treatment of Alzheimer's disease

Номер патента: US09616221B2. Автор: Yossi Gross. Владелец: Rainbow Medical Ltd. Дата публикации: 2017-04-11.

Donepezil compositions and methods of treating alzheimer's disease

Номер патента: CA3214846A1. Автор: Mahendra G. Dedhiya,Kavita Vermani,Ashok Katdare. Владелец: Forest Laboratories Holdings ULC. Дата публикации: 2015-08-13.

Riluzole for the treatment of alzheimer's disease

Номер патента: EP4240308A1. Автор: Ana PEREIRA. Владелец: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. Дата публикации: 2023-09-13.

Riluzole for the treatment of alzheimer's disease

Номер патента: US20240016783A1. Автор: Ana PEREIRA. Владелец: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. Дата публикации: 2024-01-18.

Compositions and methods for treating Alzheimer's disease and related disorders and promoting a healthy nervous system

Номер патента: US20130123370A1. Автор: Giulio M. Pasinetti. Владелец: Mount Sinai School of Medicine. Дата публикации: 2013-05-16.

Medicament for treatment of Alzheimer's disease

Номер патента: US09861640B2. Автор: Koichi Shudo,Kohichi KAWAHARA,Michita SUENOBU. Владелец: KEMPHYS Ltd. Дата публикации: 2018-01-09.

Chlorogenic acid composition and method for its use in the treatment of alzheimer's disease

Номер патента: US20200237702A1. Автор: Kodimule Shyam Prasad. Владелец: Individual. Дата публикации: 2020-07-30.

Method and apparatus for early diagnosis of Alzheimer's using non-invasive eye tomography by Teraherts

Номер патента: US20100110381A1. Автор: Ali Dabiri,Manouchehr Motamedi. Владелец: Individual. Дата публикации: 2010-05-06.

Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an hmg coa reductase inhibitor

Номер патента: WO2000028981A3. Автор: Benjamin Wolozin. Владелец: Benjamin Wolozin. Дата публикации: 2000-11-09.

Method for Treating and/or Preventing Alzheimer’s Disease

Номер патента: US20240342219A1. Автор: Chih-Kai Hsu,Han-Chung CHENG,Chi-Tang Tu. Владелец: Taiwan Mitochondrion Application Technology Co Ltd. Дата публикации: 2024-10-17.

Peptide isosteres containing a heterocycle useful in the treatment of alzheimer's disease

Номер патента: EP1450795A1. Автор: John Varghese. Владелец: Elan Pharmaceuticals LLC. Дата публикации: 2004-09-01.

Novel methods for testing inhibitors of paired helical filaments and uses for treatment of alzheimer's disease

Номер патента: WO1998025640A3. Автор: Jacek Biernat,Eva-Maria Mandelkow,Eckhard Mandelkow,Peter Friedhoff. Владелец: Mandelkow Eva Maria. Дата публикации: 1998-08-27.

Novel methods for testing inhibitors of paired helical filaments and uses for treatment of alzheimer's disease

Номер патента: EP1019069A2. Автор: Jacek Biernat,Eva-Maria Mandelkow,Eckhard Mandelkow,Peter Friedhoff. Владелец: Max Planck Gesellschaft zur Foerderung der Wissenschaften eV. Дата публикации: 2000-07-19.

Novel methods for testing inhibitors of paired helical filaments and uses for treatment of alzheimer's disease

Номер патента: WO1998025640A2. Автор: Jacek Biernat,Eva-Maria Mandelkow,Eckhard Mandelkow,Peter Friedhoff. Владелец: MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V.. Дата публикации: 1998-06-18.

Methods for preventing ectopic brain mineralization in alzheimer's disease and dementias

Номер патента: WO2023154860A1. Автор: Erming Tian,Maurizio Zangari. Владелец: Tzerma Llc. Дата публикации: 2023-08-17.

Biomarkers for detecting and/or determining a treatment regimen for alzheimer's disease

Номер патента: WO2024049764A1. Автор: Jeff Olson,Sarah Bacus,Christopher Hamm. Владелец: Seq Biomarque, Llc. Дата публикации: 2024-03-07.

Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an hmg coa reductase inhibitor

Номер патента: EP1131060A2. Автор: Benjamin Nymox Corporation WOLOZIN. Владелец: Nymox Corp. Дата публикации: 2001-09-12.

Management, care and treatment of Alzheimer's disease and related dementias

Номер патента: US20050070766A1. Автор: Barry Reisberg,Stefanie Auer. Владелец: Individual. Дата публикации: 2005-03-31.

Agent for preventing or ameliorating alzheimer's disease

Номер патента: US20240277741A1. Автор: Yasuyuki Igarashi,Kaori Takahashi,Katsuyuki Mukai,Kohei Yuyama. Владелец: Daicel Corp. Дата публикации: 2024-08-22.

Management, care and treatment of Alzheimer's disease and related dementias

Номер патента: US7122006B2. Автор: Barry Reisberg,Stefanie R. Auer. Владелец: Individual. Дата публикации: 2006-10-17.

Protective effects of oil palm composition on alzheimer?s disease

Номер патента: MY179462A. Автор: Rha ChoKyun,Sambanthamurthi Ravigadevi,Yew Ai TAN,P Weinberg Robert,J Sinskey Anthony. Владелец: Malaysian Palm Oil Board. Дата публикации: 2020-11-06.

Method of treating alzheimer's disease

Номер патента: EP4340834A1. Автор: Sharon L. Rogers. Владелец: Amyriad Pharma Inc. Дата публикации: 2024-03-27.

Improved use of cannabinoids in the treatment of alzheimer's disease

Номер патента: US20240000808A1. Автор: Mark RIDALL,Vincent T. MILETO. Владелец: Orcosa Inc. Дата публикации: 2024-01-04.

Improved use of cannabinoids in the treatment of alzheimer's disease

Номер патента: EP4243602A1. Автор: Mark RIDALL,Vincent T. MILETO. Владелец: Orcosa Inc. Дата публикации: 2023-09-20.

Automated detection of alzheimer's disease by statistical analysis with positron emission tomography images

Номер патента: WO2005117707A3. Автор: Ziad Burbar. Владелец: Ziad Burbar. Дата публикации: 2007-03-29.

Melatonin for delaying the onset of alzheimer's disease and for treating or delaying the onset of other amyloidosis-related diseases/disorders

Номер патента: WO1999048489A9. Автор: Blas Frangione,Jorge Ghiso,Miguel A Pappolla. Владелец: Univ New York. Дата публикации: 2000-07-20.

Combination therapy for the prevention or treatment of alzheimer's disease as well as kit therefor

Номер патента: CA2577332C. Автор: Frank Mattner,Walter Schmidt. Владелец: Affiris Forschungs Und Entwicklungs Gmbh. Дата публикации: 2014-12-09.

Method of treating alzheimer's disease

Номер патента: AU2022275939A1. Автор: Sharon L. Rogers. Владелец: Amyriad Pharma Inc. Дата публикации: 2023-11-16.

Method of treating alzheimer’s disease

Номер патента: US20240156812A1. Автор: Sharon L. Rogers. Владелец: Amyriad Pharma Inc. Дата публикации: 2024-05-16.

Method of treating alzheimer's disease

Номер патента: CA3217579A1. Автор: Sharon L. Rogers. Владелец: Individual. Дата публикации: 2022-11-24.

Isolated mitochondria for use in the treatment and/or prevention of alzheimer s disease

Номер патента: EP3714892A1. Автор: Chih-Kai Hsu,Han-Chung CHENG,Chi-Tang Tu. Владелец: Taiwan Mitochondrion Application Technology Co Ltd. Дата публикации: 2020-09-30.

Use of acetamide derivative in prevention and treatment of alzheimer's disease

Номер патента: US20230293537A1. Автор: Liming Zhang,Wei Dai,Yunfeng Li,Rifang Yang,Rumeng Yao. Владелец: Academy of Military Medical Sciences AMMS of PLA. Дата публикации: 2023-09-21.

An oxazine derivative for use in the prevention of alzheimer's disease in at risk patients

Номер патента: WO2018015868A1. Автор: Ulf Neumann,Cristina LOPEZ-LOPEZ. Владелец: NOVARTIS AG. Дата публикации: 2018-01-25.

Apilimod compositions and methods for using same in the treatment of alzheimer's disease

Номер патента: AU2017342262B2. Автор: Jonathan M. Rothberg,Henri Lichenstein,Chris Conrad,Marylens HERNANDEZ. Владелец: Orphai Therapeutics Inc. Дата публикации: 2023-09-28.

Peptide composition for prevention or treatment of Alzheimer's disease

Номер патента: AU2021331859A1. Автор: Sung Min Kim,Seung Jun Lee,Yong Joo Kim,Jae-Yong Park,Seung-Hyun Lee,Sujin Kim,Mi Suk Lee,Kun Ho Lee,Yeong Min Park,Wahn Soo Choi,Minho Moon,Yong Ho Park,In Duk Jung,Hee Jo Park,Seung Pyo Choi,Soo Jung Shin. Владелец: HLB Science Inc. Дата публикации: 2023-03-16.

Predictive neuromarkers of alzheimer's disease

Номер патента: EP3451903A1. Автор: Quentin BARTHELEMY,Louis MAYAUD,David OJEDA. Владелец: Mensia Technologies. Дата публикации: 2019-03-13.

Compositions and methods for the diagnosis and treatment of alzheimer's disease

Номер патента: WO2021016551A1. Автор: Rima F. KADDURAH-DAOUK,Rebecca BAILLIE,Xianlin Han,Kwangsik Nho,Andrew J. Saykin,Siamak MAHMOUDIANDEHKORDI,Comelia VAN DUIJIN,Shahzad AHMAD. Владелец: Indiana University School of Medicine. Дата публикации: 2021-01-28.

Compositions and methods for the diagnosis and treatment of alzheimer's disease

Номер патента: US20220257612A1. Автор: Rima F. KADDURAH-DAOUK,Rebecca BAILLIE,Xianlin Han,Kwangsik Nho,Andrew J. Saykin,Siamak MAHMOUDIANDEHKORDI,Shahzad AHMAD,Cornelia van Duijin. Владелец: Individual. Дата публикации: 2022-08-18.

Identification of granins as the pathogenic factor of alzheimer's disease and compositions and methods for inhibiting granin aggregation and treating alzheimer's disease

Номер патента: EP3773547A1. Автор: Seung Hyun Yoo. Владелец: Individual. Дата публикации: 2021-02-17.

Peptide composition for prevention or treatment of alzheimer's disease

Номер патента: CA3190919C. Автор: Sung Min Kim,Seung Jun Lee,Yong Joo Kim,Jae-Yong Park,Seung-Hyun Lee,Sujin Kim,Mi Suk Lee,Kun Ho Lee,Yeong Min Park,Wahn Soo Choi,Minho Moon,Yong Ho Park,In Duk Jung,Hee Jo Park,Seung Pyo Choi,Soo Jung Shin. Владелец: HLB Science Inc. Дата публикации: 2023-12-19.

Detecting longitudinal progression of alzheimer's disease (ad) based on speech analyses

Номер патента: WO2023250326A1. Автор: Edmond Huatung Teng,Laurence Kahn,Jessica Robin. Владелец: Genentech, Inc.. Дата публикации: 2023-12-28.

Methods and compositions for treating alzheimer's disease

Номер патента: EP2391370A1. Автор: Itzchak Angel,Tuvia Gilat. Владелец: Galmed International Ltd. Дата публикации: 2011-12-07.

Explainable cnn-attention network (c-attention network) architecture for automated detection of alzheimer's disease

Номер патента: US20240023876A1. Автор: Ning Wang,Koduvayur P. Subbalakshmi,Mingxuan Chen. Владелец: Stevens Institute of Technology . Дата публикации: 2024-01-25.

System, software and methods of using software for predicting efficacy of alzheimer's disease treatments

Номер патента: US20240225538A1. Автор: William W. SEELEY,Joon-Kyung SEONG,Whajin Lee,Jesse Aaron BROWN. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2024-07-11.

Explainable cnn-attention network (c-attention network) architecture for automated detection of alzheimer's disease

Номер патента: WO2022046793A1. Автор: Ning Wang,Koduvayur P. Subbalakshmi,Mingxuan Chen. Владелец: The Trustees of the Stevens Institute of Technology. Дата публикации: 2022-03-03.

Method for endovascular treatment of alzheimer's disease

Номер патента: RU2297860C1. Автор: Иван Васильевич Максимович. Владелец: Иван Васильевич Максимович. Дата публикации: 2007-04-27.

Alzheimer's disease personalized medicine

Номер патента: US20220022749A1. Автор: Janos Redei. Владелец: I2DX Inc. Дата публикации: 2022-01-27.

Biomarkers for the diagnosis and characterization of alzheimer's disease

Номер патента: EP3577455A1. Автор: Therese Koal,Matthias Arnold,Will THOMPSON,Rima F. KADDURAH-DAOUK,Xianlin Han,Rebecca A. Baillie,Kwangsik Nho,Andrew J. Saykin,Jon B. TOLEDO,Gabi KASTEMULLER,Lisa ST. JOHN-WILLIAMS,M. Arthur MOSELEY,Pudugramam Murali DORAISWAMY. Владелец: Rosa and Co LLC. Дата публикации: 2019-12-11.

Novel glucose uptake inhibitors for use in the treatment of cancer

Номер патента: US20240252508A1. Автор: Johan Thevelein,Ward VANTHIENEN. Владелец: Novelyeast BV. Дата публикации: 2024-08-01.

Csf-based prognostic biomarkers in alzheimer's disease and methods of use thereof

Номер патента: US20230003744A1. Автор: William T. Hu. Владелец: Rutgers State University of New Jersey. Дата публикации: 2023-01-05.

Methods for preventing or delaying onset of alzheimer's disease and other forms of dementia and mild cognitive impairment

Номер патента: EP3806956A2. Автор: Michael R. D'andrea. Владелец: Dandrea Michael R. Дата публикации: 2021-04-21.

Acousto-optic therapeutic equipment for improving cognitive function of alzheimer's disease

Номер патента: LU502659B1. Автор: Dongsheng Zhou. Владелец: Ninbo Kangning Hospital Ningbo Center For Mental Disease Prevention And Control. Дата публикации: 2023-02-13.

Nanoparticles of cerium oxide targeted to an amyloid beta antigen of alzheimer's disease and associated methods

Номер патента: US09463253B2. Автор: Sudipta Seal,Soumen Das,Annamaria Cimini,Barbara D'Angelo. Владелец: University Of Central Florida Research Foundation Inc. Дата публикации: 2016-10-11.

Ocular diagnosis of alzheimer's disease

Номер патента: EP1420830B1. Автор: Lee E. Goldstein,Leo T. Chylack, Jr.. Владелец: Brigham and Womens Hospital Inc. Дата публикации: 2011-03-09.

Ocular diagnosis of alzheimer's disease

Номер патента: CA2458961C. Автор: Lee E. Goldstein,Leo T. Chylack, Jr.. Владелец: Brigham and Womens Hospital Inc. Дата публикации: 2008-07-08.

Ocular diagnosis of Alzheimer's disease

Номер патента: NZ545889A. Автор: Lee E Goldstein,Leo T Chylack. Владелец: Brigham & Womens Hospital. Дата публикации: 2006-06-30.

Ocular diagnosis of alzheimer's disease

Номер патента: NZ531337A. Автор: Lee E Goldstein,Leo T Chylack. Владелец: Brigham & Womens Hospital. Дата публикации: 2006-05-26.

Method for treating alzheimer's disease

Номер патента: CA2311356C. Автор: Charles Larry Bisgaier,Mark Richard Emmerling. Владелец: Warner Lambert Co LLC. Дата публикации: 2004-07-13.

Methods and combination therapies for treating alzheimer's disease

Номер патента: CA2667553A1. Автор: David T. Hung,Andrew Asher Protter. Владелец: Medivation Neurology, Inc.. Дата публикации: 2008-05-02.

Use of aprepitant for treating alzheimer's disease

Номер патента: EP4297868A1. Автор: Robb Knie. Владелец: Hoth Therapeutics Inc. Дата публикации: 2024-01-03.

Alzheimer's disease treatment with multiple therapeutic agents delivered to the olfactory region through a special delivery catheter and iontophoresis

Номер патента: US20150080785A1. Автор: Totada R. Shantha. Владелец: Wedge Therapeutics LLC. Дата публикации: 2015-03-19.

Oxafuramine, (1r)-n-ethyl-1-[(2r)-oxolan-2-yl]-2-phenylethanamine, hydrochloride and derivatives thereof for use in treating neurodegenerative diseases with lewy body disease and/or alzheimer's disease

Номер патента: WO2023281109A1. Автор: Eric Konofal. Владелец: NLS Pharmaceutics AG. Дата публикации: 2023-01-12.

Methods for treating alzheimer's disease

Номер патента: CA3114021A1. Автор: Jeffrey L. Tate,Sharon H. Hrynkow,N. Scott Fine. Владелец: Cyclo Therapeutics Inc. Дата публикации: 2021-05-07.

Treatment of alzheimer's and cognitive impairment with andrographolides

Номер патента: EP2897608A1. Автор: Nibaldo C. INESTROSA,Juan L. HANKCKE OROZCO. Владелец: INNOBIOSCIENCE LLC. Дата публикации: 2015-07-29.

Treatment of alzheimer's and cognitive impairment with andrographolides

Номер патента: WO2014176149A4. Автор: Nibaldo C. INESTROSA,Juan L. HANKCKE OROZCO. Владелец: INNOBIOSCIENCE, LLC. Дата публикации: 2014-12-04.

Salivary abeta42 levels as prognostic indicators for alzheimer's disease

Номер патента: EP3491383A1. Автор: Edith G. Mcgeer,Patrick L. Mcgeer,Moonhee Lee,Jian-Ping Guo,Krista Kennedy. Владелец: Aurin Biotech Inc. Дата публикации: 2019-06-05.

Oxafuramine, (1r)-n-ethyl-1-[(2r)-oxolan-2-yl]-2-phenylethanamine, hydrochloride and derivatives thereof for use in treating neurodegenerative diseases with lewy body disease and/or alzheimer's disease

Номер патента: EP4366725A1. Автор: Eric Konofal. Владелец: NLS Pharmaceutics AG. Дата публикации: 2024-05-15.

Nanoparticle contrast agent for early diagnosis of alzheimer's disease by magnetic resonance imaging (mri)

Номер патента: US20170196998A1. Автор: Kwok Kin Cheng,Lawrence William Baum,Hee Lum Albert CHOW. Владелец: Chinese University of Hong Kong CUHK. Дата публикации: 2017-07-13.

Methods for preventing or delaying onset of alzheimer's disease and other forms of dementia and mild cognitive impairment

Номер патента: WO2019241329A3. Автор: Michael R. D'andrea. Владелец: Dandrea Michael R. Дата публикации: 2020-01-23.

Hyperspectral imaging for early detection of Alzheimer'S Disease

Номер патента: US09585558B2. Автор: Robert Vince,Swati Sudhakar MORE. Владелец: University of Minnesota. Дата публикации: 2017-03-07.

Preventive or therapeutic drug for Alzheimer's disease

Номер патента: AU3529897A. Автор: Ikuo Maruyama,Kazuhiro Abeyama,Hiroyuki Masayasu. Владелец: A Natterman und Cie GmbH. Дата публикации: 1998-03-05.

Methods for treating Alzheimer's disease

Номер патента: US11925659B2. Автор: Jeffrey L. Tate,Sharon H. Hrynkow,N. Scott Fine. Владелец: Cyclo Therapeutics Inc. Дата публикации: 2024-03-12.

Methods for treating alzheimer's disease

Номер патента: EP3873604A1. Автор: Jeffrey L. Tate,Sharon H. Hrynkow,N. Scott Fine. Владелец: Cycol Therapeutics Inc. Дата публикации: 2021-09-08.

Compositions for treatment of alzheimer's disease

Номер патента: WO2010114636A1. Автор: Javier Llompart,Jorge Galvez,David Land,Giulio Pasinetti. Владелец: Medisyn Technologies, Inc.. Дата публикации: 2010-10-07.

Method of medical treatment of Alzheimer's disease

Номер патента: US4950658A. Автор: Robert E. Becker,Ezio Giacobini. Владелец: Southern Illinois University System. Дата публикации: 1990-08-21.

Medicament for treatment of alzheimer's disease

Номер патента: US20160206624A1. Автор: Koichi Shudo,Kohichi KAWAHARA,Michita SUENOBU. Владелец: KEMPHYS Ltd. Дата публикации: 2016-07-21.

Electrical treatment of Alzheimer's disease

Номер патента: US11819685B2. Автор: Yossi Gross. Владелец: Rainbow Medical Ltd. Дата публикации: 2023-11-21.

Use of Medium Chain Triglycerides for the Treatment and Prevention of Alzheimer's Disease and Other Diseases Resulting from Reduced Neuronal Metabolism II

Номер патента: US20130225682A1. Автор: Henderson Samuel T.. Владелец: ACCERA, INC.. Дата публикации: 2013-08-29.

USE OF MEDIUM CHAIN TRIGLYCERIDES FOR THE TREATMENT AND PREVENTION OF ALZHEIMER'S DISEASE AND OTHER DISEASES RESULTING FROM REDUCED NEURONAL METABOLISM II

Номер патента: US20180036274A1. Автор: Henderson Samuel T.. Владелец: . Дата публикации: 2018-02-08.

Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II

Номер патента: US6835750B1. Автор: Samuel T. Henderson. Владелец: Accera Inc. Дата публикации: 2004-12-28.

Vaccine for alzheimer's disease

Номер патента: US20110076323A1. Автор: Irun R. Cohen,Alon Monsonego. Владелец: Yeda Research and Development Co Ltd. Дата публикации: 2011-03-31.

Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism

Номер патента: US20060122270A1. Автор: Samuel Henderson. Владелец: Individual. Дата публикации: 2006-06-08.

Methods and systems for management of alzheimer's disease

Номер патента: CA2489341A1. Автор: Alon Shalev. Владелец: Individual. Дата публикации: 2003-12-24.

System, software and methods of using software for predicting efficacy of alzheimer's disease treatments

Номер патента: WO2022072738A9. Автор: William W. SEELEY,Joon-Kyung SEONG. Владелец: KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION. Дата публикации: 2023-03-23.

Alkylating agent and combinations in the treatment of immune-related and liver diseases, alzheimer's diseases and fibrosis diseases

Номер патента: WO2022040110A3. Автор: Sheng Liu. Владелец: Sheng Liu. Дата публикации: 2022-03-31.

Systems and methods for color-coded visualization to aid in diagnosis and prognosis of Alzheimer's disease

Номер патента: US11989932B1. Автор: Malek Adjouadi,Mohammad Eslami,Solale Tabarestani. Владелец: Florida International University FIU. Дата публикации: 2024-05-21.

Use of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol or its prodrug for the preparation of a medicament of the treatment of lewy body dementia,alzheimer's disease,parkinson's disease or impaired social memory

Номер патента: TWI299001B. Автор: D Scheyer Richard,M Sorensen Stephen,M Hitchcock Janice. Владелец: Aventis Pharma Inc. Дата публикации: 2008-07-21.

Hyperspectral imaging for early detection of Alzheimer's disease

Номер патента: US11819276B2. Автор: Robert Vince,Swati Sudhakar MORE. Владелец: University of Minnesota. Дата публикации: 2023-11-21.

Methods of treating or preventing alzheimer's disease and associated conditions

Номер патента: US20230414658A1. Автор: Keith L. Black,Yosef Koronyo,Maya Koronyo,Altanchimeg RENTSENDORJ. Владелец: Cedars Sinai Medical Center. Дата публикации: 2023-12-28.

Hyperspectral imaging for early detection of alzheimer's disease

Номер патента: US20240156342A1. Автор: Robert Vince,Swati Sudhakar MORE. Владелец: University of Minnesota. Дата публикации: 2024-05-16.

Methods of treating or preventing alzheimer's disease and associated conditions

Номер патента: US11779600B2. Автор: Keith L. Black,Yosef Koronyo,Maya Koronyo,Altanchimeg RENTSENDORJ. Владелец: Cedars Sinai Medical Center. Дата публикации: 2023-10-10.

Methods for diagnosing alzheimer's disease

Номер патента: EP1372468A1. Автор: Martin H. Teicher,Steven B. Lowen,David G. Harper,Janet M. Lawrence,Sumer D. Verma. Владелец: Mclean Hospital Corp. Дата публикации: 2004-01-02.

Methods for diagnosing alzheimer's disease

Номер патента: EP1372468A4. Автор: Martin H Teicher,Steven B Lowen,David G Harper,Sumer D Verma,Janet M Lawrence. Владелец: Mclean Hospital Corp. Дата публикации: 2006-06-28.

Methods of treating or preventing alzheimer's disease and associated conditions

Номер патента: US20190290687A1. Автор: Yosef Koronyo,Maya Koronyo,Keith Black,Altanchimeg RENTSENDORJ. Владелец: Cedars Sinai Medical Center. Дата публикации: 2019-09-26.

Methods of treating or preventing alzheimer's disease and associated conditions

Номер патента: EP3458036A1. Автор: Keith L. Black,Yosef Koronyo,Maya Koronyo,Altanchimeg RENTSENDORJ. Владелец: Cedars Sinai Medical Center. Дата публикации: 2019-03-27.

Method for the treatment and prevention of Alzheimer's disease and central nervous system dysfunction

Номер патента: US20140179597A1. Автор: Lehrer Steven. Владелец: . Дата публикации: 2014-06-26.

Regulation of GSK-3α activity for the treatment or prevention of Alzheimer's disease

Номер патента: US7378111B2. Автор: Christopher J. Phiel,Christina A. Wilson,Virginia M-Y. Lee,Peter S. Klein. Владелец: University of Pennsylvania Penn. Дата публикации: 2008-05-27.

Regulation of GSK-3alpha activity for the treatment or prevention of Alzheimer's disease

Номер патента: US20100068308A1. Автор: Christopher J. Phiel,Christina A. Wilson,Virginia M-Y. Lee,Peter S. Klein. Владелец: University of Pennsylvania Penn. Дата публикации: 2010-03-18.

Composition for the prevention or treatment of neurodegenerative diseases

Номер патента: CA3014703C. Автор: Sanne Maria VAN DER MADE,Paul Leopold JONKER,Lucas Gerardus Willibrordus STERKMAN. Владелец: Newtricious Bv. Дата публикации: 2023-09-19.

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

Номер патента: US09669199B2. Автор: Guy DiPierro,Steven A. Giannos. Владелец: Chrono Therapeutics Inc. Дата публикации: 2017-06-06.

Composition for the use to treat alzheimer' s disease

Номер патента: EP2367529A1. Автор: Curt Hendrix. Владелец: Concourse Health Sciences LLC. Дата публикации: 2011-09-28.

A Pharmaceutical Composition Comprising An Oxazine Derivative And Its Use In The Treatment Or Prevention Of Alzheimer's Disease

Номер патента: US20190388428A1. Автор: RAMOS Rita,KNEZIC Dragutin,Achour Miloud,Galli Brumo,John Edgar,Juhnke Michael,Koradia Vishal Shamji. Владелец: . Дата публикации: 2019-12-26.

Organosulfur compounds for the prevention and treatment of neurodegenerative diseases

Номер патента: US09456999B2. Автор: David Michael Ott. Владелец: Allium Vitalis Inc. Дата публикации: 2016-10-04.

Use of nod2 agonist for the treatment, prophylaxis and/or delay of the onset of multiple sclerosis and alzheimer's disease

Номер патента: EP3793583A1. Автор: Jean Gosselin,Serge Rivest. Владелец: UNIVERSITE LAVAL. Дата публикации: 2021-03-24.

1-Aminocyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer's disease

Номер патента: US20050203191A1. Автор: Scott Mcdonald,Albrecht STÖFFLER,Hans-Joerg Moebius,Barry Reisberg,Steven Ferris. Владелец: Forest Laboratories LLC. Дата публикации: 2005-09-15.

Methods and compositions for the treatment and prevention of intermittent claudication or alzheimer's disease

Номер патента: WO2003094909A2. Автор: Eyal S. Ron. Владелец: Enos Pharmaceuticals, Inc.. Дата публикации: 2003-11-20.

Treatment of MCI and Alzheimer's disease

Номер патента: US09968574B2. Автор: Mark Lovell,Bert Lynn. Владелец: University of Kentucky Research Foundation. Дата публикации: 2018-05-15.

Use of 2-phenyl-6- (1H-imidazol-1-yl) quinazoline for the treatment of neurodegenerative diseases, preferably Alzheimer's disease

Номер патента: CN113811304A. Автор: L·C·罗瓦蒂,G·卡塞利,E·萨拉. Владелец: Rottapharm Biotech SRL. Дата публикации: 2021-12-17.

Composition for the prevention or treatment of neurodegenerative diseases

Номер патента: CA3014703A1. Автор: Sanne Maria VAN DER MADE,Paul Leopold JONKER,Lucas Gerardus Willibrordus STERKMAN. Владелец: Newtricious Bv. Дата публикации: 2017-08-31.

Gasotransmitter metabolites and alzheimer's disease

Номер патента: US20210285938A1. Автор: Christopher Kevil,Karen Y. STOKES,Johnathan Steven ALEXANDER,Elizabeth DISBROW. Владелец: Louisiana State University. Дата публикации: 2021-09-16.

Hyperspectral image-guided raman ocular imager for Alzheimer's Disease pathologies

Номер патента: AU2018372578B2. Автор: Eliav Shaked,Grzegorz Dmochowski. Владелец: Retispec Inc. Дата публикации: 2024-11-07.

Inflammasome inhibition for the treatment of Parkinson's disease, Alzheimer's disease and multiple sclerosis

Номер патента: US11219623B2. Автор: Jayakrishna Ambati,Benjamin Fowler,Kameshwari AMBATI. Владелец: University of Kentucky Research Foundation. Дата публикации: 2022-01-11.

Methods for detecting and/or predicting age-related macular degeneration and/or alzheimer's disease

Номер патента: US20210283275A1. Автор: Henryk Szmacinski,Richard Thompson,Imre Lengyel,Hui Hui ZENG. Владелец: Queens University of Belfast. Дата публикации: 2021-09-16.

Methods for detecting and/or predicting age-related macular degeneration and/or alzheimer's disease

Номер патента: EP3504554A1. Автор: Henryk Szmacinski,Richard Thompson,Imre Lengyel,Hui Hui ZENG. Владелец: University of Maryland at Baltimore. Дата публикации: 2019-07-03.

Combination comprising d-apartic acid and l-arginine or salts thereof for the improvement of cognitive activities and memory in dementia such as dementia senile and alzheimer's disease

Номер патента: EP2654743A1. Автор: Enrico D'aniello,Antimo D'ANIELLO,Gemma D'ANIELLO. Владелец: Individual. Дата публикации: 2013-10-30.

Treating alzheimer's disease utilizing a laser

Номер патента: US20230048982A1. Автор: Qiang Chen,Mitchell Steven Felder. Владелец: Halberd Corp. Дата публикации: 2023-02-16.

Nisod-like compound and its derivatives for the prevention and treatment of neurodegenerative disorders

Номер патента: US20150209370A1. Автор: Bin Huang,Yun-Ming Wang,Chien-Wei Chiang,Way-Zen Lee,Hsiu-Mei Hsieh,Guey-Jen Lee,Yaw-Syan Fu. Владелец: National Taiwan Normal University NTNU. Дата публикации: 2015-07-30.

Pharmaceutical compositions comprising a tungsten salt (vi) for the treatment of neurodegenerative disorders, particularly alzheimer's disease and schizophrenia

Номер патента: EP1972342A1. Автор: Delia ZAFRA LÓPEZ,Helena CBM-SO Fac. de Ciencias COROMINOLA OCAÑA,Joan Josep Guinovart Cirera,Jesús ÁVILA DE GRADO,Jorge CBM-SO Fac. de Ciencias DOMÍNGUEZ REYES,Ram n GOMIS DE BARBARÁ,Alberto GÓMEZ RAMOS. Владелец: Universitat de Barcelona UB. Дата публикации: 2008-09-24.

Memantine for the treatment of mild-to-moderate alzheimer's disease

Номер патента: SI1703902T1. Автор: Steven Potkin,Scott Mcdonald,Ivan Gergel,Albrecht STÖFFLER,Hans-Joerg Moebius,Yvonne Wirth. Владелец: Merz Pharma Gmbh & Co Kgaa. Дата публикации: 2011-02-28.

Pharmaceutical compositions comprising a tungsten salt (VI) for the treatment of neurodegenerative disorders, particularly Alzheimer's disease and schizophrenia

Номер патента: AU2006274821B2. Автор: Delia ZAFRA LÓPEZ,Joan Josep Guinovart Cirera,Jesús ÁVILA DE GRADO,Alberto GÓMEZ RAMOS,Ramon Gomis De Barbara,Helena Corominola Ocana,Jorge Dominguez Reyes. Владелец: Universitat de Barcelona UB. Дата публикации: 2011-10-13.

Pharmaceutical compositions comprising a tungsten salt (vi) for the treatment of neurodegenerative disorders, particularly alzheimer's disease and schizophrenia

Номер патента: CA2616960A1. Автор: Delia ZAFRA LÓPEZ,Joan Josep Guinovart Cirera,Jesús ÁVILA DE GRADO,Alberto GÓMEZ RAMOS,Ramon Gomis De Barbara,Helena Corominola Ocana,Jorge Dominguez Reyes. Владелец: Individual. Дата публикации: 2007-02-08.

Adrenoceptors antagonists for the prevention and treatment of neurodegenerative conditions

Номер патента: US20190083507A1. Автор: Michele Tagliati,Gennaro Pagano. Владелец: Cedars Sinai Medical Center. Дата публикации: 2019-03-21.

Adrenoceptors antagonists for the prevention and treatment of neurodegenerative conditions

Номер патента: EP3013342A2. Автор: Michele Tagliati,Gennaro Pagano. Владелец: Cedars Sinai Medical Center. Дата публикации: 2016-05-04.

Method for obtaining an indicator of presence for alzheimer's disease using eeg signals

Номер патента: WO2023223140A1. Автор: Pedro Miguel DE LUÍS RODRIGUES,Gabriel Afonso DA ROCHA SILVA. Владелец: Universidade Catolica Portuguesa - Ucp. Дата публикации: 2023-11-23.

Methods of diagnosing or treating alzheimer's disease

Номер патента: EP1173769A1. Автор: Roger Nitsch,Christoph Universität Zürich HOCK,Uwe Universität Basel OTTEN. Владелец: Evotec OAI AG. Дата публикации: 2002-01-23.

Method for monitoring a patient having a neurological and/or progressive disease, such as multiple sclerosis, parkinson's disease or alzheimer's disease

Номер патента: EP4341962A1. Автор: Johannes Weda,Frank DE GRAAF,Pim Petrus Cornelius VAN OIRSCHOT. Владелец: Sherpa BV. Дата публикации: 2024-03-27.

Method for monitoring a patient having a neurological and/or progressive disease, such as multiple sclerosis, parkinson's disease or alzheimer's disease

Номер патента: US20240242844A1. Автор: Johannes Weda,Frank DE GRAAF,Pim Petrus Cornelius VAN OIRSCHOT. Владелец: Sherpa BV. Дата публикации: 2024-07-18.

Methods for using specific saccharides for treating Alzheimer's disease and other amyloidoses

Номер патента: US20020119934A1. Автор: Gerardo Castillo,Alan Snow. Владелец: Individual. Дата публикации: 2002-08-29.

Hyperspectral image-guided raman ocular imager for alzheimer's disease pathologies

Номер патента: EP3716838A1. Автор: Eliav Shaked,Grzegorz Dmochowski. Владелец: Retispec Inc. Дата публикации: 2020-10-07.

Probiotic bacteria for treating alzheimer's disease

Номер патента: US20230190835A1. Автор: Frederikus Gerardus Josephus Maria van de Wiel,Marjolein WILDWATER. Владелец: Individual. Дата публикации: 2023-06-22.

Use of the chinese medicine composition and dianxianning in the preparation of a medicament for preventing or treating alzheimer's diseases

Номер патента: US20170157192A1. Автор: Yang Li,Dong Wang,Xiaoyu Chen,Hongyu Li,Dejuan Zhi,Yinghui Li. Владелец: LANZHOU UNIVERSITY. Дата публикации: 2017-06-08.

Composition for treating alzheimer's disease comprising as active ingredient mixed extract of pinellia ternata breitenbach, zizyphus jujuba var. inermis rehder, glycyrrhiza uralensis fischer, panax ginseng, zingiber officinale roscoe, scutellaria baicalensis, and coptis rhizome

Номер патента: EP4410300A1. Автор: Jae Kwang Kim,Jinsoo Seo,Hyein LEE,Tae Woo Oh,Jang-Gi Choi,Younghoon GO,Buyun KIM,Malk Eun PAK,Yeo Jin Park. Владелец: Korea Institute of Oriental Medicine KIOM. Дата публикации: 2024-08-07.

Method for diagnosing alzheimer´s disease

Номер патента: EP3465163A1. Автор: Carlo Zanotti,Alejandro Catala Espi,Gloria VENEGAS DEL VALLE. Владелец: Raman Health Technologies SL. Дата публикации: 2019-04-10.

Methods and compositions for screening and treating alzheimer's disease

Номер патента: WO2024151904A3. Автор: Peggy S. Eis,Eli Hatchwell,Edward B. Smith III,Shapour JALILZADEH. Владелец: POPULATION BIO, INC.. Дата публикации: 2024-08-22.

Alzheimer's disease-specific alterations of the ERK1/ERK2 phosphorylation ratio-alzheimer's disease-specific molecular biomarkers (ADSMB)

Номер патента: US09797913B2. Автор: Daniel L. Alkon,Tapan Kumar Khan. Владелец: Blanchette Rockefeller Neuroscience Institute. Дата публикации: 2017-10-24.

PIPERAZINE THIAZOLE DERIVATIVES USEFUL IN THE TREATMENT OF TAUOPATHIES SUCH AS ALZHEIMER'S DISEASE

Номер патента: US20160101102A1. Автор: Nettekoven Matthias,Rogers-Evans Mark,Ratni Hasane,Cecere Giuseppe,Vifian Walter,Princen Katrien,Griffioen Gerard. Владелец: REMYND NV. Дата публикации: 2016-04-14.

Individualization of therapy with alzheimer's disease agents

Номер патента: WO2002099422A2. Автор: Brian Leyland-Jones. Владелец: McGill University. Дата публикации: 2002-12-12.

Treatments and methods for treating alzheimer's disease

Номер патента: US20240238268A1. Автор: Hung Wen (Kevin) Lin. Владелец: Louisiana State University. Дата публикации: 2024-07-18.

Hyperspectral Image-Guided Ocular Imager for Alzheimer's Disease Pathologies

Номер патента: US20240341668A1. Автор: Eliav Shaked,Grzegorz Dmochowski. Владелец: Retispec Inc. Дата публикации: 2024-10-17.

Method of treating Alzheimer's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavity

Номер патента: US7776312B2. Автор: Leah Ranae Bresin Hanson,II William H. Frey,Samuel Scott Panter,Annina Roeytenberg. Владелец: HealthPartners Research Foundation. Дата публикации: 2010-08-17.

Diagnostic and therapeutic use of kcnj6 for alzheimer's disease

Номер патента: EP1745296A2. Автор: Heinz Von Der Kammer,Johannes Pohlner. Владелец: Evotec Neurosciences GmbH. Дата публикации: 2007-01-24.

Pharmaceutical compositions for the prevention and treatment of central nervous system disorders

Номер патента: CA2335012C. Автор: Merouane Bencherif. Владелец: Targacept Inc. Дата публикации: 2009-08-11.

Methods of diagnosing or prognosing alzheimer's disease

Номер патента: EP1123509A2. Автор: Roger Nitsch,John Growdon. Владелец: Roger Nitsch. Дата публикации: 2001-08-16.

Combination comprising d-apartic acid and l-arginine or salts thereof for the improvement of cognitive activities and memory in dementia such as dementia senile and alzheimer's disease

Номер патента: WO2012085954A1. Автор: Enrico D'aniello,Antimo D'ANIELLO,Gemma D'ANIELLO. Владелец: D Aniello Enrico. Дата публикации: 2012-06-28.

Treatments and methods for treating alzheimer's disease

Номер патента: WO2023039226A3. Автор: Hung Wen LIN (Kevin). Владелец: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College. Дата публикации: 2023-04-20.

[r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2]oct-3-yl) acetonitrile for reducing amyloid beta a4 formation in alzheimer's disease

Номер патента: NZ295155A. Автор: Roger Edward Markwell,Carol Wendy Gray,Julie Hawkins. Владелец: Smithkline Beecham Plc. Дата публикации: 2000-07-28.

Pharmaceutical composition for preventing or treating alzheimer's disease

Номер патента: EP4410286A1. Автор: Tao Zhao,Guimin Zhang,Honghua Li,Jingchun YAO,Chenghong SUN. Владелец: Shandong New Time Pharmaceutical Co Ltd. Дата публикации: 2024-08-07.

Methods for treating alzheimer's disease using hydroxyethylene compounds containing a heteroyclic amide bond isostere

Номер патента: US20060116413A1. Автор: VARGHESE John. Владелец: Elan Pharmaceuticals LLC. Дата публикации: 2006-06-01.

Methods of treating agitation associated with alzheimer's disease

Номер патента: US20230270738A1. Автор: Sanjay Dube. Владелец: Avanir Phrmaceuticals Inc. Дата публикации: 2023-08-31.

Agent for preventing or ameliorating alzheimer's disease

Номер патента: US11998559B2. Автор: Yasuyuki Igarashi,Kaori Takahashi,Katsuyuki Mukai,Kohei Yuyama. Владелец: Daicel Corp. Дата публикации: 2024-06-04.

Sublingual or buccal pharmaceutical compositions comprising succinic acid for treating alzheimer's disease

Номер патента: WO2009025571A1. Автор: Igor Anatolievich Pomytkin. Владелец: Buddha Biopharma Oy Ltd. Дата публикации: 2009-02-26.

System and Method for Detecting Alzheimer's Disease

Номер патента: US20210353207A1. Автор: Sandeep Chakraborty,Chi-Kuang Sun. Владелец: National Taiwan University NTU. Дата публикации: 2021-11-18.

Compounds for treating or preventing alzheimer's disease

Номер патента: US20240269128A1. Автор: Madhav Thambisetty,Myriam Gorospe,Carlos Anerillas. Владелец: US Department of Health and Human Services. Дата публикации: 2024-08-15.

Methods and compositions for screening and treating alzheimer's disease

Номер патента: US20240310389A1. Автор: Peggy S. Eis,Eli Hatchwell,Edward B. Smith, Iii,Shapour JALILZADEH. Владелец: Population Bio Inc. Дата публикации: 2024-09-19.

Methods and compositions for screening and treating alzheimer's disease

Номер патента: WO2024151904A2. Автор: Peggy S. Eis,Eli Hatchwell,Edward B. Smith III,Shapour JALILZADEH. Владелец: POPULATION BIO, INC.. Дата публикации: 2024-07-18.

Method of treating alzheimer's disease

Номер патента: US20240285680A1. Автор: Peter Y. Novak,Maxim V. Temnikov. Владелец: Vector Vitale IP LLC. Дата публикации: 2024-08-29.

Use of pharmaceutical composition comprising chlorogenic acid in preparation of drug for treating early alzheimer's disease

Номер патента: US20240316001A1. Автор: Min Xu,Jie Zhang,Liang Zhang,Fei Zhang,Ya Zhang,Wenbin Li,Wang HUANG,Yujia HUANG. Владелец: Sichuan Jiuzhang Biotechnology Co Ltd. Дата публикации: 2024-09-26.

Method of treating or preventing Alzheimer's Disease

Номер патента: US11833181B1. Автор: Mai Mostafa Khalaf Ali,Hany Mohamed Abd El-Lateef Ahmed,Ahmed Mohammed Abu-Dief Mohammed,Hazem Mohamed Shaheen,Gaber Elsaber Abd El-Wanis Batiha,Manal Aly Shalaby,Amany Mabrouk Abd Elhady Alamh. Владелец: King Faisal University SA. Дата публикации: 2023-12-05.

Methods for Alzheimer's disease treatment and cognitive enhancement

Номер патента: US09539235B2. Автор: Daniel L. Alkon,Rene Etcheberrigaray. Владелец: Cognitive Research Enterprises Inc. Дата публикации: 2017-01-10.

Methods for treating Alzheimer's disease

Номер патента: US09522124B2. Автор: Luigi Puglielli. Владелец: WISCONSIN ALUMNI RESEARCH FOUNDATION. Дата публикации: 2016-12-20.

Use of Epothilone D in Treating Tau-Associated Diseases Including Alzheimer's Disease

Номер патента: US20110230528A1. Автор: Francis Y. Lee,Charles F. Albright,Donna Marie Barten. Владелец: Bristol Myers Squibb Co. Дата публикации: 2011-09-22.

Pharmaceutical composite formulation for treating vascular dementia with alzheimer's disease

Номер патента: KR20220083020A. Автор: 나도현. Владелец: 나도현. Дата публикации: 2022-06-20.

Pharmaceutical composite formulation for treating vascular dementia with alzheimer's disease

Номер патента: KR20230090187A. Автор: 전진환,나도현,강경표. Владелец: 메디케어제약 주식회사. Дата публикации: 2023-06-21.

Phototherapy apparatus for treating alzheimer's disease

Номер патента: WO2024022381A1. Автор: Daifa Wang. Владелец: Danyang Huichuang Medical Equipment Co., Ltd.. Дата публикации: 2024-02-01.

Compositions and methods for treating alzheimer's disease utilizing a transcriptional master regulator of the retromer complex

Номер патента: WO2023201219A1. Автор: Ulrich Hengst,Claudio Andre Gouveia Martins ROQUE,Jimena BALERIOLA. Владелец: The Trustees of Columbia University in the City of New York. Дата публикации: 2023-10-19.

Composition for preventing Alzheimer's disease, containing purple bamboo salt, and method for preparing purple bamboo salt

Номер патента: US10124031B2. Автор: Sun Young PARK,Jeong Yong Cho,Kyung Sik Ham,Promyo KITIONG,JinRui ZHU. Владелец: Industry Academic Cooperation Foundation of Mokpo National University. Дата публикации: 2018-11-13.

Specific saccharide compositions and methods for treating alzheimer's disease and other amyloidoses

Номер патента: EP1014996A1. Автор: Gerardo Castillo,Alan D. Snow. Владелец: UNIVERSITY OF WASHINGTON. Дата публикации: 2000-07-05.

New synthetic drugs for treating alzheimer's disease

Номер патента: WO2024058196A1. Автор: Hiroshi Yamada,Tomoyuki Takahashi,Tetsuya Hori,Zacharie Taoufiq,Kohji TAKEI. Владелец: OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION. Дата публикации: 2024-03-21.

Pharmaceutical compositions active in preventing, stabilizing and treating alzheimer's disease

Номер патента: EP2403534A1. Автор: Umberto Cornelli. Владелец: Individual. Дата публикации: 2012-01-11.

Pharmaceutical compositions active in preventing, stabilizing and treating alzheimer's disease

Номер патента: US20120064054A1. Автор: Umberto Cornelli. Владелец: COR CON INTERNATIONAL Srl. Дата публикации: 2012-03-15.

Low Level Laser Therapy for Alzheimer's Disease

Номер патента: US20160325115A1. Автор: Dan Frenkel,Dorit Farfara,Uri Oron,Hana Tuby. Владелец: Ramot at Tel Aviv University Ltd. Дата публикации: 2016-11-10.

Use of 6-hydroxy-2-(4-methoxyphenyl)-3-[4-(2-piperidinoethoxy)-phenoxy]benzo[b]thiophene or 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidinoethoxy)-phenoxy]benzo[b]thiophene for treating Alzheimer's disease

Номер патента: NZ500175A. Автор: Henry Uhlman Bryant,Kelly Renee Bales,Steven Marc Paul,Mary Patricia Knadler. Владелец: Eli Lili And Company. Дата публикации: 2001-10-26.

Low level laser therapy for Alzheimer's disease

Номер патента: US09649507B2. Автор: Dan Frenkel,Dorit Farfara,Uri Oron,Hana Tuby. Владелец: Ramot at Tel Aviv University Ltd. Дата публикации: 2017-05-16.

Method and pharmaceutical composition for treating alzheimer's disease and disorders, disturbed or lost memory

Номер патента: RU2603470C2. Автор: Ричард Дж. ВЁРТМАН,Ингрид РИЧАРДСОН. Владелец: Массачусетс Инститьют Оф Текнолоджи. Дата публикации: 2016-11-27.

Composition for treating and preventing neurological diseases, neuroinflammation, and alzheimer's disease

Номер патента: CA3008780A1. Автор: Dan Li,Norman Relkin,John M. Williams,Joshua M. COSTIN. Владелец: Hsrx Group LLC. Дата публикации: 2017-06-22.

Pharmaceutical composition containing mitochondrial division inhibitor for preventing or treating alzheimer's disease

Номер патента: KR20160121295A. Автор: 정재인,조동규,김학균,반가히. Владелец: 성균관대학교산학협력단. Дата публикации: 2016-10-19.

Non-invasive method for diagnosing alzheimer's disease in a patient

Номер патента: CA2195877C. Автор: Leonard Scinto,Kirk R. Daffner. Владелец: Beth Israel Hospital Association. Дата публикации: 2000-12-05.

Use of a composition comprising a cytokine encoding nucleic acid for treating alzheimer's disease

Номер патента: CA2677273A1. Автор: Tai-June Yoo. Владелец: Individual. Дата публикации: 2008-08-14.

Hyperspectral image-guided ocular imager for alzheimer's disease pathologies

Номер патента: US11896382B2. Автор: Eliav Shaked,Grzegorz Dmochowski. Владелец: Retispec Inc. Дата публикации: 2024-02-13.

Fragment of neurosecretory protein VGF as a biomarker for Alzheimer's disease

Номер патента: US20070015221A1. Автор: Huw Davies,Kaj Blennow,Vladimir Podust,James McGuire,Anja Simonsen. Владелец: Ciphergen Biosystems Inc. Дата публикации: 2007-01-18.

System and method for alzheimer's disease prediction using neural network, computer-readable recording medium with stored program, and computer program product

Номер патента: US20220378361A1. Автор: Gwo-Giun Lee,Yu-Min Kuo,Yi-Ru Xie. Владелец: National Cheng Kung University NCKU. Дата публикации: 2022-12-01.

Method of treating alzheimer's disease with se-containing peptide

Номер патента: WO2002099061A2. Автор: SONG Ling,Joseph Holoshitz. Владелец: THE REGENTS OF THE UNIVERSITY OF MICHIGAN. Дата публикации: 2002-12-12.

Alz-801 for use in treating alzheimer's disease

Номер патента: AU2022405026A1. Автор: John Hey,Martin TOLAR,Susan ABUSHAKRA,Neil William FLANZRAICH. Владелец: Alzheon Inc. Дата публикации: 2024-06-20.

Phospho-tau aggregation-based biomarkers for alzheimer's disease diagnosis, differentiation, and treatment

Номер патента: WO2024097164A1. Автор: Bin Xu,Ling Wu,Shih-Hsiu Wang,Nailya GILYAZOVA,John F. ERVIN,Andrew J. LIU. Владелец: NORTH CAROLINA CENTRAL UNIVERSITY. Дата публикации: 2024-05-10.

Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product

Номер патента: AU7117596A. Автор: Lawrence R. Williams. Владелец: AMGEN INC. Дата публикации: 1997-04-17.

Composition for treating alzheimer's disease containing glial line-derived neurotrophic factor (GDNF) protein product

Номер патента: NZ319040A. Автор: Lawrence R Williams. Владелец: AMGEN INC. Дата публикации: 2001-02-23.

Materials for preventing or treating Alzheimer's disease and compositions comprising same

Номер патента: US10933080B2. Автор: Keejung Yoon,Juwan KIM. Владелец: Sungkyunkwan University Research and Business Foundation. Дата публикации: 2021-03-02.

Use of vitamin composition in preparing drug for preventing, treating, or delaying alzheimer's disease

Номер патента: US20200030358A1. Автор: Mingdong Zhou. Владелец: Zensun Shanghai Science and Technology Ltd. Дата публикации: 2020-01-30.

Use of vitamin composition in preparing drug for preventing, treating, or delaying Alzheimer's disease

Номер патента: AU2024202678A1. Автор: Mingdong Zhou. Владелец: Zensun Shanghai Science and Technology Ltd. Дата публикации: 2024-05-16.

Use of vitamin composition in preparing drug for preventing, treating, or delaying alzheimer's disease

Номер патента: US20230248756A1. Автор: Mingdong Zhou. Владелец: Zensun Shanghai Science and Technology Ltd. Дата публикации: 2023-08-10.

Alzheimer's disease-specific alterations of the erk1/erk2 phosphorylation ratio-alzheimer's disease-specific molecular biomarkers (adsmb)

Номер патента: US20140031245A1. Автор: Daniel L. Alkon,Tapan Kumar Khan. Владелец: Blanchette Rockefeller Neuroscience Institute. Дата публикации: 2014-01-30.

Health-care food for preventing and assisting treatment of alzheimer's disease, and preparation method thereof

Номер патента: AU2020202884A1. Автор: Shuiming Zhou,Yi-Hsuan Pan. Владелец: Visdon Pty Ltd. Дата публикации: 2021-10-14.

Late-onset alzheimer's disease animal model and uses thereof

Номер патента: US20190387723A1. Автор: Hiroshi Yamada,Chinthalapally Rao. Владелец: University of Oklahoma . Дата публикации: 2019-12-26.

Late-onset Alzheimer's disease animal model and uses thereof

Номер патента: US12004493B2. Автор: Hiroshi Yamada,Chinthalapally Rao. Владелец: University of Oklahoma . Дата публикации: 2024-06-11.

Screening of agents for treatment of alzheimer's disease

Номер патента: US6245575B1. Автор: Michael John Smith,Masato Hasegawa,Michel Goedert,Ross Jakes,Maria Grazia Spillantini,Richard Anthony Crowther. Владелец: Medical Research Council. Дата публикации: 2001-06-12.

Novel biomarker for diagnosis of alzheimer's disease, discovered from blood-derived exosomes, and method for diagnosing alzheimer's disease using same

Номер патента: US20240053365A1. Автор: So Youn Kim,Gunjoo Park. Владелец: PCL Inc. Дата публикации: 2024-02-15.

Alzheimer's disease biomarker, and screening method therefor and application thereof

Номер патента: US20240369583A1. Автор: YU Chen,Yijing Chen,Yingying Fan. Владелец: Shenzhen Institute of Advanced Technology of CAS. Дата публикации: 2024-11-07.

Spectroscopic method for Alzheimer's disease diagnosis

Номер патента: US09891108B2. Автор: Igor K. Lednev. Владелец: Research Foundation of State University of New York. Дата публикации: 2018-02-13.

Method for in vitro diagnosing of alzheimer's disease on basis of albumin redox-status in cerebrospinal fluid

Номер патента: RU2696485C2. Автор: ГАМОН Сальвадор ГРАНЧА,РЬЕРОЛА Монтсеррат КОСТА,ФЕРНАНДЕС Ана Мария ОРТИС. Владелец: Грифольс Уорлдуайд Оперейшнс Лимитед. Дата публикации: 2019-08-02.

Novel biomarker for diagnosis of Alzheimer's disease, discovered from blood-derived exosomes, and method for diagnosing Alzheimer's disease using same

Номер патента: GB2616796A. Автор: Youn Kim So,Park Gunjoo. Владелец: PCL Inc. Дата публикации: 2023-09-20.

Intelligent early screening model and construction method thereof for alzheimer’s disease

Номер патента: US20240233962A9. Автор: Chun Chen,Qingren Yang. Владелец: Wenzhou Medical University. Дата публикации: 2024-07-11.

Screening of agents for treatment of alzheimer's disease

Номер патента: WO1997044669A1. Автор: Michael John Smith,Masato Hasegawa,Michel Goedert,Ross Jakes,Maria Grazia Spillantini,Richard Anthony Crowther. Владелец: Medical Research Council. Дата публикации: 1997-11-27.

Neurofilamental proteins as biomarker for alzheimer's disease

Номер патента: WO2008148492A8. Автор: Bernd Bohrmann,Peter Berndt. Владелец: F. Hoffmann-La Roche AG. Дата публикации: 2009-11-05.

Method for predicting the likelihood of developing alzheimer's disease (ad)

Номер патента: RU2663451C1. Автор: Татьяна Павловна Клюшник,Любовь Васильевна Андросова,Анатолий Никифорович Симонов,Наталия Михайловна Михайлова. Владелец: Федеральное государственное бюджетное научное учреждение "Научный центр психического здоровья". Дата публикации: 2018-08-06.

Detection of fragments of nectin-1 for the diagnosis of alzheimer's disease

Номер патента: WO2008148098A3. Автор: Howard J Federoff,Seung T Lim. Владелец: Seung T Lim. Дата публикации: 2009-04-30.

Method for Differentiation of Alzheimer's Disease into Subgroups

Номер патента: US20080070263A1. Автор: Inge Grundke-Iqbal,Khalid Iqbal,Michael Flory. Владелец: Research Foundation for Mental Hygiene Inc. Дата публикации: 2008-03-20.

Method for detecting alzheimer's disease, and detection reagent

Номер патента: EP4400841A1. Автор: Koji Ueda,Kohei Yuyama,Yukifusa IGETA. Владелец: Tosoh Corp. Дата публикации: 2024-07-17.

Biomarker and methods for early diagnosis of alzheimer's disease

Номер патента: RU2687272C2. Автор: Аннегрет ФОЙЕРХЕЛЬМ-ХАЙДЛЬ. Владелец: Предемтек Аг. Дата публикации: 2019-05-13.

Peripheral blood mononuclear cells (pbmc) phenotypes as biomarkers for patients with alzheimer's disease and/or mild cognitive impairment (mci)

Номер патента: WO2023012064A1. Автор: Philip DENNER,Anja Schneider,Eugenio FAVA,Wera ROTH,Pranjal DHOLE,Josephine BLERSCH. Владелец: Deutsches Zentrum Für Neurodegenerative Erkrankungen E. V. (Dzne). Дата публикации: 2023-02-09.

Peripheral blood mononuclear cells (pbmc) phenotypes as biomarkers for patients with alzheimer's disease and/or mild cognitive impairment (mci)

Номер патента: EP4377695A1. Автор: Philip DENNER,Anja Schneider,Eugenio FAVA,Wera ROTH,Pranjal DHOLE,Josephine BLERSCH. Владелец: Deutsches Zentrum fuer Neurodegenerative Erkrankungen eV. Дата публикации: 2024-06-05.

Phage mediated immuno-pcr for the diagnosis of alzheimer's disease

Номер патента: WO2023144765A1. Автор: Salvatore Cuzzocrea,Emanuela ESPOSITO,Sabrina Conoci,Salvatore Guglielmino,Laura Maria DE PLANO,Domenico FRANCO,Maria Giovanna Rizzo,Irene Paterniti,Michela Campolo. Владелец: Universita’ Degli Studi Di Messina. Дата публикации: 2023-08-03.

Methods and systems for identifying patients with mild cognitive impairment with risk of transition to alzheimer's disease

Номер патента: RU2603601C2. Автор: Кейтлин Мари ЧИОУФОЛО,Джейм Дэвид ШАФФЕР. Владелец: КОНИНКЛЕЙКЕ ФИЛИПС ЭЛЕКТРОНИКС Н.В.. Дата публикации: 2016-11-27.

Method for diagnosis and monitoring of Alzheimer's disease

Номер патента: EP2211183A1. Автор: Sandip Ray,Anton Wyss-Coray. Владелец: Satoris Inc. Дата публикации: 2010-07-28.

Spectroscopic method for alzheimer's disease diagnosis

Номер патента: US20150276482A1. Автор: Igor K. Lednev. Владелец: Research Foundation of State University of New York. Дата публикации: 2015-10-01.

Diagnostic Screens for Alzheimer's Disease

Номер патента: US20110045483A1. Автор: Zsuzsanna Nagy. Владелец: Oxford University Innovation Ltd. Дата публикации: 2011-02-24.

Diagnostic and therapeutic use of f-box proteins for alzheimer's disease and related neurodegenerative disorders

Номер патента: US20040241694A1. Автор: Rainer Hipfel,Heinz Von Der Kammer,Johannes Pohlner. Владелец: Evotec Neurosciences GmbH. Дата публикации: 2004-12-02.

Detection of Beta Amyloid Protein as Alzheimer's Disease-Causing Factor in Palatine Tonsil and Use Thereof

Номер патента: US20240329057A1. Автор: Do Hyun Kim,Jung Eun Lee,Jung Yeon Lim,Seung Ho Yang,Sung Won Kim,Il Hwan LEE,Jung Ho CHUN. Владелец: Industry Academic Cooperation Foundation of Catholic University of Korea. Дата публикации: 2024-10-03.

Biomarkers for prediction, diagnosis, and monitoring of Alzheimer's disease

Номер патента: US09529002B2. Автор: Balwant RAI,Jasdeep Kaur. Владелец: Individual. Дата публикации: 2016-12-27.

Intelligent early screening model and construction method thereof for alzheimer's disease

Номер патента: LU504548B1. Автор: Chun Chen. Владелец: Univ Wenzhou Medical. Дата публикации: 2023-12-20.

Intelligent early screening model and construction method thereof for alzheimer’s disease

Номер патента: US20240136071A1. Автор: Chun Chen,Qingren Yang. Владелец: Wenzhou Medical University. Дата публикации: 2024-04-25.

Diagnostic and therapeutic use of f-box proteins for alzheimer's disease and related neurodegenerative disorders

Номер патента: EP1423704A1. Автор: Rainer Hipfel,Heinz Von Der Kammer,Johannes Pohlner. Владелец: Evotec Neurosciences GmbH. Дата публикации: 2004-06-02.

Detection of fragments of nectin-1 for the diagnosis of alzheimer's disease

Номер патента: US20100285597A1. Автор: Howard Federoff,Seung T. Lim. Владелец: UNIVERSITY OF ROCHESTER. Дата публикации: 2010-11-11.

A biomarker for determining alzheimer's disease

Номер патента: WO2023198960A1. Автор: Rashid Giniatullin,Tarja Malm,Ilpo Kuronen,Ilkka FAGERLUND,Dilyara NURKHAMETOVA. Владелец: University Of Eastern Finland. Дата публикации: 2023-10-19.

Materials and methods relating to alzheimer's disease

Номер патента: EP3004894A1. Автор: Malcolm Andrew Ward,Ian Hugo Pike,Hans Dieter ZUCHT. Владелец: Electrophoretics Ltd. Дата публикации: 2016-04-13.

Diagnosis of alzheimer's disease by detecting auto-antibodies against y-box binding protein-1 (yb-1)

Номер патента: EP4314834A1. Автор: Harald Heidecke,Peter Mertens. Владелец: CELLTREND GMBH. Дата публикации: 2024-02-07.

A diagnostic blood test method for the detection of alzheimer's disease

Номер патента: US20230296629A1. Автор: Anett Hudák,Tamás Letoha. Владелец: Pharmacoidea Kft. Дата публикации: 2023-09-21.

Catecholamine concentrations in a blood sample and arterial hypertension status in a subject for a differential diagnosis of neurodegenerative diseases including alzheimer's disease

Номер патента: WO2020216689A1. Автор: Romain VERPILLOT,Hervé THIRIEZ,Rudy BEAUJEAN. Владелец: Sas Alzohis. Дата публикации: 2020-10-29.

A diagnostic blood test method for the detection of alzheimer's disease

Номер патента: EP4185874A1. Автор: Anett Hudák,Tamás Letoha. Владелец: Pharmacoidea Kft. Дата публикации: 2023-05-31.

A diagnostic blood test method for the detection of alzheimer's disease

Номер патента: WO2022018468A1. Автор: Anett Hudák,Tamás Letoha. Владелец: Pharmacoidea Kft. Дата публикации: 2022-01-27.

Catecholamine concentrations in a blood sample and arterial hypertension status in a subject for a differential diagnosis of neurodegenerative diseases including alzheimer's disease

Номер патента: EP3959522A1. Автор: Romain VERPILLOT,Hervé THIRIEZ,Rudy BEAUJEAN. Владелец: Sas Alzohis. Дата публикации: 2022-03-02.

Methods and compositions for the diagnosis and prognosis of Alzheimer's disease

Номер патента: US09726678B2. Автор: Stephen Peter Fitzgerald,John V. Lamont,Paul Innocenzi,Massimiliano Corsi. Владелец: Randox Laboratories Ltd. Дата публикации: 2017-08-08.

Methods of diagnosing renal salt wasting syndrome and alzheimer's disease and methods of treating the same

Номер патента: US20010021508A1. Автор: John K. Maesaka. Владелец: Individual. Дата публикации: 2001-09-13.

Biomarkers of Alzheimer's Disease Progression

Номер патента: US20160252531A1. Автор: Morten Karsdal,Kim Henriksen. Владелец: Nordic Bioscience AS. Дата публикации: 2016-09-01.

Methods of diagnosing renal salt wasting syndrome and alzheimer's disease and methods of treating the same

Номер патента: EP1109929A1. Автор: John K. Apartment 11D MAESAKA. Владелец: Winthrop University Hospital. Дата публикации: 2001-06-27.

Methods of diagnosing renal salt wasting syndrome and alzheimer's disease and methods of treating the same

Номер патента: US20020197652A1. Автор: John Maesaka. Владелец: Winthrop University Hospital. Дата публикации: 2002-12-26.

Biomarkers and methods for determining risk factors for alzheimer's disease

Номер патента: EP3674711A3. Автор: Steven W. Graves,John S.K. Kauwe. Владелец: Individual. Дата публикации: 2020-10-28.

Diagnostic assay for alzheimer's disease

Номер патента: US20150212098A1. Автор: Richard O'Brien,Jennifer Van Eyk,Xiaogian Liu. Владелец: JOHNS HOPKINS UNIVERSITY. Дата публикации: 2015-07-30.

Detection of alzheimer's disease and other diseases using a photoaffinity labeling method

Номер патента: AU3324593A. Автор: Boyd E Haley. Владелец: University of Kentucky Research Foundation. Дата публикации: 1993-07-28.

Cellular markers for diagnosis of alzheimer's disease and for alzheimer's disease progression

Номер патента: EP2831584A1. Автор: Michal Eisenbach-Schwartz,Ester Yoles. Владелец: NEUROQUEST Ltd. Дата публикации: 2015-02-04.

Method of diagnosing on increased risk of alzheimer's disease

Номер патента: EP2718729A1. Автор: Matej Oresic,Hilkka Soininen,Tuulia HYÖTYLÄINEN. Владелец: Eastern Finland, University of. Дата публикации: 2014-04-16.

Biomarkers and differential diagnosis of alzheimer's disease and other neurodegenerative disorders

Номер патента: US20160363599A1. Автор: Edward J. Goetzl. Владелец: Nanosomix Inc. Дата публикации: 2016-12-15.

Diagnostic assay for Alzheimer's disease

Номер патента: US09678086B2. Автор: Richard O'Brien,Jennifer Van Eyk,Xiaogian Liu. Владелец: JOHNS HOPKINS UNIVERSITY. Дата публикации: 2017-06-13.

Methods for identifying and targeting the molecular subtypes of alzheimer's disease

Номер патента: US20230395255A1. Автор: Bin Zhang,Lap Ho,Ryan A NEFF,Vahram HAROUTUNIAN,Xianxiao ZHOU. Владелец: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. Дата публикации: 2023-12-07.

Methods, systems, and kits for prediction, detection, monitoring, and treatment of alzheimer's disease

Номер патента: EP4237857A1. Автор: Balwant RAI,Jasdeep Kaur. Владелец: Baseline Global Inc. Дата публикации: 2023-09-06.

Biomarkers for prediction, diagnosis, and monitoring of alzheimer's disease

Номер патента: US20170067913A1. Автор: Balwant RAI,Jasdeep Kaur. Владелец: Individual. Дата публикации: 2017-03-09.

Generating image-based biomarkers for alzheimer's disease and related dementias

Номер патента: EP4414998A1. Автор: Eli Gibson,Long Xie. Владелец: Siemens Healthineers AG. Дата публикации: 2024-08-14.

Generating image-based biomarkers for alzheimer's disease and related dementias

Номер патента: US20240273727A1. Автор: Eli Gibson,Long Xie. Владелец: Siemens Healthineers AG. Дата публикации: 2024-08-15.

Process for detection of alzheimer's disease from a serum sample

Номер патента: US9835621B2. Автор: Mark A. Lovell,Bert C. Lynn. Владелец: University of Kentucky Research Foundation. Дата публикации: 2017-12-05.

Fibroblast growth patterns for diagnosis of alzheimer's disease

Номер патента: CA2776501C. Автор: Daniel L. Alkon,Tapan Kumar Khan,Florin Valentin Chirila. Владелец: WEST VIRGINIA UNIVERSITY. Дата публикации: 2022-04-19.

A biomarker for alzheimer's disease using blood samples from clinically diagnosed alzheimer's disease subjects

Номер патента: US20220260595A1. Автор: Thomas Arendt,Elise Brownell,Herman Weiss,Paula TRZEPACZ,Gerald COMMISSIONG. Владелец: Todos Medical Ltd. Дата публикации: 2022-08-18.

Methods of diagnosing alzheimer's disease

Номер патента: CA2574825A1. Автор: Michael R. D'andrea. Владелец: Michael R. D'andrea. Дата публикации: 2006-02-09.

Methods of diagnosing alzheimer's disease

Номер патента: EP1776590A1. Автор: Michael R. D'andrea. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2007-04-25.

Protein Biomarkers for Alzheimer's Disease Detection

Номер патента: US20110091991A1. Автор: Chun-Chia Cheng,Shui-Cheng Lee,Shiau-Shiun Guan. Владелец: Institute of Nuclear Energy Research. Дата публикации: 2011-04-21.

Methods and kits for the differential diagnosis of Alzheimer's disease versus frontotemporal dementia and for the diagnosis of frontotemporal dementia, comprising FAS-L and CK 18 as biomarkers

Номер патента: US8753607B2. Автор: Manuela G. Neuman. Владелец: Individual. Дата публикации: 2014-06-17.

Methods of diagnosing alzheimer's disease

Номер патента: WO2006014876A1. Автор: Michael R. D'andrea. Владелец: Janssen Pharmaceutica N.V.. Дата публикации: 2006-02-09.

Methods and kits for the differential diagnosis of alzheimer's disease versus frontotemporal dementia, and for the diagnosis of frontotemporal dementia, comprising fas-l and ckl 18 as biomarkers

Номер патента: EP2279420A1. Автор: Manuela G. Neuman,Morris Freedman. Владелец: Individual. Дата публикации: 2011-02-02.

Methods and kits for the differential diagnosis of alzheimer's disease versus frontotemporal dementia, and for the diagnosis of frontotemporal dementia, comprising fas-l and ckl 18 as biomarkers

Номер патента: WO2009114945A9. Автор: Manuela G. Neuman,Morris Freedman. Владелец: Neuman Manuela G. Дата публикации: 2010-01-21.

Methods and kits for the differential diagnosis of Alzheimer's disease versus frontotemporal dementia and for the diagnosis of frontotemporal dementia, comprising FAS-L and CK 18 as biomarkers

Номер патента: US20120015381A1. Автор: Manuela G. Neuman. Владелец: Individual. Дата публикации: 2012-01-19.

Diagnostic biomarker profiles for the detection and diagnosis of alzheimer's disease

Номер патента: WO2013010003A1. Автор: Robert G. Nagele. Владелец: UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY. Дата публикации: 2013-01-17.

Non-invasive assessment of alzheimer's disease

Номер патента: US20240003918A1. Автор: Thomas H. Tulip,Michael Reitermann,Mathotaarachchilage Sulantha Sanjeewa MATHOTAARACHCHI. Владелец: Enigma Biointelligence Inc. Дата публикации: 2024-01-04.

Systems, assays, and methods for determining risk factors for Alzheimer's disease

Номер патента: US10761100B2. Автор: Steven W. Graves,John S. K. Kauwe, III. Владелец: BRIGHAM YOUNG UNIVERSITY. Дата публикации: 2020-09-01.

Methods for detecting alzheimer's disease

Номер патента: EP1869474A1. Автор: Doris Damian,Aram Adourian,Amir Handzel. Владелец: Bg Medicine Inc. Дата публикации: 2007-12-26.

Blood indicators of alzheimer's disease

Номер патента: WO2022168006A1. Автор: Paul Alan Cox,Sandra Anna BANACK. Владелец: The Institute for Ethnomedicine dba Brain Chemistry Labs. Дата публикации: 2022-08-11.

Non-invasive assessment of alzheimer's disease

Номер патента: EP4252243A2. Автор: Michael Reitermann,Thomas TULIP,Mathotaarachchilage S. S. MATHOTAARACHCHI. Владелец: Mathotaarachchi Mathotaarachchilage. Дата публикации: 2023-10-04.

Systems, Assays, and Methods for Determining Risk Factors for Alzheimer's Disease

Номер патента: US20170138964A1. Автор: Steven W. Graves,John S.K. Kauwe. Владелец: BRIGHAM YOUNG UNIVERSITY. Дата публикации: 2017-05-18.

Blood indicators of alzheimer's disease

Номер патента: EP4287941A1. Автор: Paul Alan Cox,Sandra Anna BANACK. Владелец: Institute For Ethnomedicine dba Brain Chemistry Labs. Дата публикации: 2023-12-13.

Blood indicators of alzheimer's disease

Номер патента: CA3207470A1. Автор: Paul Alan Cox,Sandra Anna BANACK. Владелец: Institute For Ethnomedicine dba Brain Chemistry Labs. Дата публикации: 2022-08-11.

Innovative blood platelets biomarker for early diagnosis of alzheimer's disease

Номер патента: US20120058573A1. Автор: Ricardo B. Maccioni,Gonzalo Farias. Владелец: Servicios Cientificos Neuroinnovation Ltda. Дата публикации: 2012-03-08.

Method for diagnosis of alzheimer's disease

Номер патента: EP1177447A1. Автор: Allen B. Reitz,Carlos R. Plata Salaman,Adrian Dawkes,Haou-Yan Wang. Владелец: Ortho McNeil Pharmaceutical Inc. Дата публикации: 2002-02-06.

Detection of Alzheimer's disease and other diseases using a photoaffinity labeling method

Номер патента: US5272055A. Автор: Boyd Haley. Владелец: University of Kentucky Research Foundation. Дата публикации: 1993-12-21.

Systems, assays, and methods for determining risk factors for alzheimer's disease

Номер патента: EP3164703A1. Автор: Steven W. Graves,John S.K. Kauwe. Владелец: Individual. Дата публикации: 2017-05-10.

Blood indicators of alzheimer's disease

Номер патента: AU2022216529A1. Автор: Paul Alan Cox,Sandra Anne Banack. Владелец: Inst For Ethnomedicine dba Brain Chemistry Labs. Дата публикации: 2023-08-17.

Methods for diagnosis and prognosis of alzheimer's disease

Номер патента: EP4332575A1. Автор: Cristina María PEDRERO PRIETO,Juan Ramón PEINADO MENA,Yoana RABANAL RUIZ. Владелец: UNIVERSIDAD DE CASTILLA LA MANCHA. Дата публикации: 2024-03-06.

Methods for monitoring disease progression of alzheimer's disease using csf markers from longitudinal samples

Номер патента: WO2008106076A3. Автор: Viswanath Devanarayan,Adam J Simon. Владелец: Adam J Simon. Дата публикации: 2008-11-20.

Diagnostic assay for alzheimer's disease

Номер патента: US5234814A. Автор: John P. Card,Leonard G. Davis,Robert G. Siman. Владелец: DuPont Merck Pharmaceutical Co. Дата публикации: 1993-08-10.

Use of Alzheimer's disease marker

Номер патента: CN105353135A. Автор: 刘璐,府伟灵,刘跃平,余抒. Владелец: First Affiliated Hospital of TMMU. Дата публикации: 2016-02-24.

METHOD FOR DETECTION OF PrP-INTERACTING Aβ OLIGOMERIC SPECIES IN BIOLOGICAL MATERIALS AS A DIAGNOSIS OF ALZHEIMER'S DISEASE

Номер патента: WO2013173699A3. Автор: Stephen M. Strittmatter,Mikhail KOSTYLEV. Владелец: YALE UNIVERSITY. Дата публикации: 2014-01-03.

Cell-Based Biosensor for Early Alzheimer's Disease Detection

Номер патента: US20210109080A1. Автор: Melissa A. Moss,Brittany E. Watson. Владелец: UNIVERSITY OF SOUTH CAROLINA. Дата публикации: 2021-04-15.

Mass spectrometry analysis of markers for alzheimer's disease

Номер патента: WO2024044763A1. Автор: Allan Levey,Duc Duong,James Lah,Nicholas Seyfried,Caroline WATSON. Владелец: EMORY UNIVERSITY. Дата публикации: 2024-02-29.

Specific salivary biomarkers for risk detection, early diagnosis, prognosis and monitoring of alzheimer's and parkinson's diseases

Номер патента: CA2877975C. Автор: Balwant RAI,Jasdeep Kaur. Владелец: Oasis Diagnostics Corp. Дата публикации: 2021-09-21.

Early-stage alzheimer's disease autoantibody biomarkers, target antigens and diagnostic uses thereof

Номер патента: US20200340990A1. Автор: Robert G. Nagele. Владелец: ROWAN UNIVERSITY. Дата публикации: 2020-10-29.

Use of anabolic steroids in the manufacture of a medicament for the treatment of senile dementia and Alzheimer's disease

Номер патента: DE3856017T2. Автор: Chaovanee Aroonsakul. Владелец: Individual. Дата публикации: 1998-04-23.

Diagnostic method for Alzheimer's disease

Номер патента: US09625474B2. Автор: Kaj Blennow,Tormod Fladby,Lisbeth Johnsen. Владелец: INVEN2 AS. Дата публикации: 2017-04-18.

Biosensor using cell that expresses chemosensory receptor that can detect sugar, and alzheimer's disease diagnostic apparatus comprising same

Номер патента: US09846166B2. Автор: Jeong Ok Lim,JEUNG SOO HUH,Won Ju Cho. Владелец: Industry Academic Cooperation Foundation of KNU. Дата публикации: 2017-12-19.

Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology

Номер патента: US6787318B1. Автор: Jun Tan,Terrence Town,Michael Mullan. Владелец: ROSKAMP RESEARCH INSTITUTE LLC. Дата публикации: 2004-09-07.

Cell cycle-based blood test to diagnose alzheimer's disease

Номер патента: WO2008003516A1. Автор: Thomas Arendt,Jens Stieler,F. Randall Grimes,William J. Gartner,Donald F. Weber. Владелец: Universität Leipzig. Дата публикации: 2008-01-10.

Biomarkers for alzheimer's disease

Номер патента: EP4370931A1. Автор: Reinhold Schmidt,Andrea Armirotti,Gianfranco SPALLETTA,Giuliana Ottonello,Pietro Franceschi. Владелец: FONDAZIONE SANTA LUCIA. Дата публикации: 2024-05-22.

Novel blood cell biomarker for late onset alzheimer's disease

Номер патента: US20230333091A1. Автор: Christopher Wheeler. Владелец: Cedars Sinai Medical Center. Дата публикации: 2023-10-19.

Deep learning and self-assembled-monolayer-based alzheimer's disease diagnosis method, and sers substrate therefor

Номер патента: EP4372759A1. Автор: Min Young Lee,Sungho Jo,Minjoon Kim,Yeonsik JUNG,Hyung Joon Park,Sejoon HUH. Владелец: Korea Institute of Materials Science KIMS. Дата публикации: 2024-05-22.

Alzheimer's disease diagnostic panels and methods for their use

Номер патента: US20150198618A1. Автор: Paul Edward Kearney,Xiao-jun LI. Владелец: Integrated Diagnostics Inc. Дата публикации: 2015-07-16.

Cell model for alzheimer's disease pathology

Номер патента: WO2008002620A3. Автор: George S Bloom,Michelle E King. Владелец: Michelle E King. Дата публикации: 2008-12-11.

Multiplexed biomarkers for monitoring the alzheimer's disease state of a subject

Номер патента: WO2006110621A3. Автор: Norman R. Relkin,Erin Finehout,Kelvin H. Lee. Владелец: Cornell Research Foundation, Inc.. Дата публикации: 2011-05-26.

Saposin d and fam3c are biomarkers for alzheimer's disease

Номер патента: US20090226897A1. Автор: Kaj Blennow,Huw Alun Davies,Anja Hviid Simonsen,James Norton Mcguire,Vladimir N. Podust. Владелец: Vermillion Inc. Дата публикации: 2009-09-10.

Methods and materials for identifying biomarkers and/or pathways associated with alzheimer's disease

Номер патента: WO2024015951A3. Автор: Sarah S. Bacus,Jeff Olson,Christopher A. Hamm. Владелец: Seq Biomarque, Llc. Дата публикации: 2024-04-04.

Treatment of vascular dysfunction and alzheimer's disease

Номер патента: EP1532258A4. Автор: Berislav V Zlokovic. Владелец: Socratech LLC. Дата публикации: 2006-11-02.

Method for diagnosing alzheimer's disease (AD)

Номер патента: US09625459B2. Автор: Frank Mattner,Walter Schmidt,Andreas Mairhofer,Achim Schneeberger,Martina LUTTEROVA,Guenther Staffler. Владелец: Affiris AG. Дата публикации: 2017-04-18.

Diagnostic assay for alzheimer's disease

Номер патента: CA2037105A1. Автор: Hossein A. Ghanbari,Peter Davies. Владелец: Individual. Дата публикации: 1991-08-27.

Lymphocyte-based morphometric test for alzheimer's disease

Номер патента: WO2018183703A1. Автор: Daniel L. Alkon,Florin Valentin Chirila. Владелец: NeuroDiagnostics LLC. Дата публикации: 2018-10-04.

Methods and kits for assessing alzheimer's disease

Номер патента: WO2023196927A1. Автор: Christopher Campbell,Martin Stengelin,Steven E. ARNOLD,Pia Kivisakk WEBB. Владелец: MESO SCALE TECHNOLOGIES, LLC.. Дата публикации: 2023-10-12.

Saposin d and fam3c are biomarkers for alzheimer's disease

Номер патента: EP1877416A2. Автор: Kaj Blennow,Huw Alun Davies,Anja Hviid Simonsen,James Norton Mcguire,Vladimir N. Podust. Владелец: Vermillion Inc. Дата публикации: 2008-01-16.

Multi-modality neural network for alzheimer's disease classifcation

Номер патента: US20240233945A1. Автор: Rishabh Sharma,Rachid Fahmi,Ludovic Sibille. Владелец: Siemens Medical Solutions USA Inc. Дата публикации: 2024-07-11.

G PROTEIN-COUPLED RECEPTOR ANTAGONIST AND ITS USE FOR PREVENTING AND TREATING ALZHEIMER'S DISEASE

Номер патента: US20120004254A1. Автор: Pei Gang,Ni Yanxiang,Zhao Xiaohui. Владелец: Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. Дата публикации: 2012-01-05.

METHODS FOR ASSESSING RISK OF ALZHEIMER'S DISEASE IN A PATIENT

Номер патента: US20120003649A1. Автор: Atwood Craig S.. Владелец: WISCONSIN ALUMNI RESEARCH FOUNDATION. Дата публикации: 2012-01-05.

Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders

Номер патента: MY135225A. Автор: WISCHIK Claude Michel,Harrington Charles Robert,Rickard Janet Elizabeth,Horsley David. Владелец: Wista Lab Ltd. Дата публикации: 2008-02-29.

Method for differential diagnosis of alzheimer's disease, vascular and mixed dementia

Номер патента: RU2578188C1. Автор: Степан Григорьевич Григорьев,Лидия Аркадьевна Алексеева,Владимир Юрьевич Лобзин,Андрей Юрьевич Емелин. Владелец: Федеральное государственное бюджетное военное образовательное учреждение высшего профессионального образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА). Дата публикации: 2016-03-20.

Medication for treating alzheimer's disease and method of treating alzheimer's disease

Номер патента: RU2542445C2. Автор: Олег Ильич Эпштейн. Владелец: Олег Ильич Эпштейн. Дата публикации: 2015-02-20.

Therapeutic agent for alzheimer's disease and method of treating alzheimer's disease

Номер патента: RU2536232C2. Автор: Олег Ильич Эпштейн. Владелец: Олег Ильич Эпштейн. Дата публикации: 2014-12-20.

Therapy of alzheimer's disease with using amyloid-beta peptide antibodies, and mixtures thereof

Номер патента: RU2353389C2. Автор: Арнон Розенталь,Джил ЛЕВКОВИЦ. Владелец: Ринат Ньюросайенс Корп.. Дата публикации: 2009-04-27.

Peptide with protective action against alzheimer's disease

Номер патента: RU2372355C1. Автор: Наталья Викторовна Бобкова,Татьяна Даниловна Волкова,Ольга Марковна Вольпина,Дмитрий Отарович Короев,Виктор Ионович Цетлин,Наталья Игоревна Медвинская,Ирина Юрьевна Александрова. Владелец: Учреждение Российской академии наук Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН. Дата публикации: 2009-11-10.

N'-(2-Chloro-6-Methylbenzoyl)-4-Methyl-3[2-(3-Quinolyl) Ethynyl]-Benzohydrazide for treatment of Alzheimer's disease.

Номер патента: OA21248A. Автор: Nitin Krishnaji Damle,Vikram Krishna Ramanathan,Shakti Kamalchand JAIN,Sanjay Nandlalhi MANDHANE,Durgesh Ashokkumar SONI. Владелец: SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED. Дата публикации: 2024-03-18.

Compounds for treatment of alzheimer's disease.

Номер патента: OA21243A. Автор: Robert Henk Henning,Guido Krenning,Adrianus Cornelis Van Der Graaf,Daniël Henri SWART,Pieter Cornelis VOGELAAR,Christina Françoise DE VEIJMESTDAGH. Владелец: SULFATEQ B.V.. Дата публикации: 2024-03-18.

Peptide for use in the treatment or prevention of alzheimer's disease

Номер патента: GB202004879D0. Автор: . Владелец: Ulmschneider Martin. Дата публикации: 2020-05-20.

Use of Medium Chain Triglycerides for the Treatment and Prevention of Alzheimer's Disease and Other Diseases Resulting from Reduced Neuronal Metabolism

Номер патента: US20120196932A1. Автор: . Владелец: ACCERA, INC.. Дата публикации: 2012-08-02.

Aspartic proteases, termed aspartyl protease 1 and 2 (ASP1 and ASP2) and gene variants thereof and their role in Alzheimer's disease

Номер патента: NZ517297A. Автор: Mark Gurney,Michael Jerome Bienkowski. Владелец: Upjohn Co. Дата публикации: 2004-04-30.

Method for diagnosis of alzheimer's disease

Номер патента: TWI622771B. Автор: 林佳靜,蔡澄偉. Владелец: 百威研發股份有限公司. Дата публикации: 2018-05-01.

KIT AND METHOD FOR THE PREMORTEM IN VITRO DETECTION OF ALZHEIMER'S DISEASE

Номер патента: US20120094308A1. Автор: Sanchez Ramos Celia. Владелец: UNIVERSIDAD COMPLUTENSE DE MADRID. Дата публикации: 2012-04-19.

NOVEL PEPTIDE FOR AUGMENTING AND EXPRESSION OF BDNF AND PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES INCLUDING ALZHEIMER'S DISEASE OR PARKINSON'S DISEASE, COMPRISING THE SAME

Номер патента: US20120208747A1. Автор: JUNG Woo Ram,Kim Kil Lyong,Kim Hong Gi,Park Dong Ik,Shin Min Kyoo. Владелец: SUNGYUNKWAN UNIVERSITY FOUNDATION FOR CORPORATE COLLABORATION. Дата публикации: 2012-08-16.

IMAGING AGENTS AND THEIR USE FOR THE DIAGNOSTIC IN VIVO OF NEURODEGENERATIVE DISEASES, NOTABLY ALZHEIMER'S DISEASE AND DERIVATIVE DISEASES

Номер патента: US20120263646A1. Автор: . Владелец: GUERBET. Дата публикации: 2012-10-18.

Compositions and methods for treating alzheimer's disease

Номер патента: WO2024192296A1. Автор: Ottavio Arancio,Luana Fioriti,Paul Edward FRASER. Владелец: Teh Trustees Of Columbia University In The City Of New York. Дата публикации: 2024-09-19.

Protein markers for mild cognitive impairment and alzheimer's disease

Номер патента: WO2024213092A1. Автор: Nancy Yuk-yu Ip,Kit Yu Fu,Yuanbing JIANG,Hyebin UHM,Chui Fun Fanny IP. Владелец: Hong Kong Center For Neurodegenerative Diseases Limited. Дата публикации: 2024-10-17.

Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease

Вам могут быть интересны следующие патенты

Главная

Проекты и услуги

Контакты